Source: Data as uploaded by States-UTs on HMIS portal, status as of 20 July 2018.
\\n\\n
More than half of the publishers listed alongside IntechOpen (18 out of 30) are Social Science and Humanities publishers. IntechOpen is an exception to this as a leader in not only Open Access content but Open Access content across all scientific disciplines, including Physical Sciences, Engineering and Technology, Health Sciences, Life Science, and Social Sciences and Humanities.
\\n\\nOur breakdown of titles published demonstrates this with 47% PET, 31% HS, 18% LS, and 4% SSH books published.
\\n\\n“Even though ItechOpen has shown the potential of sci-tech books using an OA approach,” other publishers “have shown little interest in OA books.”
\\n\\nAdditionally, each book published by IntechOpen contains original content and research findings.
\\n\\nWe are honored to be among such prestigious publishers and we hope to continue to spearhead that growth in our quest to promote Open Access as a true pioneer in OA book publishing.
\\n\\n\\n\\n
\\n"}]',published:!0,mainMedia:{caption:"IntechOpen Maintains",originalUrl:"/media/original/113"}},components:[{type:"htmlEditorComponent",content:'
Simba Information has released its Open Access Book Publishing 2020 - 2024 report and has again identified IntechOpen as the world’s largest Open Access book publisher by title count.
\n\nSimba Information is a leading provider for market intelligence and forecasts in the media and publishing industry. The report, published every year, provides an overview and financial outlook for the global professional e-book publishing market.
\n\nIntechOpen, De Gruyter, and Frontiers are the largest OA book publishers by title count, with IntechOpen coming in at first place with 5,101 OA books published, a good 1,782 titles ahead of the nearest competitor.
\n\nSince the first Open Access Book Publishing report published in 2016, IntechOpen has held the top stop each year.
\n\n\n\nMore than half of the publishers listed alongside IntechOpen (18 out of 30) are Social Science and Humanities publishers. IntechOpen is an exception to this as a leader in not only Open Access content but Open Access content across all scientific disciplines, including Physical Sciences, Engineering and Technology, Health Sciences, Life Science, and Social Sciences and Humanities.
\n\nOur breakdown of titles published demonstrates this with 47% PET, 31% HS, 18% LS, and 4% SSH books published.
\n\n“Even though ItechOpen has shown the potential of sci-tech books using an OA approach,” other publishers “have shown little interest in OA books.”
\n\nAdditionally, each book published by IntechOpen contains original content and research findings.
\n\nWe are honored to be among such prestigious publishers and we hope to continue to spearhead that growth in our quest to promote Open Access as a true pioneer in OA book publishing.
\n\n\n\n
\n'}],latestNews:[{slug:"intechopen-supports-asapbio-s-new-initiative-publish-your-reviews-20220729",title:"IntechOpen Supports ASAPbio’s New Initiative Publish Your Reviews"},{slug:"webinar-introduction-to-open-science-wednesday-18-may-1-pm-cest-20220518",title:"Webinar: Introduction to Open Science | Wednesday 18 May, 1 PM CEST"},{slug:"step-in-the-right-direction-intechopen-launches-a-portfolio-of-open-science-journals-20220414",title:"Step in the Right Direction: IntechOpen Launches a Portfolio of Open Science Journals"},{slug:"let-s-meet-at-london-book-fair-5-7-april-2022-olympia-london-20220321",title:"Let’s meet at London Book Fair, 5-7 April 2022, Olympia London"},{slug:"50-books-published-as-part-of-intechopen-and-knowledge-unlatched-ku-collaboration-20220316",title:"50 Books published as part of IntechOpen and Knowledge Unlatched (KU) Collaboration"},{slug:"intechopen-joins-the-united-nations-sustainable-development-goals-publishers-compact-20221702",title:"IntechOpen joins the United Nations Sustainable Development Goals Publishers Compact"},{slug:"intechopen-signs-exclusive-representation-agreement-with-lsr-libros-servicios-y-representaciones-s-a-de-c-v-20211123",title:"IntechOpen Signs Exclusive Representation Agreement with LSR Libros Servicios y Representaciones S.A. de C.V"},{slug:"intechopen-expands-partnership-with-research4life-20211110",title:"IntechOpen Expands Partnership with Research4Life"}]},book:{item:{type:"book",id:"10728",leadTitle:null,fullTitle:"Blood Groups - More than Inheritance of Antigenic Substances",title:"Blood Groups",subtitle:"More than Inheritance of Antigenic Substances",reviewType:"peer-reviewed",abstract:"Every cell in our body including red blood cells is covered with special markers called antigens, a substance that triggers the immune system response. Millions of antigens are present on the membrane of red blood cells and are ignored by the immune system because they are self-antigens. However, if a person receives a transfusion of blood that contains different antigens from their own blood, there will be a severe and immediate attack by the cells of the immune system. Therefore, it is important to use the patient’s same blood group for the transfusion. The blood group antigens not only perform a critical role in the function of cells but can also be used by viruses to gain access into the cells. This book includes nine chapters on different blood group antigens and their activities behind the scenes. Chapters address blood antigens and their association with cardiovascular diseases, thromboembolic diseases, malaria, and many other diseases and infections.",isbn:"978-1-83969-903-0",printIsbn:"978-1-83969-902-3",pdfIsbn:"978-1-83969-904-7",doi:null,price:119,priceEur:129,priceUsd:155,slug:"blood-groups-more-than-inheritance-of-antigenic-substances",numberOfPages:144,isOpenForSubmission:!1,isInWos:null,isInBkci:!1,hash:"b5e79b54a382651f3130c9ee5ab862b4",bookSignature:"Kaneez Fatima Shad",publishedDate:"August 17th 2022",coverURL:"https://cdn.intechopen.com/books/images_new/10728.jpg",numberOfDownloads:415,numberOfWosCitations:0,numberOfCrossrefCitations:0,numberOfCrossrefCitationsByBook:null,numberOfDimensionsCitations:0,numberOfDimensionsCitationsByBook:null,hasAltmetrics:0,numberOfTotalCitations:0,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"May 10th 2021",dateEndSecondStepPublish:"June 7th 2021",dateEndThirdStepPublish:"August 6th 2021",dateEndFourthStepPublish:"October 25th 2021",dateEndFifthStepPublish:"December 24th 2021",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6",editedByType:"Edited by",kuFlag:!1,featuredMarkup:null,editors:[{id:"31988",title:"Prof.",name:"Kaneez",middleName:null,surname:"Fatima Shad",slug:"kaneez-fatima-shad",fullName:"Kaneez Fatima Shad",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRhwqQAC/Profile_Picture_1643703122186",biography:"Professor Kaneez Fatima Shad, an Australian neuroscientist with a medical background, obtained a Ph.D. from the Faculty of Medicine, University of New South Wales (UNSW), Australia, in 1994, followed by a postdoc at the Allegheny University of Health Sciences, Philadelphia, USA. She taught medical and biological sciences at various universities in Australia, the United States, United Arab Emirates, Bahrain, Pakistan, and Brunei. During this period, she was also engaged in research by obtaining local and international grants (a total of more than $3 million USD) and developing products such as a rapid diagnostic test for stroke and other vascular disorders (i.e., schizophrenia). She has published more than sixty-eight articles in refereed journals, edited nine books, authored ten book chapters, presented at more than ninety international conferences, and mentored thirty-four postgraduate students. She is an international mentor and a protocol development specialist.",institutionString:"University of Technology Sydney",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"7",totalChapterViews:"0",totalEditedBooks:"8",institution:{name:"University of Technology Sydney",institutionURL:null,country:{name:"Australia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"183",title:"Hematology",slug:"hematology"}],chapters:[{id:"78884",title:"Are ABO Gene Alleles Responsible for Cardiovascular Diseases and Venous Thromboembolism and Do They Play a Role in COVID?",doi:"10.5772/intechopen.100479",slug:"are-abo-gene-alleles-responsible-for-cardiovascular-diseases-and-venous-thromboembolism-and-do-they-",totalDownloads:107,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Cardiovascular diseases (CVD) including coronary heart disease and stroke are leading causes of death and disability globally. Studies of the association between ABO blood groups and CVD have consistently demonstrated an increased risk of coronary heart disease, myocardial infarction, cerebral ischaemic stroke, peripheral arterial disease and venous thromboembolism (VTE) including deep vein thrombosis and pulmonary thromboembolism in patients who possess a non-O blood group type. The most likely mechanism is thought to be the increase in von Willebrand Factor (vWF) and factor VIII levels seen in patients with a non-O blood group. Other postulated mechanisms include elevations in circulating inflammatory markers such as endothelial cell and platelet adhesion molecules in subjects with a non-O blood group. More recently, it has also been recognised that individuals with a non-O blood group type carry a higher risk of SARS-C0V-2 infection and COVID-19 related complications. The increased levels in vWF and factor VIII amongst individuals with a non-O blood group who have contracted SARS-CoV-2 infection may result in an additive thrombophilic effect to that caused by the SARS-CoV-2 virus. Another postulated mechanism is that individuals with an O-blood group are protected by anti-A and B antibodies which possibly inhibit the binding of the SARS-CoV-2 spike protein to lung epithelium angiotensin converting enzyme-2 receptors. There are over 35 minor blood groups on red blood cells, some of which such as Kidd, Lewis and Duffy have been associated with CVD either alone or in combination with a non-O blood group allele(s). However, their role in SARS-CoV-2 infection and mechanism of action for an association with CVD remain unknown. This review explores the relationship between ABO and minor blood groups with CVD and VTE, with a focus on potential mechanisms underlying this relationship and the potential role of ABO blood group types in COVID.",signatures:"Dennis J. Cordato, Wissam Soubra, Sameer Saleem and Kaneez Fatima Shad",downloadPdfUrl:"/chapter/pdf-download/78884",previewPdfUrl:"/chapter/pdf-preview/78884",authors:[{id:"31988",title:"Prof.",name:"Kaneez",surname:"Fatima Shad",slug:"kaneez-fatima-shad",fullName:"Kaneez Fatima Shad"},{id:"429558",title:"Dr.",name:"Sameer",surname:"Saleem",slug:"sameer-saleem",fullName:"Sameer Saleem"},{id:"429559",title:"Dr.",name:"Wissam",surname:"Soubra",slug:"wissam-soubra",fullName:"Wissam Soubra"},{id:"429560",title:"Prof.",name:"Dennis J.",surname:"Cordato",slug:"dennis-j.-cordato",fullName:"Dennis J. Cordato"}],corrections:null},{id:"80396",title:"Human Blood",doi:"10.5772/intechopen.102293",slug:"human-blood",totalDownloads:0,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"The human blood is composed of 3 layers of humors when separated into its different components. The component that is clear, slightly yellow (plasma), the whitish viscous-like (buffy coat) and the red fluid (red cells). The plasma component is composed of proteins; however, it will not be discussed in this chapter. The buffy coat is composed of white blood cells and platelets. The white blood cells are composed of granulocytes and agranulocytes; all of which take part in immune defense. The granulocytes, including monocytes have non-specific immune response while agranulocytes, which include B and T cells have specific immune response. The platelets function to help maintain normal hemostasis during vascular injury. Blood group antigens are found on the surface of red cells and are composed of proteins, carbohydrates and lipids. They are mostly inherited on autosomes with the exception of two which have been found to be inherited on the X chromosomes. With the advance of technology, some of their physiological functional roles have been elucidated. These include; structural integrity, cationic exchange, transporters, adhesion and receptor functions, and cell to cell communication. However, these mechanisms have been capitalized by infectious agents to gain entry to the human body causing disease.",signatures:"Francisca Varpit and Vela Galama",downloadPdfUrl:"/chapter/pdf-download/80396",previewPdfUrl:"/chapter/pdf-preview/80396",authors:[{id:"420760",title:"M.Sc.",name:"Francisca",surname:"Varpit",slug:"francisca-varpit",fullName:"Francisca Varpit"},{id:"445476",title:"Mr.",name:"Vela",surname:"Galama",slug:"vela-galama",fullName:"Vela Galama"}],corrections:null},{id:"80474",title:"ABO Blood Group and Thromboembolic Diseases",doi:"10.5772/intechopen.102757",slug:"abo-blood-group-and-thromboembolic-diseases",totalDownloads:49,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Thromboembolic diseases are usually inherited in the family. The tendency to repeat in an individual is a phenomenon that allows it to be studied. The inheritance and recurrence of thromboembolic diseases, of course, have individual risk factors for this occurrence. In the past, the ABO blood group was only needed for transfusion and organ transplant therapy. Over time, scientists think that blood type is a risk factor for certain diseases, including thromboembolism. Many studies divide between type O and non-O blood groups, both of which are distinguished by the presence of antigens on the cell surface and antibodies in the plasma of individuals. Type O does not have A, B antigens but has antibodies against A, B antigens, and vice versa for the non-O type. Many studies have shown that the non-O blood group has a risk factor for thromboembolic diseases, commonly due to higher levels of von Willebrand factor (VWF) and factor VIII (FVIII). These thromboembolic events can occur in arteries or venous. Thromboembolic manifestations are often associated with cardiovascular diseases for arterial thrombosis; and deep vein thrombosis (DVT) and pulmonary embolism (PE) for venous thromboembolism (VTE).",signatures:"Yetti Hernaningsih",downloadPdfUrl:"/chapter/pdf-download/80474",previewPdfUrl:"/chapter/pdf-preview/80474",authors:[{id:"421251",title:"Associate Prof.",name:"Yetti",surname:"Hernaningsih",slug:"yetti-hernaningsih",fullName:"Yetti Hernaningsih"}],corrections:null},{id:"80136",title:"Duffy Antigens and Malaria: The African Experience",doi:"10.5772/intechopen.102014",slug:"duffy-antigens-and-malaria-the-african-experience",totalDownloads:1,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"The Duffy blood group antigen is also known as Duffy Antigen Receptor for Chemokines (DARC) serves more functions than just a blood group antigen for serological reactions. It is a receptor for pro-inflammatory chemokines and Plasmodium vivax invasion of the red blood cells. A point mutation in the promoter region of the Duffy gene disrupts the binding of a transcription factor, leading to a lack of expression of the antigen on the erythrocytes. This Duffy negative phenotype is found predominantly in the African population. This mutation is advantageous as individuals with the Fy(a-b-) phenotype are less susceptible to P. vivax malaria. Malaria is caused by plasmodium parasites and it is endemic in Africa, where it is one of the leading causes of morbidity and mortality. It is believed that the absence of Duffy antigen in most Africans contributed to the resistance to P. vivax and by extension, reduced the burden of malaria in these endemic areas.",signatures:"Chima Akunwata",downloadPdfUrl:"/chapter/pdf-download/80136",previewPdfUrl:"/chapter/pdf-preview/80136",authors:[{id:"422020",title:"Dr.",name:"Chima",surname:"Akunwata",slug:"chima-akunwata",fullName:"Chima Akunwata"}],corrections:null},{id:"82161",title:"Blood Groups: More than Inheritance of Antigenic Substances - Susceptibility to Some Diseases",doi:"10.5772/intechopen.104593",slug:"blood-groups-more-than-inheritance-of-antigenic-substances-susceptibility-to-some-diseases",totalDownloads:12,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Blood group antigens represent polymorphic traits inherited among individuals and populations. The objective of this chapter is to review articles that have reported; the association between blood group antigens and susceptibility to some diseases. Findings showed that O blood group had a greater frequency of severe infections such as E coli, cholera and blood group A was associated with incidence of smallpox and some bacterial infections. These are principally based on presence or absence of “H-like” and “A and B-like” antigens markers. Antigens A, B and H are connected to N-glycans of vWF and reduces the half-life of the protein (10 hours) for group O while non-O groups, 25 hours. The loss of A, B, and H antigens as malignancy progresses was linked to potential metastasis. Similarly, some tumors have A or A-like antigens this explains the propensity of group A to develop tumors. Blood type incompatibility between mother and foetus sensitizes the mother to develop alloantibodies that could potentially cause death of the foetus in utero, a condition known hydrops. Reviewed articles have reported close link between blood group antigens and susceptibility diseases. More studies are required to rationalize the mechanism associated to this.",signatures:"Williams Bitty Azachi and Kuschak Mathias Dakop",downloadPdfUrl:"/chapter/pdf-download/82161",previewPdfUrl:"/chapter/pdf-preview/82161",authors:[{id:"422796",title:"M.Sc.",name:"Williams",surname:"Bitty Azachi",slug:"williams-bitty-azachi",fullName:"Williams Bitty Azachi"},{id:"463736",title:"Dr.",name:"Kuschak",surname:"Mathias Dakop",slug:"kuschak-mathias-dakop",fullName:"Kuschak Mathias Dakop"}],corrections:null},{id:"80344",title:"RH Groups",doi:"10.5772/intechopen.102421",slug:"rh-groups",totalDownloads:30,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:1,abstract:"In 1939, a mother gave birth to a stillborn baby and underwent blood transfusion with ABO-matched blood from her husband. This resulted in a hemolytic transfusion reaction (HTR). Levine and Stetson postulated that a novel antigen was present in the baby and father, which was absent in the mother. Therefore, the mother’s immune system recognized this antigen and produced antibodies against it. This condition has been known as the hemolytic disease of the newborn for a long period of time. Since the antenatal management of the fetus has been developed, the term has been modified to hemolytic disease of the fetus and newborn (HDFN). This case led to the discovery of the antibody against the first antigen of the RH blood group system, the D antigen. To date, 56 antigens have been recognized within the RH blood group system. The five main antigens are D, C, c, E, and e. As observed in the above-mentioned case, the antibodies against these antigens are implicated in HTR and HDFN.",signatures:"Amr J. Halawani",downloadPdfUrl:"/chapter/pdf-download/80344",previewPdfUrl:"/chapter/pdf-preview/80344",authors:[{id:"418311",title:"Assistant Prof.",name:"Amr J.",surname:"Halawani",slug:"amr-j.-halawani",fullName:"Amr J. Halawani"}],corrections:null},{id:"80254",title:"Neutrophil-Specific Antigens: Immunobiology, Genetics and Roles in Clinical Disorders",doi:"10.5772/intechopen.102431",slug:"neutrophil-specific-antigens-immunobiology-genetics-and-roles-in-clinical-disorders",totalDownloads:48,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Neutrophils are the most abundant nucleated cells in blood circulation and play important roles in the innate and adaptive immune responses. Neutrophil-specific antigens, only expressed on neutrophils, are glycoproteins originally identified in studies on neonatal neutropenia due to fetal-maternal incompatibility and autoimmune neutropenia of infancy. The most investigated neutrophil–specific antigens are the NA and NB antigens that their incompatibilities also cause transfusion-induced febrile reactions and acute lung injury, a potentially fatal reaction, and in bone marrow transplantation, causing graft rejection. NA antigens are members of the immunoglobulin superfamily and are low-affinity Fc-receptors FcγRIIIb (CD16b). Fc receptors connect the F(ab), the antigen-binding fragment of the antibody molecules, to neutrophils and lead them to recognize and phagocytize the targeted antigens. The NB (CD177) antigen belongs to the urokinase-type Plasminogen Activator Receptor Superfamily (uPAR, CD59, Ly6), but its specific functions have not been fully determined. It is known, however, that NB antigen binds proteinase-3 (PR3 to the neutrophil membrane), a serine protease. In clinical studies, it was also demonstrated that NB expression is highly elevated in Polycythemia Vera and is unexpectedly expressed in some cancer tissues. Neutrophil-specific antigens are examples of antigens that have important biological and clinical activities beyond antigenicity.",signatures:"Parviz Lalezari and Behnaz Bayat",downloadPdfUrl:"/chapter/pdf-download/80254",previewPdfUrl:"/chapter/pdf-preview/80254",authors:[{id:"437700",title:"Dr.",name:"Parviz",surname:"Lalezari",slug:"parviz-lalezari",fullName:"Parviz Lalezari"},{id:"438437",title:"Dr.",name:"Behnaz",surname:"Bayat",slug:"behnaz-bayat",fullName:"Behnaz Bayat"}],corrections:null},{id:"80716",title:"The ABO Blood Group System and Plasmodium falciparum (Pf ) Infection in Three Ethnic Groups Living in the Stable and Seasonal Malaria Transmission Areas of Burkina Faso (BF)",doi:"10.5772/intechopen.102475",slug:"the-abo-blood-group-system-and-em-plasmodium-falciparum-em-em-pf-em-infection-in-three-ethnic-groups",totalDownloads:104,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:1,abstract:"Genetic factors, including red blood cell polymorphisms, influence the severity of disease due to infection with Plasmodium falciparum (Pf). Studies show that these genetic factors associated with malaria susceptibility or resistance vary geographically, ethnically, and racially. We performed cross-sectional surveys in population living in rural villages from three ethnic groups. The blood group (BG) was determined genetically using two polymorphisms (rs8176719 and rs8176746). Out of 548 participants, 29.7% were Mossi, 38.2% were Fulani, and 32.1% were Rimaibe. The distribution of BG was, respectively, A: 25.5%, B: 26.6%, AB: 7.3%, and O: 40.5%. BG O was not only the common blood type overall, but was higher in Fulani (52.6%) than others. Fulani was associated with a reduced risk of infection and lower parasite densities than sympatric populations. The subjects with non-O blood were less susceptible to malaria infection. An association between ethnicity and malaria infection during the high transmission season as well as an association between the non-O blood group and malaria infections according to ethnicity was found. This was also true when ethnic groups were considered separately. Our results have demonstrated that the Fulani are not only less susceptible to Pf malaria infection, but when infected have lower parasite densities. Individuals with non-O blood are at lower risk of infection.",signatures:"Edith Christiane Bougouma, Alphonse Ouedraogo and Sodiomon Bienvenu Sirima",downloadPdfUrl:"/chapter/pdf-download/80716",previewPdfUrl:"/chapter/pdf-preview/80716",authors:[{id:"319317",title:"Dr.",name:"Edith",surname:"Bougouma",slug:"edith-bougouma",fullName:"Edith Bougouma"},{id:"319864",title:"Dr.",name:"Sodiomon Bienvenu",surname:"Sirima",slug:"sodiomon-bienvenu-sirima",fullName:"Sodiomon Bienvenu Sirima"},{id:"436448",title:"Dr.",name:"Alphonse",surname:"Ouedraogo",slug:"alphonse-ouedraogo",fullName:"Alphonse Ouedraogo"}],corrections:null},{id:"78997",title:"ABO Blood Groups and Risk of Glioma",doi:"10.5772/intechopen.100566",slug:"abo-blood-groups-and-risk-of-glioma",totalDownloads:67,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Gliomas are one of the most common primary brain tumors and the etiology of gliomas remains unknown in most cases. The aim of this case–control study was to investigate possible association between incidence in relation to glioma and certain blood groups. This study included 100 histopathologically verified cases of glioma and 200 age and sex-matched controls without malignant diseases that were admitted to the same hospital. The results revealed that the patients with group AB were at 3.5-fold increased risk of developing glioma compared to the patients with other ABO blood groups. In this particular study, there was more male patients with glioma with the blood group AB. However, mechanisms that explain the relationship between the blood groups ABO and a cancer risk are unclear. Several hypotheses have been proposed, including the one with a modulatory role of blood group ABO antigens. In addition, the blood group ABO system regulates the level of circulating proinflammatory and adhesion molecules which play a significant role in the tumorigenesis process. Additionally, the recent discovery that includes the von Willebrand factor (vWF) as an important modulator of angiogenesis and apoptosis provides one plausible explanation as regards the role of the blood group ABO in the tumorigenesis process. To our knowledge, this is the first study that examined the relationship of blood group in patients diagnosed with glioma among the Serbian population. Moreover, for the first time our study results suggested that blood group AB increased the risk of glioma. The results of this study suggested that the blood group AB could be one of hereditary factors which had an influence on the occurrence of glioma. The further research is needed on a larger sample, to confirm these findings and the possible mechanisms by which the ABO system contributes to the pathology of glioma.",signatures:"Ana Azanjac Arsic",downloadPdfUrl:"/chapter/pdf-download/78997",previewPdfUrl:"/chapter/pdf-preview/78997",authors:[{id:"419461",title:"Associate Prof.",name:"Ana",surname:"Azanjac Arsic",slug:"ana-azanjac-arsic",fullName:"Ana Azanjac Arsic"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},subseries:null,tags:null},relatedBooks:[{type:"book",id:"1624",title:"Patch Clamp Technique",subtitle:null,isOpenForSubmission:!1,hash:"24164a2299d5f9b1a2ef1c2169689465",slug:"patch-clamp-technique",bookSignature:"Fatima Shad Kaneez",coverURL:"https://cdn.intechopen.com/books/images_new/1624.jpg",editedByType:"Edited by",editors:[{id:"31988",title:"Prof.",name:"Kaneez",surname:"Fatima Shad",slug:"kaneez-fatima-shad",fullName:"Kaneez Fatima Shad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5780",title:"Serotonin",subtitle:"A Chemical Messenger Between All Types of Living Cells",isOpenForSubmission:!1,hash:"5fe2c461c95b4ee2d886e30b89d71723",slug:"serotonin-a-chemical-messenger-between-all-types-of-living-cells",bookSignature:"Kaneez Fatima Shad",coverURL:"https://cdn.intechopen.com/books/images_new/5780.jpg",editedByType:"Edited by",editors:[{id:"31988",title:"Prof.",name:"Kaneez",surname:"Fatima Shad",slug:"kaneez-fatima-shad",fullName:"Kaneez Fatima Shad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1359",title:"Underlying Mechanisms of Epilepsy",subtitle:null,isOpenForSubmission:!1,hash:"85f9b8dac56ce4be16a9177c366e6fa1",slug:"underlying-mechanisms-of-epilepsy",bookSignature:"Fatima Shad Kaneez",coverURL:"https://cdn.intechopen.com/books/images_new/1359.jpg",editedByType:"Edited by",editors:[{id:"31988",title:"Prof.",name:"Kaneez",surname:"Fatima Shad",slug:"kaneez-fatima-shad",fullName:"Kaneez Fatima Shad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6683",title:"Ion Channels in Health and Sickness",subtitle:null,isOpenForSubmission:!1,hash:"8b02f45497488912833ba5b8e7cdaae8",slug:"ion-channels-in-health-and-sickness",bookSignature:"Kaneez Fatima Shad",coverURL:"https://cdn.intechopen.com/books/images_new/6683.jpg",editedByType:"Edited by",editors:[{id:"31988",title:"Prof.",name:"Kaneez",surname:"Fatima Shad",slug:"kaneez-fatima-shad",fullName:"Kaneez Fatima Shad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7842",title:"Basic and Clinical Understanding of Microcirculation",subtitle:null,isOpenForSubmission:!1,hash:"a57d5a701b51d9c8e17b1c80bc0d52e5",slug:"basic-and-clinical-understanding-of-microcirculation",bookSignature:"Kaneez Fatima Shad, Seyed Soheil Saeedi Saravi and Nazar Luqman Bilgrami",coverURL:"https://cdn.intechopen.com/books/images_new/7842.jpg",editedByType:"Edited by",editors:[{id:"31988",title:"Prof.",name:"Kaneez",surname:"Fatima Shad",slug:"kaneez-fatima-shad",fullName:"Kaneez Fatima Shad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9489",title:"Neurological and Mental Disorders",subtitle:null,isOpenForSubmission:!1,hash:"3c29557d356441eccf59b262c0980d81",slug:"neurological-and-mental-disorders",bookSignature:"Kaneez Fatima Shad and Kamil Hakan Dogan",coverURL:"https://cdn.intechopen.com/books/images_new/9489.jpg",editedByType:"Edited by",editors:[{id:"31988",title:"Prof.",name:"Kaneez",surname:"Fatima Shad",slug:"kaneez-fatima-shad",fullName:"Kaneez Fatima Shad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10494",title:"Erythrocyte",subtitle:"A Peripheral Biomarker For Infection and Inflammation",isOpenForSubmission:!1,hash:"fa5f4b6ef59e28b6e7c1a739c57c5d2f",slug:"erythrocyte-a-peripheral-biomarker-for-infection-and-inflammation",bookSignature:"Kaneez Fatima Shad",coverURL:"https://cdn.intechopen.com/books/images_new/10494.jpg",editedByType:"Edited by",editors:[{id:"31988",title:"Prof.",name:"Kaneez",surname:"Fatima Shad",slug:"kaneez-fatima-shad",fullName:"Kaneez Fatima Shad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7181",title:"Erythrocyte",subtitle:null,isOpenForSubmission:!1,hash:"267d215004c995048557176978208b15",slug:"erythrocyte",bookSignature:"Anil Tombak",coverURL:"https://cdn.intechopen.com/books/images_new/7181.jpg",editedByType:"Edited by",editors:[{id:"202814",title:"Associate Prof.",name:"Anil",surname:"Tombak",slug:"anil-tombak",fullName:"Anil Tombak"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6634",title:"Homeostasis",subtitle:"An Integrated Vision",isOpenForSubmission:!1,hash:"3731dfa513781db054545963a4394938",slug:"homeostasis-an-integrated-vision",bookSignature:"Fernanda Lasakosvitsch and Sergio Dos Anjos Garnes",coverURL:"https://cdn.intechopen.com/books/images_new/6634.jpg",editedByType:"Edited by",editors:[{id:"117630",title:"Dr.",name:"Fernanda",surname:"Lasakosvitsch Castanho",slug:"fernanda-lasakosvitsch-castanho",fullName:"Fernanda Lasakosvitsch Castanho"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6273",title:"Thrombocytopenia",subtitle:null,isOpenForSubmission:!1,hash:"182f67f8c83b1d8897447f05207feae9",slug:"thrombocytopenia",bookSignature:"Pankaj Abrol",coverURL:"https://cdn.intechopen.com/books/images_new/6273.jpg",editedByType:"Edited by",editors:[{id:"90782",title:"Dr.",name:"Pankaj",surname:"Abrol",slug:"pankaj-abrol",fullName:"Pankaj Abrol"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"79356",slug:"erratum-covid-19-transmission-in-children-implications-for",title:"Erratum: COVID-19 Transmission in Children: Implications for Schools",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/78823.pdf",downloadPdfUrl:"/chapter/pdf-download/78823",previewPdfUrl:"/chapter/pdf-preview/78823",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/78823",risUrl:"/chapter/ris/78823",chapter:{id:"77986",slug:"covid-19-transmission-in-children-implications-for-schools",signatures:"Evelyn Mendoza-Torres, Franklin Torres, Wendy Rosales-Rada, Liliana Encinales, Lil Avendaño, María Fernanda Pérez, Ivana Terán, David Vergara, Estefanie Osorio-Llanes, Paige Fierbaugh, Wendy Villamizar, Aileen Y. Chang and Jairo Castellar-Lopez",dateSubmitted:"June 15th 2021",dateReviewed:"July 12th 2021",datePrePublished:"September 13th 2021",datePublished:"March 16th 2022",book:{id:"10707",title:"Primary Health Care",subtitle:null,fullTitle:"Primary Health Care",slug:"primary-health-care",publishedDate:"March 16th 2022",bookSignature:"Ayşe Emel Önal",coverURL:"https://cdn.intechopen.com/books/images_new/10707.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"25840",title:"Prof.",name:"Ayse Emel",middleName:null,surname:"Onal",slug:"ayse-emel-onal",fullName:"Ayse Emel Onal"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"342716",title:"Assistant Prof.",name:"Aileen",middleName:null,surname:"Y. Chang",fullName:"Aileen Y. Chang",slug:"aileen-y.-chang",email:"chang@email.gwu.edu",position:null,institution:null},{id:"342718",title:"Dr.",name:"Evelyn",middleName:null,surname:"Mendoza-Torres",fullName:"Evelyn Mendoza-Torres",slug:"evelyn-mendoza-torres",email:"evelyn.mendozat@unilibre.edu.co",position:null,institution:{name:"Free University of Colombia",institutionURL:null,country:{name:"Colombia"}}},{id:"427633",title:"Dr.",name:"Franklin",middleName:null,surname:"Torres",fullName:"Franklin Torres",slug:"franklin-torres",email:"dummy+427633@intechopen.com",position:null,institution:null},{id:"427634",title:"Dr.",name:"Wendy",middleName:null,surname:"Rosales-Rada",fullName:"Wendy Rosales-Rada",slug:"wendy-rosales-rada",email:"dummy+427634@intechopen.com",position:null,institution:null},{id:"427635",title:"Dr.",name:"Liliana",middleName:null,surname:"Encinales",fullName:"Liliana Encinales",slug:"liliana-encinales",email:"dummy+427635@intechopen.com",position:null,institution:null},{id:"427636",title:"Dr.",name:"Lil",middleName:null,surname:"Avendaño",fullName:"Lil Avendaño",slug:"lil-avendano",email:"dummy+427636@intechopen.com",position:null,institution:null},{id:"427637",title:"Dr.",name:"María Fernanda",middleName:null,surname:"Pérez",fullName:"María Fernanda Pérez",slug:"maria-fernanda-perez",email:"dummy+427637@intechopen.com",position:null,institution:null},{id:"427638",title:"Dr.",name:"Ivana",middleName:null,surname:"Terán",fullName:"Ivana Terán",slug:"ivana-teran",email:"dummy+427638@intechopen.com",position:null,institution:null},{id:"427639",title:"Dr.",name:"David",middleName:null,surname:"Vergara",fullName:"David Vergara",slug:"david-vergara",email:"dummy+427639@intechopen.com",position:null,institution:null},{id:"427640",title:"Dr.",name:"Estefanie",middleName:null,surname:"Osorio-Llanes",fullName:"Estefanie Osorio-Llanes",slug:"estefanie-osorio-llanes",email:"dummy+427640@intechopen.com",position:null,institution:null},{id:"427641",title:"Dr.",name:"Paige",middleName:null,surname:"Fierbaugh",fullName:"Paige Fierbaugh",slug:"paige-fierbaugh",email:"dummy+427641@intechopen.com",position:null,institution:null},{id:"427642",title:"Dr.",name:"Wendy",middleName:null,surname:"Villamizar",fullName:"Wendy Villamizar",slug:"wendy-villamizar",email:"dummy+427642@intechopen.com",position:null,institution:null},{id:"457495",title:"Dr.",name:"Jairo",middleName:null,surname:"Castellar-Lopez",fullName:"Jairo Castellar-Lopez",slug:"jairo-castellar-lopez",email:"dummy+427643@intechopen.com",position:null,institution:null}]}},chapter:{id:"77986",slug:"covid-19-transmission-in-children-implications-for-schools",signatures:"Evelyn Mendoza-Torres, Franklin Torres, Wendy Rosales-Rada, Liliana Encinales, Lil Avendaño, María Fernanda Pérez, Ivana Terán, David Vergara, Estefanie Osorio-Llanes, Paige Fierbaugh, Wendy Villamizar, Aileen Y. Chang and Jairo Castellar-Lopez",dateSubmitted:"June 15th 2021",dateReviewed:"July 12th 2021",datePrePublished:"September 13th 2021",datePublished:"March 16th 2022",book:{id:"10707",title:"Primary Health Care",subtitle:null,fullTitle:"Primary Health Care",slug:"primary-health-care",publishedDate:"March 16th 2022",bookSignature:"Ayşe Emel Önal",coverURL:"https://cdn.intechopen.com/books/images_new/10707.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"25840",title:"Prof.",name:"Ayse Emel",middleName:null,surname:"Onal",slug:"ayse-emel-onal",fullName:"Ayse Emel Onal"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"342716",title:"Assistant Prof.",name:"Aileen",middleName:null,surname:"Y. Chang",fullName:"Aileen Y. Chang",slug:"aileen-y.-chang",email:"chang@email.gwu.edu",position:null,institution:null},{id:"342718",title:"Dr.",name:"Evelyn",middleName:null,surname:"Mendoza-Torres",fullName:"Evelyn Mendoza-Torres",slug:"evelyn-mendoza-torres",email:"evelyn.mendozat@unilibre.edu.co",position:null,institution:{name:"Free University of Colombia",institutionURL:null,country:{name:"Colombia"}}},{id:"427633",title:"Dr.",name:"Franklin",middleName:null,surname:"Torres",fullName:"Franklin Torres",slug:"franklin-torres",email:"dummy+427633@intechopen.com",position:null,institution:null},{id:"427634",title:"Dr.",name:"Wendy",middleName:null,surname:"Rosales-Rada",fullName:"Wendy Rosales-Rada",slug:"wendy-rosales-rada",email:"dummy+427634@intechopen.com",position:null,institution:null},{id:"427635",title:"Dr.",name:"Liliana",middleName:null,surname:"Encinales",fullName:"Liliana Encinales",slug:"liliana-encinales",email:"dummy+427635@intechopen.com",position:null,institution:null},{id:"427636",title:"Dr.",name:"Lil",middleName:null,surname:"Avendaño",fullName:"Lil Avendaño",slug:"lil-avendano",email:"dummy+427636@intechopen.com",position:null,institution:null},{id:"427637",title:"Dr.",name:"María Fernanda",middleName:null,surname:"Pérez",fullName:"María Fernanda Pérez",slug:"maria-fernanda-perez",email:"dummy+427637@intechopen.com",position:null,institution:null},{id:"427638",title:"Dr.",name:"Ivana",middleName:null,surname:"Terán",fullName:"Ivana Terán",slug:"ivana-teran",email:"dummy+427638@intechopen.com",position:null,institution:null},{id:"427639",title:"Dr.",name:"David",middleName:null,surname:"Vergara",fullName:"David Vergara",slug:"david-vergara",email:"dummy+427639@intechopen.com",position:null,institution:null},{id:"427640",title:"Dr.",name:"Estefanie",middleName:null,surname:"Osorio-Llanes",fullName:"Estefanie Osorio-Llanes",slug:"estefanie-osorio-llanes",email:"dummy+427640@intechopen.com",position:null,institution:null},{id:"427641",title:"Dr.",name:"Paige",middleName:null,surname:"Fierbaugh",fullName:"Paige Fierbaugh",slug:"paige-fierbaugh",email:"dummy+427641@intechopen.com",position:null,institution:null},{id:"427642",title:"Dr.",name:"Wendy",middleName:null,surname:"Villamizar",fullName:"Wendy Villamizar",slug:"wendy-villamizar",email:"dummy+427642@intechopen.com",position:null,institution:null},{id:"457495",title:"Dr.",name:"Jairo",middleName:null,surname:"Castellar-Lopez",fullName:"Jairo Castellar-Lopez",slug:"jairo-castellar-lopez",email:"dummy+427643@intechopen.com",position:null,institution:null}]},book:{id:"10707",title:"Primary Health Care",subtitle:null,fullTitle:"Primary Health Care",slug:"primary-health-care",publishedDate:"March 16th 2022",bookSignature:"Ayşe Emel Önal",coverURL:"https://cdn.intechopen.com/books/images_new/10707.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"25840",title:"Prof.",name:"Ayse Emel",middleName:null,surname:"Onal",slug:"ayse-emel-onal",fullName:"Ayse Emel Onal"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"9566",leadTitle:null,title:"Bioethics in Medicine and Society",subtitle:null,reviewType:"peer-reviewed",abstract:"Bioethics is the application of ethics to the broad field of medicine, including the ethics of patient care, research, and public health. In this book, prominent authors from around the globe discuss the complexities of bioethics as they apply to our current world. Topics range from the philosophical bioethics of the evolution of thinking about marriage from a religious standpoint to the bioethics of radiation protection to value-based medicine and cancer screening for breast cancer. Bioethics in Medicine and Society is wide-ranging, with additional chapters on the ethics of geoengineering, complementary and alternative medicine, and end-of-life ethical dilemmas. Readers with find that the field of bioethics has broad implications throughout society from our most intimate interpersonal relationships to policies being implemented on a global scale.",isbn:"978-1-83881-178-5",printIsbn:"978-1-83881-177-8",pdfIsbn:"978-1-83881-179-2",doi:"10.5772/intechopen.87361",price:139,priceEur:155,priceUsd:179,slug:"bioethics-in-medicine-and-society",numberOfPages:368,isOpenForSubmission:!1,isSalesforceBook:!1,isNomenclature:!1,hash:"16f1f01dc302bf4f0042445f11965fa1",bookSignature:"Thomas F. Heston and Sujoy Ray",publishedDate:"May 19th 2021",coverURL:"https://cdn.intechopen.com/books/images_new/9566.jpg",keywords:null,numberOfDownloads:10789,numberOfWosCitations:0,numberOfCrossrefCitations:4,numberOfDimensionsCitations:12,numberOfTotalCitations:16,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"May 28th 2020",dateEndSecondStepPublish:"June 18th 2020",dateEndThirdStepPublish:"August 17th 2020",dateEndFourthStepPublish:"November 5th 2020",dateEndFifthStepPublish:"January 4th 2021",dateConfirmationOfParticipation:null,remainingDaysToSecondStep:"2 years",secondStepPassed:!0,areRegistrationsClosed:!0,currentStepOfPublishingProcess:5,editedByType:"Edited by",kuFlag:!1,biosketch:"A practicing physician and a Clinical Associate Professor who received his medical degree from Saint Louis University School of Medicine, where he was also awarded a Distinction in Research Award. He studied positron emission tomography at Johns Hopkins University and after his fellowship was an Assistant Professor (adjunct) in the Department of Radiology. He has been in practice for more than 20 years.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"217926",title:"Dr.",name:"Thomas F.",middleName:null,surname:"Heston",slug:"thomas-f.-heston",fullName:"Thomas F. Heston",profilePictureURL:"https://mts.intechopen.com/storage/users/217926/images/system/217926.jpg",biography:"Thomas F. Heston, MD, is a clinical associate professor at the Elson S. Floyd College of Medicine, Washington State University, Spokane, Washington, USA. After graduating from St. Louis University Medical School, St. Louis, Missouri, USA, Dr. Heston went on to do his internship at Duke University, Durham, North Carolina, USA, then completed residencies in nuclear medicine and family medicine. He subsequently completed a fellowship in molecular imaging at Johns Hopkins University, Baltimore, Maryland, USA, and served on the Hopkins faculty as an adjunct assistant professor. He has served as the chair of the Ethics Committee at Deaconess Medical Center, Spokane, Washington.",institutionString:"Washington State University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"5",institution:{name:"Washington State University",institutionURL:null,country:{name:"United States of America"}}}],coeditorOne:{id:"226527",title:"Dr.",name:"Sujoy",middleName:null,surname:"Ray",slug:"sujoy-ray",fullName:"Sujoy Ray",profilePictureURL:"https://mts.intechopen.com/storage/users/226527/images/system/226527.jpg",biography:"Dr. Sujoy Ray holds an MBBS and MD in Psychiatry. He is also a member of the Royal College of Psychiatrists, London, England. He is currently an assistant professor at IQ City Medical College, India. Dr. Ray has published many articles and reviews. He has been involved in screening trials and providing clinical answers based on evidence about psychiatry. He has regularly participated in medical education programs and various workshops related to psychiatry and research methodology. Dr. Ray held presentations at national and international conferences during his undergraduate and residency days. His topics of interest include mood disorders, schizophrenia, delirium, and obsessive-compulsive disorder.",institutionString:"IQ City Medical College Hospital, India",position:null,outsideEditionCount:null,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"0",institution:null},coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"167",title:"Bioethics",slug:"medicine-bioethics"}],chapters:[{id:"74036",title:"The Quality of Life in the Light of Immanence and Its Sacrality in the Light of Transcendence",slug:"the-quality-of-life-in-the-light-of-immanence-and-its-sacrality-in-the-light-of-transcendence",totalDownloads:549,totalCrossrefCites:0,authors:[{id:"323203",title:"Ph.D. Student",name:"Ungureanu",surname:"Mihail Adeodatus",slug:"ungureanu-mihail-adeodatus",fullName:"Ungureanu Mihail Adeodatus"},{id:"327593",title:"Prof.",name:"Astărăstoae",surname:"Vasile",slug:"astarastoae-vasile",fullName:"Astărăstoae Vasile"}]},{id:"73554",title:"The Results Are Positive for Both Sides in the Great Majority of Cases When Organ Donor Families and Their Recipients Decide to Communicate with Each Other, US Experience in Tens of Thousands of Cases Shows",slug:"the-results-are-positive-for-both-sides-in-the-great-majority-of-cases-when-organ-donor-families-and",totalDownloads:368,totalCrossrefCites:0,authors:[{id:"322379",title:"Mr.",name:"Reg",surname:"Green",slug:"reg-green",fullName:"Reg Green"}]},{id:"73282",title:"End-of-Life Ethical Dilemmas",slug:"end-of-life-ethical-dilemmas",totalDownloads:329,totalCrossrefCites:0,authors:[{id:"323163",title:"M.D.",name:"J. Filipe",surname:"Monteiro",slug:"j.-filipe-monteiro",fullName:"J. Filipe Monteiro"}]},{id:"73899",title:"The Psychological Impact on Families of Departed Patients with Infectious Diseases",slug:"the-psychological-impact-on-families-of-departed-patients-with-infectious-diseases",totalDownloads:290,totalCrossrefCites:0,authors:[{id:"31214",title:"Dr.",name:"Doina-Carmen",surname:"Manciuc",slug:"doina-carmen-manciuc",fullName:"Doina-Carmen Manciuc"},{id:"49014",title:"Ms.",name:"Maria Alexandra",surname:"Largu",slug:"maria-alexandra-largu",fullName:"Maria Alexandra Largu"},{id:"332594",title:"Dr.",name:"Georgiana",surname:"Lacatusu",slug:"georgiana-lacatusu",fullName:"Georgiana Lacatusu"},{id:"336610",title:"Dr.",name:"Cristina",surname:"Vasilescu",slug:"cristina-vasilescu",fullName:"Cristina Vasilescu"}]},{id:"73705",title:"Innovation and Research in Cardiac Surgery: Bioethical Aspects",slug:"innovation-and-research-in-cardiac-surgery-bioethical-aspects",totalDownloads:244,totalCrossrefCites:0,authors:[{id:"222866",title:"Dr.",name:"Andrea",surname:"Montalto",slug:"andrea-montalto",fullName:"Andrea Montalto"},{id:"292737",title:"Dr.",name:"Francesco",surname:"Musumeci",slug:"francesco-musumeci",fullName:"Francesco Musumeci"}]},{id:"73577",title:"Ethical Concerns Regarding Breast Cancer Screening",slug:"ethical-concerns-regarding-breast-cancer-screening",totalDownloads:509,totalCrossrefCites:1,authors:[{id:"34088",title:"Dr.",name:"José Maria",surname:"Soares",slug:"jose-maria-soares",fullName:"José Maria Soares"},{id:"263327",title:"Prof.",name:"Edmund",surname:"Chada Baracat",slug:"edmund-chada-baracat",fullName:"Edmund Chada Baracat"},{id:"323161",title:"Dr.",name:"Rodrigo",surname:"Goncalves",slug:"rodrigo-goncalves",fullName:"Rodrigo Goncalves"},{id:"330856",title:"Dr.",name:"Maria Carolina",surname:"Formigoni",slug:"maria-carolina-formigoni",fullName:"Maria Carolina Formigoni"},{id:"330857",title:"Prof.",name:"José Roberto",surname:"Filassi",slug:"jose-roberto-filassi",fullName:"José Roberto Filassi"}]},{id:"72653",title:"Ethical Evaluation of Clinical Research on Complementary and Alternative Medicine",slug:"ethical-evaluation-of-clinical-research-on-complementary-and-alternative-medicine",totalDownloads:390,totalCrossrefCites:1,authors:[{id:"179771",title:"Prof.",name:"Omur",surname:"Sayligil",slug:"omur-sayligil",fullName:"Omur Sayligil"}]},{id:"71886",title:"Evaluation of the Research Protocol by Ethical Committee",slug:"evaluation-of-the-research-protocol-by-ethical-committee",totalDownloads:574,totalCrossrefCites:0,authors:[{id:"316658",title:"Dr.",name:"Paulo",surname:"Santos",slug:"paulo-santos",fullName:"Paulo Santos"},{id:"316660",title:"Prof.",name:"Alberto",surname:"Hespanhol",slug:"alberto-hespanhol",fullName:"Alberto Hespanhol"},{id:"316944",title:"Prof.",name:"Pedro",surname:"Teixeira",slug:"pedro-teixeira",fullName:"Pedro Teixeira"},{id:"316945",title:"Dr.",name:"Helena",surname:"Beça",slug:"helena-beca",fullName:"Helena Beça"}]},{id:"75086",title:"Ethics in Laboratory Medicine: An Overview of Considerations for Ethical Issues",slug:"ethics-in-laboratory-medicine-an-overview-of-considerations-for-ethical-issues",totalDownloads:988,totalCrossrefCites:0,authors:[{id:"215119",title:"Dr.",name:"Pawan Kumar",surname:"Kare",slug:"pawan-kumar-kare",fullName:"Pawan Kumar Kare"},{id:"336295",title:"Dr.",name:"Neerja",surname:"Aggarwal",slug:"neerja-aggarwal",fullName:"Neerja Aggarwal"},{id:"346649",title:"Dr.",name:"Sudip",surname:"Kumar Datta",slug:"sudip-kumar-datta",fullName:"Sudip Kumar Datta"}]},{id:"72899",title:"Biomedical Ethics and Communicative Maxims: Case Studies in Outpatient Health",slug:"biomedical-ethics-and-communicative-maxims-case-studies-in-outpatient-health",totalDownloads:399,totalCrossrefCites:0,authors:[{id:"303863",title:"Prof.",name:"Jonathan",surname:"De Rothewelle",slug:"jonathan-de-rothewelle",fullName:"Jonathan De Rothewelle"}]},{id:"72792",title:"Parkinsonism and Potential of Mucuna Beans",slug:"parkinsonism-and-potential-of-mucuna-beans",totalDownloads:649,totalCrossrefCites:1,authors:[{id:"307840",title:"Dr.",name:"Prajakta P.",surname:"Kamble",slug:"prajakta-p.-kamble",fullName:"Prajakta P. Kamble"},{id:"308178",title:"Dr.",name:"Suresh S.",surname:"Suryawanshi",slug:"suresh-s.-suryawanshi",fullName:"Suresh S. Suryawanshi"},{id:"317797",title:"Prof.",name:"Viawas A.",surname:"Bapat",slug:"viawas-a.-bapat",fullName:"Viawas A. Bapat"},{id:"317798",title:"Prof.",name:"Jyoti P.",surname:"Jadhav",slug:"jyoti-p.-jadhav",fullName:"Jyoti P. Jadhav"}]},{id:"73395",title:"Ethical Values in Radiation Protection",slug:"ethical-values-in-radiation-protection",totalDownloads:384,totalCrossrefCites:0,authors:[{id:"322527",title:"Ph.D.",name:"Hiromichi",surname:"Fumoto",slug:"hiromichi-fumoto",fullName:"Hiromichi Fumoto"}]},{id:"75717",title:"Medical Act and Negligence: Ethical Concerns",slug:"medical-act-and-negligence-ethical-concerns",totalDownloads:334,totalCrossrefCites:0,authors:[{id:"325004",title:"Dr.",name:"Julio César",surname:"Ballesteros Del Olmo",slug:"julio-cesar-ballesteros-del-olmo",fullName:"Julio César Ballesteros Del Olmo"}]},{id:"72954",title:"Value-Based Healthcare",slug:"value-based-healthcare",totalDownloads:845,totalCrossrefCites:0,authors:[{id:"321359",title:"Dr.",name:"Patrick",surname:"Rech Ramos",slug:"patrick-rech-ramos",fullName:"Patrick Rech Ramos"}]},{id:"73482",title:"Bioethical Implications and Major Infrastructure Works",slug:"bioethical-implications-and-major-infrastructure-works",totalDownloads:230,totalCrossrefCites:0,authors:[{id:"207486",title:"Dr.",name:"Jose Marcos Da",surname:"Silva",slug:"jose-marcos-da-silva",fullName:"Jose Marcos Da Silva"}]},{id:"75128",title:"Climate Change: A Forced Choice Ethical Paradigm",slug:"climate-change-a-forced-choice-ethical-paradigm",totalDownloads:377,totalCrossrefCites:0,authors:[{id:"323245",title:"M.D.",name:"Daniel",surname:"Menkes",slug:"daniel-menkes",fullName:"Daniel Menkes"}]},{id:"74203",title:"The Ethical Desirability of Geoengineering: Challenges to Justice",slug:"the-ethical-desirability-of-geoengineering-challenges-to-justice",totalDownloads:323,totalCrossrefCites:0,authors:[{id:"228437",title:"Dr.",name:"Augustine",surname:"Pampalny",slug:"augustine-pampalny",fullName:"Augustine Pampalny"}]},{id:"75548",title:"Ethical Considerations for Global Pediatric Cardiac Surgical Assistance Programs",slug:"ethical-considerations-for-global-pediatric-cardiac-surgical-assistance-programs",totalDownloads:284,totalCrossrefCites:0,authors:[{id:"246692",title:"Dr.",name:"William",surname:"Novick",slug:"william-novick",fullName:"William Novick"}]},{id:"73910",title:"Internet of Things and Distributed Denial of Service as Risk Factors in Information Security",slug:"internet-of-things-and-distributed-denial-of-service-as-risk-factors-in-information-security",totalDownloads:459,totalCrossrefCites:0,authors:[{id:"322517",title:"Dr.",name:"Jairo Eduardo",surname:"Márquez Díaz",slug:"jairo-eduardo-marquez-diaz",fullName:"Jairo Eduardo Márquez Díaz"}]},{id:"74618",title:"Evolution of Catholic Marriage Morality in the Twentieth Century from a Baby-Making Contract to a Love-Making Covenant - Part I: Era of John Paul II",slug:"evolution-of-catholic-marriage-morality-in-the-twentieth-century-from-a-baby-making-contract-to-a-1",totalDownloads:249,totalCrossrefCites:0,authors:[{id:"324886",title:"Prof.",name:"Edward",surname:"Collins Vacek S.J.",slug:"edward-collins-vacek-s.j.",fullName:"Edward Collins Vacek S.J."}]},{id:"74571",title:"Medical Ethics",slug:"medical-ethics",totalDownloads:386,totalCrossrefCites:0,authors:[{id:"151696",title:"Dr.",name:"Dabota Yvonne",surname:"Buowari",slug:"dabota-yvonne-buowari",fullName:"Dabota Yvonne Buowari"},{id:"276207",title:"Dr.",name:"Kehinde Kazeem",surname:"Kanmodi",slug:"kehinde-kazeem-kanmodi",fullName:"Kehinde Kazeem Kanmodi"}]},{id:"74252",title:"The New Challenges for Medical Ethics",slug:"the-new-challenges-for-medical-ethics",totalDownloads:704,totalCrossrefCites:1,authors:[{id:"203859",title:"Prof.",name:"Liliana",surname:"Lorettu",slug:"liliana-lorettu",fullName:"Liliana Lorettu"},{id:"335904",title:"Dr.",name:"Jocelyn",surname:"Aubut",slug:"jocelyn-aubut",fullName:"Jocelyn Aubut"},{id:"335905",title:"Dr.",name:"Rosagemma",surname:"Ciliberti",slug:"rosagemma-ciliberti",fullName:"Rosagemma Ciliberti"}]},{id:"73284",title:"Plato in Contemporary Medical Ethics: Holism and Care",slug:"plato-in-contemporary-medical-ethics-holism-and-care",totalDownloads:450,totalCrossrefCites:0,authors:[{id:"323441",title:"Dr.",name:"Tudor-Ștefan",surname:"Rotaru",slug:"tudor-stefan-rotaru",fullName:"Tudor-Ștefan Rotaru"}]},{id:"74551",title:"Evolution of Catholic Marriage Morality in the Twentieth Century from a Baby-Making Contract to a Love-Making Covenant - Part II: Code of Cannon Law to Vatican II",slug:"evolution-of-catholic-marriage-morality-in-the-twentieth-century-from-a-baby-making-contract-to-a-lo",totalDownloads:478,totalCrossrefCites:0,authors:[{id:"324886",title:"Prof.",name:"Edward",surname:"Collins Vacek S.J.",slug:"edward-collins-vacek-s.j.",fullName:"Edward Collins Vacek S.J."}]}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"247041",firstName:"Dolores",lastName:"Kuzelj",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/247041/images/7108_n.jpg",email:"dolores@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"6653",title:"eHealth",subtitle:"Making Health Care Smarter",isOpenForSubmission:!1,hash:"c65db68c389c911ae57b1181b3e0db07",slug:"ehealth-making-health-care-smarter",bookSignature:"Thomas F. Heston",coverURL:"https://cdn.intechopen.com/books/images_new/6653.jpg",editedByType:"Edited by",editors:[{id:"217926",title:"Dr.",name:"Thomas F.",surname:"Heston",slug:"thomas-f.-heston",fullName:"Thomas F. Heston"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9139",title:"Topics in Primary Care Medicine",subtitle:null,isOpenForSubmission:!1,hash:"ea774a4d4c1179da92a782e0ae9cde92",slug:"topics-in-primary-care-medicine",bookSignature:"Thomas F. Heston",coverURL:"https://cdn.intechopen.com/books/images_new/9139.jpg",editedByType:"Edited by",editors:[{id:"217926",title:"Dr.",name:"Thomas F.",surname:"Heston",slug:"thomas-f.-heston",fullName:"Thomas F. Heston"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7952",title:"Smart Healthcare",subtitle:null,isOpenForSubmission:!1,hash:"a2d80535e2d71781a0cd3e2c0597a375",slug:"smart-healthcare",bookSignature:"Thomas F. Heston",coverURL:"https://cdn.intechopen.com/books/images_new/7952.jpg",editedByType:"Edited by",editors:[{id:"217926",title:"Dr.",name:"Thomas F.",surname:"Heston",slug:"thomas-f.-heston",fullName:"Thomas F. Heston"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8332",title:"Telehealth",subtitle:null,isOpenForSubmission:!1,hash:"dd9601c901f7fe3803ae69dbd571feba",slug:"telehealth",bookSignature:"Thomas F. Heston",coverURL:"https://cdn.intechopen.com/books/images_new/8332.jpg",editedByType:"Edited by",editors:[{id:"217926",title:"Dr.",name:"Thomas F.",surname:"Heston",slug:"thomas-f.-heston",fullName:"Thomas F. Heston"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6615",title:"Nursing",subtitle:null,isOpenForSubmission:!1,hash:"ec518aff724f10de937340ca865b5e94",slug:"nursing",bookSignature:"Nilgun Ulutasdemir",coverURL:"https://cdn.intechopen.com/books/images_new/6615.jpg",editedByType:"Edited by",editors:[{id:"191796",title:"Associate Prof.",name:"Nilgun",surname:"Ulutasdemir",slug:"nilgun-ulutasdemir",fullName:"Nilgun Ulutasdemir"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6568",title:"Reflections on Bioethics",subtitle:null,isOpenForSubmission:!1,hash:"8da3f5e7819e769f07a77dc3f0f357c2",slug:"reflections-on-bioethics",bookSignature:"José Antonio Morales-González and María Eugenia Aguilar Nájera",coverURL:"https://cdn.intechopen.com/books/images_new/6568.jpg",editedByType:"Edited by",editors:[{id:"109774",title:"Dr.",name:"Jose Antonio",surname:"Morales-Gonzalez",slug:"jose-antonio-morales-gonzalez",fullName:"Jose Antonio Morales-Gonzalez"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7798",title:"Neuroethics in Principle and Praxis",subtitle:"Conceptual Foundations",isOpenForSubmission:!1,hash:"c331b07083fed290d6be2ccf32f1118f",slug:"neuroethics-in-principle-and-praxis-conceptual-foundations",bookSignature:"Denis Larrivee",coverURL:"https://cdn.intechopen.com/books/images_new/7798.jpg",editedByType:"Edited by",editors:[{id:"206412",title:"Prof.",name:"Denis",surname:"Larrivee",slug:"denis-larrivee",fullName:"Denis Larrivee"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"39272",title:"Utilization of Portable Digital Camera for Detecting Cataract",doi:"10.5772/48428",slug:"utilization-of-portable-digital-camera-for-detecting-cataract",body:'
Cataract is a kind of eye disease [1]; that is a clouding in the lens of the eye that affects vision. Cataract exhibits a lot of whitish color inside a pupil. The three classes of cataracts are immature, mature and hypermature, which differ in seriousness. In an immature cataract, a whitish color appears inside the pupil but less so than in mature or hypermature cataracts. Usually, the condition is not yet serious. A Hypermature cataract exhibits much whitish color inside the pupil and can cause the lens of the eye to break if surgery is not carried out. This condition is very dangerous. Figure 1 shows examples of the range of serious and non-serious conditions.
The World Health Report published in 2001 estimated that there were 20 million people who are bilaterally blind (i.e., with eyesight of less than 3/60 in the better eye) whose blindness was caused by age related cataracts [2]. That number will have increased to 40 million by the year 2020. Increasing age is associated with an increasing prevalence of cataracts, but in most developing countries, cataracts often occur earlier in life. One of the developing countries that have the highest number of people with cataracts is Indonesia. There are about 6 million people in Indonesia who suffer from cataracts, but Indonesia only has about 1160 ophthalmologists for a population of more than 200 million people (one for every 350.000 people). In addition, ophthalmologists are not evenly distributed. Many ophthalmologists are located in the capital city, yet many people have no access to ophthalmologists because of geographic conditions.
Usually ophthalmologists will use various equipment like slit lamp or ophthalmoscope to determine the type, opacities and the location of the cataract, and to distinguish it from other eye diseases that have symptoms similar to cataracts. Basically, both equipments use a light source to determine the condition of the patient\'s eye lens. By using these kinds of equipment, lens opacities can be assessed by observing the width of the edge of the iris in a cloudy lens. If the remote location and the large shadow means immature cataracts, if it is a small shadow and close to the pupil occurs in mature cataracts. It is expected with early diagnosis, the cataract can be monitored whether to continue or will cause complications that must be treated to prevent blindness; However, using this equipment have some limitations including expensive price and special training needed. It will be a problem for some developing countries which has a limited number of both ophthalmologists and health facilities like Indonesia, Nepal, and Vietnam, for example. To solve this problem, we developed a method for detecting cataract based on digital image processing techniques. These techniques support the use of low-cost and easy-to-use equipment such as digital camera. We choose to use a digital camera as the main equipment with reference to the working principle of the slit-lamp camera and ophthalmoscope in which this equipment using the light to check the condition of the eye lens, so we adopted the use of the slit-lamp camera or ophthalmoscope light with a flash light on digital camera lenses to represent the condition. The two types of equipment are shown in Figure 2.
Example of eye images
In our method, we extracted all information about cataract from pupil area only because all information about cataracts comes from the lens only. This is based on the fact that the opacities as an important sign of cataracts occur in the lens. However, when using a compact digital camera, we found problems such as insufficient image quality and uncontrolled illumination. For example, if we employ intensity value for screening cataract, i.e. higher intensity corresponds to a serious condition; it would fail for a cataract eye image taken under low illumination as shown in Figure 3. It appears that a non-serious condition eye image has an average intensity about 155 inside a pupil while a serious condition eye image only has an average intensity about 55 inside a pupil. In order to develop a robust cataract screening techniques, we proposed to use specular reflection analysis as the core method for cataract screening because specular reflection always brighter than surrounding area and it is not depend on illumination condition. We also were considering texture information as the supporting method.
This chapter will discuss step by step instructions on the use of digital cameras as the main equipment for detecting cataract, complete with an explanation of image processing techniques for the analysis of digital images produced by digital cameras.
Examination using (a) slit lamp (b) our system
Example of photographs under uncontrolled illumination
As discussed in Section 1, we extracted all information inside the pupil including specular reflection and texture appearance because all information about cataract is taken from the pupil region only. The pupil of the eye is simply a hole in the iris through which one can peer into the eye. It appears black because of the darkness inside [3][4]. Based on these definitions, we can conclude that the color of the pupil is universal; it does not depend on ethnicity, although the color of the iris is different for different ethnicity, as shown in Figure 4.
Color of pupil does not depend on ethnicity
The pupil gets wider in the dark but narrower in light. When narrow, the diameter is 3 to 4 millimeters. In the dark it will be the same at first, but will approach the maximum distance for a wide pupil of 5 to 8 mm depending on a person’s age [5]. There are some definitions regarding pupil size in Figure 5.
Definitions of pupil
The pupil’s size always changes while the iris’s size is fixed, therefore, to make pupil size independent in various conditions, in this paper we will use a ratio between pupil and iris as a unit to express size measurement, indicated by the symbol Pr and ex pressing by Equation 1.
In general, the algorithm used in pupil localization is using 3 stages. Before performing these steps, the original image size changed to 50%. This is done to simplify the image processing operations.
Masking Step, namely the separation process of facial images based on skin color. How this is done by utilizing the luminance component and Cb and Cr to form the face of the box based on skin color as described in Figure 6.
Face masking process
Region of eye Step, when it was getting a face image in the box and then take the eye area. Cutting the eye area is based on the normal form has a face that the proportion of 1 / 3 the length of a human face [6] as described in Figure 7.
Estimation of eye area
Pupils Step, at this stage to use Lab color characteristics to determine the image of the pupil. Then using a fixed radius circle Hough to determine the center point of the circle which is the center point of pupil candidates as described in Figure 8.
Pupil circle
The core of our method is specular reflection analysis. We develop our algorithm refer to the working principles of ophthalmoscope and slit lamp. An ophthalmoscope is an instrument that enables a doctor to examine the inside of a person\'s eye. The instrument has an angled mirror, various lenses, and a light source. A slit lamp is an instrument that enables a doctor to examine the entire eye under high magnification and that allows measurement of depth. The slit lamp focuses a bright light into the eye. Both equipments have a similarity for diagnosing cataract.
Figure 9 describes the principle work of the specular reflection method. Light hits the frontal surface of the lens and makes a reflection called frontside reflection. But actually light also hits the rear side of the lens. For a non serious condition, there is not a whitish color inside the lens so it will be reflected again, which is called backside reflection. For a serious condition especially, because there is a lot of clouding in the lens, light will not be reflected again. The different characteristics are shown in Figure 10. Based on the reflection theorem, the direction of the normal vector always goes to the center of the pupil, so when we look at the image appearance we can find the relationship of the location between the two reflections and the center of the pupil; they are on a single line
Model of reflection characteristics in eye
Using the relationship between both reflections, we conducted a search to find the backside reflection, as depicted in Figure 11. Using coordinate of the center and the radius of frontside reflection, we then searched for the backside reflection by searching for areas of higher intensity beside frontside reflection compared with their immediately surrounding areas in a line that expressed by Equation 2
Where
In fact, the shapes of specular reflections are varied as described in Figure 12. As shown in Figure 12, some variations of the specular reflections shape are circle, cube, rectangular and ellipse, although we used the same flash light during taking photographs. Therefore, during searched for backside reflections area as described in Figure 11, we considered to assume various shapes of specular reflections and did intensity searching based on the shape that we assumed before as shown in Figure 13.
Example of Reflection Appearance
Searching backside reflection area data
Various shapes of specular reflections inside the pupil
Intensity tracking using various shapes of specular reflections
We apply Eq. 2 which the value of
The size using for intensity tracking
Then, we compare the performance of each shapes of specular reflections in order to provide a recommendation on the tendency of specular reflection\'s shape that can give the best results for cataract screening sistem we apply an Eq.4.
Based on the result of intensity tracking as shown in Figure 11, we implemented a differential function in a discrete system to develop an automatic screening between the serious condition and not serious condition based on intensity tracking result and expressed by Equation 3.
Where I is intensity and S is a distance between center of frontside reflection and the next circle that will be investigated. During intensity searching, if D(S) >0 it means there is an increasing intensity value. Otherwise if D(S) <0 it means there is a decreasing intensity value. Based on the discussion in above paragraph, that non serious condition always have a great increasing intensity that indicated existence of backside reflection but it doesn’t mean that serious condition didn’t have increasing intensity during intensity tracking. Because we have variations of the numbers of intensity searching so we define normalized number of increasing value determined by Equation 4.
Where P is the numbers of point that has increasing intensity value and n is the numbers of point along an intensity tracking line. The main characteristic of serious and non-serious conditions depends on the presence of backside reflection in an image that is shown by increasing intensity in an area during intensity searching. Figure 15 shows the examples of the result of intensity tracking for serious and non-serious.
Analyzing backside reflection
An important approach to region description is to quantify texture content. In statistical texture analysis, the descriptor measures properties such as smoothness, coarseness and regularity. Basically, there are two kinds of textures inside the pupil; smooth and coarse. This can be calculated by the uniformity value expressed in Eq.5. Where U is the value of uniformity, H is probability histogram of the intensity levels in a region, and N is the number of pixel in an image, Let i = 0, 1, 2, ….,, L − 1, be the corresponding histogram, where L is the value of possible intensity. Uniformity will be maximum when all gray levels are equal [7]. Whitish color inside the lens has two kinds’ distributions. First, whitish color spread smoothly inside the pupil. In the early stage, this kind of cataract has a thin layer of whitish color and covers the whole lens surface gradually until the whitish color layer becomes thick. Second, whitish color spread uneven inside the lens. It will appear a coarse texture inside the pupil. Almost all non serious conditions have a smooth texture with a high value of uniformity.
For example, in a 3 x 3 region and belongs to a smooth texture as shown in Figure 16, the uniformity is shown in calculation below:
Example of Smooth Texture
Another example, in a 3 x 3 region and belongs to a coarse texture as shown in Figure 17, the uniformity is shown in calculation below:
Example of coarse Texture
Figure 18(a) shows an image of eye in serious condition with a high value of uniformity caused by the whitish color is spreading smoothly inside the pupil. In the early stage, this kind of cataract has a thin layer of whitish color and covers the whole lens surface gradually until the whitish color layer becomes thick. Figure 18(b) shows an image of an eye with a coarse texture because the whitish color is spreading unevenly inside the pupil. Figure 18(c) shows an image of an eye in non-serious condition. Almost all non-serious conditions have a smooth texture with a high value of uniformity.
The equation to measure an average intensity expressed in Equation 6, where m is mean (average) of intensity, I is possible intensity, and N is number of pixel in an image [7]. It will be very simple intuition that cataract eyes have brighter intensities than normal eyes.
Example of Texture Appearance
For example, in a 3x3 region as shown in Figure 19, the average intensity is shown in calculation below :
An example of average intensity
The whitish color inside a pupil has a corresponding with increasing intensity. Figure 20 shows an eye normal image and a cataract eye image. It appears that a cataract eye image has a higher intensity than a normal eye image. By assuming that a serious condition has a higher intensity than a non-serious condition, we distinguish both conditions.
Intensity difference between normal and cataract
To build the system, we used Matlab R2007B with image processing toolbox. Also, for building a classifier to classify between serious and non-serious condition, we use SVM toolbox developed by Canu [3]. In order to make a classification for cataract screening we need two kinds of data: training data and testing data. Training data used to train the system to recognize the characteristics of a serious condition and non-serious condition so the system can determine the threshold for distinguishing between two conditions automatically. While testing data used to evaluate system performance refer to the characteristics obtained in the training data.
To test the performance of our system, we use several parameters. The first is True Positive Rate (TPR). TPR determines a classifier or a diagnostic test performance on classifying positive instances correctly among all positive samples available during the test. The second is FPR (False Positive Rate). FPR, on the other hand, defines how many incorrect positive results occur among all negative samples available during the test.
Criterion values for getting TPR and FPR parameters are described in Figure 21.
Parameter for measuring performance
To evaluate the overall system performance, we use cross validation techniques in which we did evaluation several times until all data were evaluated.. So that all images produced by various kinds of cameras are grouped into two groups. The first group is the images that show the serious conditions, while the second group is the images that show the non-serious conditions. We did some testing times by taking 90% of data as training data and 10% of data as testing data. Data changed each time, until finally all data used as training data and testing data. Figure 22 shows a summary of performance our algorithm. The result shows that current method has a good performance than other method.
Performance comparison for each method
As discussed in subsection 2.3, the core of our method is specular reflection analysis. Referring to the reflection theorem, light hits the frontal surface of the lens and makes a reflection called frontside reflection. However, light also hits the rear side of the lens. For a non-serious condition, there is not a whitish color inside the lens, therefore, it will be reflected again, which is called backside reflection. For a serious condition especially, because there is a lot of clouding in the lens, light will not be reflected again. In order to investigate the availability of frontside reflection and backside reflection inside the lens, and also to obtain a minimum distance between two reflections that can be observed by our algorithm, we did a simulation. Refer to the experiments, our algorithm can observe availability of two reflections with minimum ratio between distance and iris of about 0.125. It is an important value because if our algorithm fails to investigate availability of the two reflections, will face problems. First, patient really has a serious condition. Second, it is caused by a wrong position between camera and patient during taking a photograph.
Regarding these problems, we have to make sure that we put camera and patient in an appropriate position. Therefore, a simulation of the angle’s position is very important. In our simulation, we assume that a light is attached in camera. The purposes are:
Getting an optimal position of angle between camera and lens.
Getting an optimal pupil size to get an appropriate distance between two reflections.
The lens has an ellipsoid, biconvex shape. It is typically circa 10 mm in diameter and has an axial length of about 4 mm [5]. An iris is a colored disk inside the eye with diameter of about 12 mm [5]. Figure 23 describes the shape and size of the lens, pupil and iris in our simulation.
Typical shape and size of pupil
In this part, there are three conditions. First is a condition where the reflection does not occur inside the lens. Second is a condition where only a frontside reflection occurs and can be observed inside the lens. Third is an appropriate condition where a frontside reflection and backside reflection occur and can be observed in an image plane. Figures 24-26 show each condition, respectively.
During simulation, we change the position of the camera with light attached based on angle () between camera and lens. It starts from angle 1o to angle 180o. Figure 24 shows that the position of light cannot reach the lens because light hits the surface of the iris; therefore, there is no reflection in the lens
Condition in which no reflection occurs
Figure 25 shows that light hits the frontal surface of the lens therefore, a reflection occurs and is observed. However, when the light hits the rear side of the lens, a reflection occurs but it cannot be observed in the image plane. Therefore, in this condition, only frontside reflection is observed in the image plane. Figure 26 shows an appropriate condition in which both reflections occur and are observed in the image plane. This kind of parameter will be useful for distinguishing between serious and non-serious conditions.
Condition in which only frontside reflection occurs and is observed in an image plane
An appropriate condition in which both reflections occur and are observed in an image plane
In the real condition, As already discussed in the section 1, that our system is expected to be used by all people in all places, so that the equipment will be used in our system must also be simple as shown in Figure 28. Brief description about the function of equipment is described in the following paragraph.
Chin rest - This is equipment for patient to lean forward and place his or her in the chin rest and forehead against the bar. We use a simple chin rest created manually by using a board that is placed on something that could make it stand upright. The main goal is to put the patient\'s chin so that patients feel comfortable during taking a photograph. On the other hand, by using a chin rest so will allow a user to get the right eye image during taking a photograph because the patient does not move his head movement that will result in the patient\'s eye movement. We should be emphasized here that this tool is not absolutely necessary in our system, if users can take photograph that make an appropriate input image and the patient feel comfortable, not moving their head so that the position of the eyes in a state of permanent, then the use of these tools are not needed.
Tripod - Tripods are used for both still and motion photography to prevent camera movement. The main purpose of using a tripod in our system is to make it easier to get good quality photo because the camera will be in a fixed position and not moving so the possibility of blur can be prevented. Another reason is to get more accurate angular position between the camera and the patient because they will affect the existence of specular reflection inside a pupil as be described in above paragraph. It should be noted here that as well as the use of chin rest, the use of a tripod in our system is not an absolute thing. If users able to get an appropriate input image without using a tripod therefore this equipment is not required in our system.
Digital Camera - This is the most important equipment in our system because all the input images are taken from a digital camera. In our system, we use all types of digital cameras from various brands available such as Canon and Nikon. We do not consider about the performance of cameras such as the number of pixels, zooming capabilities,and other facilities. Most important for our system is the camera has flash facility as a light source to get specular reflections, has a macro facility to get a good enough quality when taking photographs for the pupil of the eye area. Referring to Figure 2, it can be said that the performance of each camera is almost evenly.
System performance based on types and brands of digital camera
Scale - This is equipment to provide guidance angle camera placement. We use a kind of plastic mats that have been marked to measure the angle between the patient and the camera.
Personal Computer - The main function is an interface for analyzing of input images that have been obtained in the data acquisition session. Our method written in the form of graphical user interface (GUI) so that user easily uses it just by pressing the command buttons available. Users do not need to analyze the complicated result because our methods give results about the patient\'s condition which he included in serious or non serious condition.
Equipment were used in our system
Figure 29 and Figure 30 describe about the implementation of data acquisition in the real condition.
Side view of camera configuration
View from above camera configuration
Regarding the conditions in developing countries which have limitations both of eye doctors and health facilities, using simple equipment such as digital camera for cataract screening is promising and sufficient. Because digital camera is small and easily carried out, easy to use and inexpensive. Also, the method for supporting digital camera has a good performance for distinguishing between serious and non-serious condition; therefore, it is very useful for determining people who need a surgery as soon as possible.
Acknowledgement
We Would like to thank the head and staffs of the Kamandaka Eye Clinic in Purwokerto Indonesia, Students and staffs of Electrical Engineering Dept, Jenderal Soedirman University Indonesia.The staffs of NAIST Japan, all members of the Advanced Intelligence Laboratory at NAIST, and members of the elder peoples house (CHOMEISHO) in Ikoma Japan, for their permission and willingness have photographs taken of cataract and normal patients. Also, this work is partly supported by the Konika Minolta Imaging Science Foundation and the Foundation for NAIST, also DIPA Jenderal Soedirman University through International Research Collaboration Project.
The COVID-19 pandemic has brought attention to the necessity of emergency preparedness and response (EP&R) in India\'s education, training, capacity building, and infrastructure development. During the pandemic, healthcare workers, particularly pharmacy professionals (PPs) in India, continued to deliver medication, supplies, and services. In India, the public-private healthcare system is complex and of variable quality. Gaps in pharmacy practice education and training, as well as a lack of understanding about pharmacists\' roles, cause complications for patients. This lack of difference complicates job requirements and successful placement of healthcare professionals in patient care, EP&R task forces, and policy representation. During this unprecedented pandemic situation, we have also observed malpractice and bogus distribution in the healthcare and pharmaceutical arena in terms of personal protective kits, medications, injectable, life-saving oxygen, and other products. The following are a few of the incidents. The central division police in Bangalore (India’s Global BPO & IT Hub) filed a complaint of bed-blocking at a private hospital and arrested three people, one of whom is an Arogya Mitra (primary contact for beneficiaries at every empaneled hospital care provider), for allegedly extorting Rs. 1.20 lakh from the son of a COVID-19 patient who later died. In the last few weeks, at least 178 COVID-19 patients in India have died due to a lack of oxygen. Another 70 deaths have been linked by patients’ families to a lack of oxygen, though this has been refuted by authorities. “Death of COVID patients due to non-supply of oxygen not less than genocide,” the Allahabad High Court ruled in response to reports spreading on social media regarding the death of COVID-19 patients in Lucknow and Meerut due to a shortage of oxygen [1]. Five persons were arrested after the Delhi police raided an industrial manufacturing site in Uttarakhand\'s Kotdwar, where duplicate Remdesivir injections were being made. This reflects the reality of Good Pharmacy Practice in this country, as well as the ethical norms that apply to it. It is critical to re-evaluate and re-establish pharmacy practice standards in healthcare settings throughout the country, in accordance with World Health Organization (WHO) and International Pharmaceutical Federation (FIP) principles. As a result, healthcare workers have a great deal of reliance and responsibility, especially in current pandemic circumstances. The pharmacy zone is adaptive, growing, and becoming more diverse, providing a comprehensive range of job and management opportunities [2]. PPs are human service professionals tasked with keeping people safe by distributing drugs according to prescriptions. In India, there are about 1,000,000 (1 million) enrolled PPs working in diverse capacities and contributing to the country\'s well-being, making it the world\'s third-largest medical service with active gathering. In its real definition, pharmacy practice, which encompasses clinical, community, and hospital pharmacy, is referred to as overall healthcare. PPs form a crucial link between physicians, nurses, and patients in the social community group through the adaptation and application of GPP in healthcare settings, with the ultimate emphasis on patient well-being and protection. In order to instill quality and elevate the standard in this chaotic scenario, the country must take stringent steps. Good pharmacy practice (GPP) is defined by the International Pharmaceutical Federation and the World Health Organization as practices that fulfill the individual requirements of patients or people who use pharmacy services by providing adequate evidence-based care. Pharmaceutical assistance is defined in developed countries as a pharmaceutical practice model that includes attitudes, ethical values, behaviors, skills, appointments, and co-responsibility to prevent diseases, promote, and recover health in an integrated manner as part of the healthcare process, highlighting, among other requirements, the institution\'s full adoption of the GPP. In the context of the Indian healthcare system and adopting a "new normal" due to the unprecedented event of COVID-19, there is a need for a GPP program designed by the Indian Government or its stakeholders, as well as raising the standard and importance of GPP for healthcare professionals in the current scenario.
India is a developing country in southern Asia with 29 states and seven union territories, 22 nationally recognized languages, and a population of 1.38 billion. India is a rural country with an agriculture-based economy, with rural areas accounting for over 75% of the population. In recent decades, India\'s average income has risen dramatically, resulting in growing urbanization, improved middle-class access to a better lifestyle, and increasing awareness of health insurance. Male and female literacy rates have climbed to 82% and 65%, respectively. According to reports, the average life expectancy is 69.9 years [3]. According to World Bank research from 2020, about 400 million Indians live on less than $1.25 a day, and 44% of children are hungry. Even though the government has taken attempts to reduce baby and maternal death rates, they remain high. Ancient Hindus acknowledged pharmacy as a complementary healing profession, and they specialized in vegetable treatments. Vedic and Brahmanic medicine were the two periods of Hindu medicine. The Vedic period or Vedic age (c. 1500–c. 500 BCE), and was a rudimentary period. During the Vedic period, sin was thought to be a major source of disease. Between 800 BC and 1000 AD, the Brahmanic period was a high-quality time for Hindu medical education. The works of Charaka, Susruta, and Vagbhat, which are based on ancient Vedic themes, are the three great masterpieces of Brahmanic medicine [4]. The origins of pharmacy in India can be traced back to Ayurveda, which dates to 5000 BC. Lord Brahma initially taught Ayurveda, or "life science," which was further transmitted by Charaka and Sushruta [5]. The Charaka Samhita, early work on Ayurveda, focuses on vegetable goods as well as some animal and earth goods. The classification of medications in this book is based on how they affect different bodily parts [4]. In 900 AD, Tamilnadu established a hospital to treat piles, jaundice, bleeding, and tuberculosis [5]. Tantrism was a prominent philosophical and religious movement that emerged in India after the downfall of Buddhism; it brought the art and science of the production of metallic compounds, particularly mercury and sulfur, to the fore [4]. In 1811, Scotch M. Bathgate built the first chemist shop in Calcutta, which is regarded as the birthplace of pharmacy practice in India. In December 1860, Madras Medical School began pharmacy instruction, enrolling students with only middle school education; the pharmacy degree was 2 years long. Madras Medical College (MMC), Chennai, established the diploma course in pharmacy in 1874. The Bengal Chemists and Druggists Association was founded in 1926 after the Calcutta Chemists and Druggists Association was founded in 1920. The first issue of the official
Many issues face India\'s healthcare system, including the need to lower mortality rates, enhance physical infrastructure, provide health insurance, and train healthcare experts and workers. A rise in communicable diseases, lifestyle diseases, and noncommunicable diseases has been recorded. Diseases such as poliomyelitis, leprosy, and newborn tetanus will be eradicated; nevertheless, certain previously controlled infectious diseases, such as dengue fever, viral hepatitis, tuberculosis, malaria, and pneumonia, have resurfaced or developed medication resistance.
Even though Indians are now more affluent as a result of the rise of the middle class, their eating habits have shifted dramatically to unhealthy, high-sugar, high-fat diets, leading to an increase in lifestyle diseases such as hypertension, cancer, and diabetes. Furthermore, India\'s healthcare institutions and services would be burdened by the expanding older population.
Due to a dearth of hospital beds and skilled medical personnel such as doctors, nurses, and pharmacists, the people do not have access to their medical needs. In comparison to urban areas, healthcare services are much scarcer in rural communities. Females have an adversely skewed proportion in the healthcare workforce when compared to males. In the 11th five-year plan, total healthcare expenditure (comprising state funds, private funds, and external flows) accounted for 4.1% of GDP (GDP). The 12th five-year plan (2012–2017) intends to raise public health spending from 1.1% of GDP to 2–3% of GDP [6].
The state is responsible for the healthcare system. This system is currently managed by both public and private (for profit and nonprofit) groups. Policymaking, planning, guiding, aiding, reviewing, and coordinating the activities of various provincial health authorities are all responsibilities of the federal government, as is providing financing to implement national healthcare initiatives [7]. Allopathic hospitals, hospital beds, Indian System of Medicine and Homeopathy hospitals, subcenters, Pharmacy Health Care (PHC), Community Health Center (CHC), blood banks, Eye Bank, psychiatric hospitals, and cancer hospitals are all part of India\'s healthcare infrastructure [7]. The Department of Ayurveda, Yoga, and Naturopathy, as well as Unani, Siddha, and Homeopathy, provide medical and healthcare services (AYUSH). The ownership of the public sector is split between the federal and state governments, municipalities, and panchayats (local governments). Dispensaries, primary health centers, subcenters, and health posts are among the facilities. Teaching hospitals, secondary-level hospitals, first-level referral hospitals (community health centers/rural hospitals), dispensaries, primary health centers, subcenters, and health posts are among the facilities. Public facilities for specific occupational groups are also included, including organized labor (Employees State Insurance Scheme), defense, government employees (Central Government Health Scheme), railways, post and telegraph, and mining, to name a few. The private sector (profit/nonprofit) is the most prevalent, with services ranging from >1000 beds to two beds. Health-related facilities are available through the federal government healthcare program in 25 cities, with 246 allopathic dispensaries [7]. Private healthcare providers are currently treating 78% of outpatients and 60% of inpatients in India. Private healthcare providers range from world-class hospitals that promote medical tourism by providing world-class treatments to international clients and Indians who can afford it to private doctors who have minimal medical expertise or formal training on the other end of the spectrum. Furthermore, the private sector controls 80% of doctors, 26% of nurses, and 49% of hospital beds, demonstrating its power.
In contrast to India, the number of hospitals in other nations is not given. However, according to World Bank statistics, available at https://data.worldbank.org/indicator/SH.MED.BEDS.ZS India\'s accessible beds per 1000 population is lower than that of a lot of other countries. As a state of concern, public health and hospitals are largely responsible for the upkeep, providing health treatment to individuals, and maintaining hospital information. However, the following details are provided below:
Number of Primary Health Centers (PHCs), Community Health Centers (CHCs), Sub-District/Divisional Hospitals (SDHs), District Hospitals (DHs), and beds in India, by State/UT, as uploaded by the States/UTs on the Ministry\'s Health Management Information System (HMIS) portal.
Number of government hospitals and beds in rural and urban areas in India, broken down by state/UT, as published in National Health Portal 2018.
The Ministry of AYUSH provides information on the number of AYUSH hospitals and beds in each state/UT.
Total and state-by-state number of hospitals and beds maintained by the Ministry of Defense.
Number of railway hospitals and beds, as reported in the National Health Portal 2018 publication.
Number of State Insurance Corporation employees, hospitals, and beds, per state/UT, and total, as published in the National Health Portal 2018.
State/UT | No. of public facilities | No. of beds available in public facilities | ||||
---|---|---|---|---|---|---|
PHC | CHC | SDH | DH | Total | ||
Andaman & Nicobar Islands | 27 | 4 | 3 | 34 | 1246 | |
Andhra Pradesh | 1417 | 198 | 31 | 20 | 1666 | 60,799 |
Arunachal Pradesh | 122 | 62 | 15 | 199 | 2320 | |
Assam | 1007 | 166 | 14 | 33 | 1220 | 19,115 |
Bihar | 2007 | 63 | 33 | 43 | 2146 | 17,796 |
Chandigarh | 40 | 2 | 1 | 4 | 47 | 3756 |
Chhattisgarh | 813 | 166 | 12 | 32 | 1023 | 14,354 |
Dadra & Nagar Haveli | 9 | 2 | 1 | 1 | 13 | 568 |
Daman & Diu | 4 | 2 | 2 | 8 | 298 | |
Delhi | 534 | 25 | 9 | 47 | 615 | 20,572 |
Goa | 31 | 4 | 2 | 3 | 40 | 2666 |
Gujarat | 1770 | 385 | 44 | 37 | 2236 | 41,129 |
Haryana | 500 | 131 | 24 | 28 | 683 | 13,841 |
Himachal Pradesh | 516 | 79 | 61 | 15 | 671 | 8706 |
Jammu & Kashmir | 702 | 87 | 29 | 818 | 11,342 | |
Jharkhand | 343 | 179 | 13 | 23 | 558 | 7404 |
Karnataka | 2547 | 207 | 147 | 42 | 2943 | 56,333 |
Kerala | 933 | 229 | 82 | 53 | 1297 | 39,511 |
Lakshadweep | 4 | 3 | 2 | 1 | 10 | 250 |
Madhya Pradesh | 1420 | 324 | 72 | 51 | 1867 | 38,140 |
Maharashtra | 2638 | 430 | 101 | 70 | 3239 | 68,998 |
Manipur | 87 | 17 | 1 | 9 | 114 | 2562 |
Meghalaya | 138 | 29 | 13 | 180 | 4585 | |
Mizoram | 65 | 10 | 3 | 9 | 87 | 2312 |
Nagaland | 134 | 21 | 11 | 166 | 1944 | |
Odisha | 1360 | 377 | 27 | 35 | 1799 | 16,497 |
Puducherry | 40 | 4 | 5 | 4 | 53 | 4462 |
Punjab | 521 | 146 | 47 | 28 | 742 | 13,527 |
Rajasthan | 2463 | 579 | 64 | 33 | 3139 | 51,844 |
Sikkim | 25 | 2 | 1 | 4 | 32 | 1145 |
Tamil Nadu | 1854 | 385 | 310 | 32 | 2581 | 72,616 |
Telangana | 788 | 82 | 47 | 15 | 932 | 17,358 |
Tripura | 114 | 22 | 12 | 9 | 157 | 4895 |
Uttar Pradesh | 3277 | 671 | 174 | 4122 | 58,310 | |
Uttarakhand | 275 | 69 | 19 | 20 | 383 | 6660 |
West Bengal | 1374 | 406 | 70 | 55 | 1905 | 51,163 |
Source: Data as uploaded by States-UTs on HMIS portal, status as of 20 July 2018.
States/UTs | Rural hospitals | Urban hospitals | As on | ||
---|---|---|---|---|---|
No. | Beds | No. | Beds | ||
Andhra Pradesh | 193 | 6480 | 65 | 16,658 | 01.01.2017 |
Arunachal Pradesh* | 208 | 2136 | 10 | 268 | 31.12.2017 |
Assam | 1176 | 10,944 | 50 | 6198 | 31.12.2017 |
Bihar | 930 | 6083 | 103 | 5936 | 31.12.2016 |
Chhattisgarh | 169 | 5070 | 45 | 4342 | 01.01.2016 |
Goa* | 17 | 1405 | 25 | 1608 | 31.12.2017 |
Gujarat | 364 | 11,715 | 122 | 20,565 | 31.12.2016 |
Haryana* | 609 | 6690 | 59 | 4550 | 31.12.2016 |
Himachal Pradesh* | 705 | 5665 | 96 | 6734 | 31.12.2017 |
Jammu & Kashmir | 56 | 7234 | 76 | 4417 | 30.12.2016 |
Jharkhand | 519 | 5842 | 36 | 4942 | 31.12.2015 |
Karnataka* | 2471 | 21,072 | 374 | 49,093 | 31.12.2017 |
Kerala | 981 | 16,865 | 299 | 21,139 | 01.01.2017 |
Madhya Pradesh | 334 | 10,020 | 117 | 18,819 | 01.01.2016 |
Maharashtra | 273 | 12,398 | 438 | 39,048 | 31.12.2015 |
Manipur | 23 | 730 | 7 | 697 | 01.01.2014 |
Meghalaya* | 143 | 1970 | 14 | 2487 | 31.12.2017 |
Mizoram* | 56 | 604 | 34 | 1393 | 31.12.2017 |
Nagaland | 21 | 630 | 15 | 1250 | 31.12.2015 |
Odisha* | 1655 | 6339 | 149 | 12,180 | 31.12.2017 |
Punjab* | 510 | 5805 | 172 | 12,128 | 31.12.2017 |
Rajasthan | 602 | 21,088 | 150 | 10,760 | 31.12.2016 |
Sikkim* | 24 | 260 | 9 | 1300 | 31.12.2017 |
Tamil Nadu* | 692 | 40,179 | 525 | 37,353 | 31.12.2017 |
Telangana* | 802 | 7668 | 61 | 13,315 | 31.12.2017 |
Tripura* | 99 | 1140 | 56 | 3277 | 31.12.2017 |
Uttar Pradesh* | 4442 | 39,104 | 193 | 37,156 | 31.12.2017 |
Uttarakhand | 410 | 3284 | 50 | 5228 | 31.12.2015 |
West Bengal | 1272 | 19,684 | 294 | 58,882 | 01.01.2015 |
Andaman & Nicobar Islands | 27 | 575 | 3 | 500 | 31.12.2016 |
Chandigarh | 0 | 0 | 4 | 778 | 31.12.2016 |
Dadra & Nagar Haveli* | 10 | 273 | 1 | 316 | 31.12.2017 |
Daman & Diu | 5 | 240 | 0 | 0 | 31.12.2015 |
Delhi | 0 | 0 | 109 | 24,383 | 01.01.2015 |
Lakshadweep | 9 | 300 | 0 | 0 | 01.01.2016 |
Puducherry | 3 | 96 | 11 | 3473 | 01.01.2016 |
INDIA | 19,810 | 279,588 | 3772 | 431,173 |
States/UTs provided information for the year 2017 and PHCs are also included in the number of hospitals.
Source: National Health Profile 2018/Directorate General of State Health Services.
Notes: Government hospitals include central government, state government, and local govt. bodies. Figures are provisional.
Srl no. | State/UT | Number of hospitals | Number of beds | ||||||
---|---|---|---|---|---|---|---|---|---|
Govt. | Local Body | Others | Total | Govt. | Local Body | Others | Total | ||
1 | Andhra Pradesh | 8 | 0 | 0 | 8 | 365 | 0 | 0 | 365 |
2 | Arunachal Pradesh | 11 | 0 | 1 | 12 | 100 | 0 | 25 | 125 |
3 | Assam | 4 | 0 | 0 | 4 | 205 | 0 | 0 | 205 |
4 | Bihar | 8 | 0 | 0 | 8 | 950 | 0 | 0 | 950 |
5 | Chhattisgarh | 7 | 0 | 8 | 15 | 370 | 0 | 470 | 840 |
6 | Delhi | 4 | 0 | 1 | 5 | 390 | 0 | 210 | 600 |
7 | Goa | 0 | 2 | 0 | 2 | 0 | 150 | 0 | 150 |
8 | Gujarat | 35 | 29 | 0 | 64 | 1495 | 1763 | 0 | 3258 |
9 | Haryana | 4 | 0 | 7 | 11 | 145 | 0 | 600 | 745 |
10 | Himachal Pradesh | 34 | 0 | 0 | 34 | 710 | 0 | 0 | 710 |
11 | Jammu & Kashmir | 2 | 0 | 0 | 2 | 75 | 0 | 0 | 75 |
12 | Jharkhand | 1 | 4 | 0 | 5 | 50 | 300 | 0 | 350 |
13 | Karnataka | 156 | 0 | 57 | 213 | 2455 | 0 | 7740 | 10,195 |
14 | Kerala | 162 | 0 | 0 | 162 | 4054 | 0 | 0 | 4054 |
15 | Madhya Pradesh | 23 | 0 | 0 | 23 | 690 | 0 | 0 | 690 |
16 | Maharashtra | 5 | 0 | 66 | 71 | 812 | 0 | 8024 | 8836 |
17 | Manipur | 10 | 0 | 0 | 10 | 0 | 0 | 0 | 0 |
18 | Meghalaya | 10 | 0 | 0 | 10 | 100 | 0 | 0 | 100 |
19 | Mizoram | 2 | 0 | 0 | 2 | 100 | 0 | 0 | 100 |
20 | Nagaland | 2 | 0 | 0 | 2 | 10 | 0 | 0 | 10 |
21 | Odisha | 9 | 0 | 5 | 14 | 593 | 0 | 310 | 903 |
22 | Punjab | 5 | 0 | 4 | 9 | 100 | 0 | 108 | 208 |
23 | Rajasthan | 137 | 0 | 0 | 137 | 1391 | 0 | 0 | 1391 |
24 | Sikkim | 1 | 0 | 0 | 1 | 10 | 0 | 0 | 10 |
25 | Tamil Nadu | 293 | 0 | 0 | 293 | 2381 | 0 | 0 | 2381 |
26 | Tripura | 4 | 0 | 0 | 4 | 60 | 0 | 0 | 60 |
27 | Uttar Pradesh | 2315 | 0 | 1 | 2316 | 11,361 | 0 | 100 | 11,461 |
28 | Uttarakhand | 404 | 0 | 1 | 405 | 2023 | 0 | 50 | 2073 |
29 | West Bengal | 11 | 0 | 11 | 22 | 530 | 0 | 620 | 1150 |
30 | Andaman & Nicobar Islands | 5 | 0 | 0 | 5 | 90 | 0 | 0 | 90 |
31 | Chandigarh | 0 | 0 | 2 | 2 | 0 | 0 | 80 | 80 |
32 | Dadra &Nagar Haveli | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
33 | Daman &Diu | 2 | 0 | 0 | 2 | 20 | 0 | 0 | 20 |
34 | Lakshdweep | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
35 | Puducherry | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
36 | Telangana | 20 | 0 | 0 | 20 | 841 | 0 | 0 | 841 |
Total (A) | 3694 | 35 | 164 | 3893 | 32,476 | 2213 | 18,337 | 53,026 | |
B. CGHS & central government organizations | 50 | 0 | 0 | 50 | 2216 | 0 | 0 | 2216 | |
Total (A+B) | 3744 | 35 | 164 | 3943 | 34,692 | 2213 | 18,337 | 55,242 |
Source: Ministry of AYUSH.
S. no. | Name of state | No. of hospitals | No. of beds |
---|---|---|---|
1 | Assam | 8 | 2357 |
2 | Andhra Pradesh | 1 | 306 |
3 | Andaman & Nicobar Islands | 1 | 107 |
4 | Arunachal Pradesh | 1 | 198 |
5 | Bihar | 2 | 348 |
6 | Delhi | 2 | 1993 |
7 | Goa | 2 | 175 |
8 | Gujarat | 5 | 666 |
9 | Haryana | 3 | 1458 |
10 | Himachal Pradesh | 6 | 699 |
11 | Jammu & Kashmir | 11 | 2643 |
12 | Jharkhand | 2 | 649 |
13 | Karnataka | 3 | 1090 |
14 | Kerala | 5 | 744 |
15 | Madhya Pradesh | 7 | 1402 |
16 | Maharastra | 11 | 4202 |
17 | Manipur | 1 | 74 |
18 | Meghalaya | 1 | 247 |
19 | Nagaland | 2 | 398 |
20 | Odisha | 2 | 147 |
21 | Punjab | 10 | 2990 |
22 | Rajasthan | 11 | 2115 |
23 | Sikkim | 2 | 247 |
24 | Tamil Nadu | 3 | 373 |
25 | Telangana | 3 | 764 |
26 | Tripura | 1 | 49 |
27 | Uttarakhand | 5 | 1402 |
28 | Uttar Pradesh | 15 | 4570 |
29 | West Bengal | 7 | 2107 |
Total | 133 | 34,520 |
Source: Ministry of Defense
S. no. | Zone/PU | Total no. of hospitals | Total no. of indoor beds |
---|---|---|---|
1 | Central Railway | 11 | 1164 |
2 | Eastern Railway | 8 | 1587 |
3 | East central Railway | 9 | 819 |
4 | East coast Railway | 4 | 339 |
5 | Northern Railway | 9 | 1101 |
6 | North Central Railway | 5 | 586 |
7 | North East Railway | 6 | 927 |
8 | North East Frontier Railway | 10 | 1107 |
9 | North Western Railway | 8 | 584 |
10 | Southern Railway | 10 | 1131 |
11 | South Central Railway | 7 | 714 |
12 | South Eastern Railway | 6 | 1086 |
13 | South East Central Railway | 5 | 250 |
14 | South Western Railway | 3 | 300 |
15 | Western Railway | 9 | 976 |
16 | West Central Railway | 7 | 456 |
17 | Intergral Coach Factory | 1 | 101 |
18 | Rail Coach Factory | 1 | 60 |
19 | Chittaranjan Locomotive Works | 1 | 197 |
20 | Diesal Locomotive Works | 1 | 105 |
21 | Diesel Loco Modernisation Works | 1 | 50 |
22 | Rail Wheel Factory | 1 | 46 |
23 | Research Design and Standards Organization | 1 | 30 |
24 | Metro/Kolkata | 1 | 30 |
25 | MCF/Raibareli | 1 | 2 |
26 |
Source: National Health Profile 2018 (as on 21/3/2018).
S. no. | States/UTs | Total no. of hospital | Total no. of beds |
---|---|---|---|
1 | Andhra Pradesh | 5 | 345 |
2 | Assam | 1 | 75 |
3 | Bihar | 3 | 50 |
4 | Chandigarh [Adm.] | 1 | 70 |
5 | Chhattisgarh | 0 | 0 |
6 | Delhi | 4 | 1416 |
7 | Goa | 1 | 15 |
8 | Gujarat | 12 | 910 |
9 | Himachal Pradesh | 2 | 150 |
10 | Haryana | 7 | 781 |
11 | Jammu & Kashmir | 1 | 50 |
12 | Jharkhand | 3 | 210 |
13 | Karnataka | 11 | 1675 |
14 | Kerala | 12 | 1178 |
15 | Madhya Pradesh | 7 | 725 |
16 | Meghalaya | 0 | 0 |
17 | Maharashtra | 13 | 2390 |
18 | Nagaland | 0 | 0 |
19 | Odisha | 6 | 325 |
20 | Puducherry | 1 | 75 |
21 | Punjab | 8 | 647 |
22 | Rajasthan | 6 | 495 |
23 | Sikkim | 0 | 0 |
24 | Tamil Nadu | 10 | 1856 |
25 | Telangana | 7 | 907 |
26 | Tripura | 0 | 0 |
27 | Uttar Pradesh | 16 | 1886 |
28 | Uttarakhand | 0 | 0 |
29 | West Bengal | 14 | 3534 |
Total |
Source: National Health Profile 2018.
The hospital pharmacy is one of the most important departments in the hospital, and it is responsible for drug procurement, storage, compounding, dispensing, manufacturing, testing, packaging, and distribution. This section is also in charge of pharmaceutical science and education research, which is carried out by skilled and knowledgeable pharmacists. The hospital pharmacy has a significant impact on healthcare cost economics. In today\'s hospital pharmacy, medication monitoring and drug information services are combined. Purchasing, storing, handling, pricing, and dispensing pharmaceuticals are all skills that a hospital pharmacist possesses. In addition, pharmacists give drug information to all healthcare professionals and the public, as well as serve as a link between the patient and the doctor. The criteria for acquiring pharmaceuticals, chemical and biological medications, and other items are provided by hospital pharmacists. They are also in charge of manufacturing and distributing pharmaceuticals like transfusion fluids, parenteral goods, pills, capsules, ointments, stock combinations, and safe drug storage. Hospital pharmacists can sterilize and dispense parenteral drugs made in hospitals. They fill, label, and distribute all medicine packages. Hospital pharmacists oversee purchasing pharmaceuticals, ensuring correct drug storage conditions, keeping records, and distributing pharmaceuticals to the outpatient department. In addition, hospital pharmacists provide drug monitoring services for inpatients and participate in hospital research programs [8]. Due to low wages, the hospital parts of a pharmacist\'s job have historically been overlooked in India; also, pharmacists have never been trained for a patient-centered role. Medical practitioners have never embraced pharmacists for clinical functions, while pharmacists have been hesitant to accept their profession\'s clinical obligations. Many Indian hospitals have begun to assign pharmacists a clinical role, with encouraging outcomes, but India still lags behind other countries in this regard. In India, the concept of a hospital pharmacy is confined to the dispensing of medications at hospital pharmacies [9].
Hospital pharmacies require certain personnel.
The dispensing, manufacturing, quality assurance, and clinical pharmacy services are all integrated within the hospital pharmacy. Personnel requirements for an inpatient pharmacy are determined by the nature and scope of services supplied by the department. The number of hospital pharmacists required is determined by the workload and the number of beds in the hospital. Small hospitals typically require a minimum of three pharmacists; however, this varies depending on the number of beds. Table 1 shows the number of pharmacists necessary based on the number of beds in a hospital [8].
Pharmacist requirement | |
---|---|
Bed strength | No. of pharmacists required |
Up to 50 beds | 3 |
Up to 100 beds | 5 |
Up to 200 beds | 8 |
Up to 300 beds | 10 |
Up to 500 beds | 15 |
Pharmacist requirement in hospitals.
According to 2011 data, the number of government hospital beds in rural and urban locations is shown in Table 2.
State | Rural hospital beds (government) | Urban hospital beds (government) | Total beds (government) | Proportion of rural and urban beds |
---|---|---|---|---|
Bihar | 1830 | 16,686 | 18,516 | 10:90 |
Chhattisgarh | 3270 | 6158 | 9428 | 35:65 |
Jharkhand | N.A. | N.A. | N.A. | N.A. |
Madhya Pradesh | 10,040 | 18,493 | 28,533 | 35:65 |
Odisha | 7099 | 8715 | 15,814 | 45:55 |
Rajasthan | 13,754 | 12,236 | 25,990 | 53:47 |
Uttar Pradesh | 15,450 | 40,934 | 56,384 | 27:73 |
Uttarakhand | 3746 | 4219 | 7965 | 47:53 |
EAG states | 55,189 | 107,477 | 162,630 | 34:66 |
Non-EAG states | 114,673 | 511,187 | 622,310 | 18:82 |
All India | 169,862 | 618,664 | 784,940 | 20.5:79.5 |
State and union territory wise number hospitals and beds in rural and urban areas in India.
N.A., not available.
Source: GOI, Table 6.2.2 State/UT wise number of govt. hospitals and beds in rural and urban areas (including CHCs) in India (provisional), in “Health infrastructure” in “National Health Profile, 2011,” Central Bureau of Health Intelligence, Ministry of Health and Family Welfare, 2011.
Personnel who work in hospital pharmacies must be knowledgeable and well-trained. The director of the pharmacy must have a postgraduate degree in hospital pharmacy, pharmacology, or pharmaceutics and serves as a liaison between pharmacy and non-pharmacy personnel. The hospital pharmacy\'s structure is depicted in the Flowchart below (Figure 1).
Organization structure of hospital pharmacy. Source: Nahata [
Even we have seen the present status, there were no significant improvements.
In India, the Pharmacy Act of 1948 was passed to ensure that every practicing pharmacist had a registration certificate [11, 12, 13]. On completion of the minimum diploma in pharmacy, educational institutes authorized by the PCI can grant this credential. A pharmacy diploma involves at least 2 years of education and 500 h of practical training, including three months in a community or hospital pharmacy [11]. These pharmacists with a diploma represent most of the workforce and run most community pharmacies in India today. A bachelor\'s degree in pharmacy is designed to meet the needs of the pharmaceutical business, with most graduates working in pharmaceutical companies or regulatory agencies. In comparison to community pharmacy, many B. Pharm graduates prefer to work in the pharmaceutical business because of the higher pay scale and other benefits.
In practice, these pharmacists with a diploma or bachelor\'s degree are still unheard of in half of the community pharmacies. Most patients come to community pharmacists for help on sexually transmitted diseases, minor ailments, contraceptive options, and menstruation issues [11]. The majority of community pharmacies are administered by people with minimal awareness of health issues or medical training, and pharmacists are hired on low pay rates. Most pharmacists in community pharmacies lack counseling abilities and are simply able to deliver medications. Despite the public\'s negative opinion of pharmacists and the idea that pharmacies are like grocery stores, community pharmacies remain the principal provider of low-cost medical treatment.
In India nowadays, the average cost of a prescription per patient who visited a private clinic is around 1000–1500 rupees, and the number of prescriptions per drug has increased. The marketing efforts of pharmaceutical companies have a significant impact on doctors\' prescribing patterns. Pharmaceutical companies spend less on R&D than they do on marketing. Medical representatives are trained by pharmaceutical companies to advertise and sell pharmaceuticals utilizing printed product materials, medicine samples, and gifts. Around 80,000 medical representatives are hired by pharmaceutical companies in India, and they are paid well.
In addition to their pay, they are offered significant incentives. General practitioners have been found to prescribe new products under the influence of sales reps. Furthermore, medical representatives promote medications by stating more indications than are officially registered.
One of the main tools used by pharmaceutical firms to advertise their medication is gifts (ranging from a table-top reminder to an air conditioner), gratification, foreign excursions, pleasure excursions, and so on. From clocks to air conditioners, calendars to cars, rubber bands to refrigerators, telephone indexes to television, and office items to overseas trips, the variety of gifts includes stationery, timepieces, bags, books, folders, office desks, medical supplies, and household items—from clocks to air conditioners, calendars to cars, rubber bands to refrigerators, telephone indexes to television, and office items to overseas trips. According to Chren and associates, there is an implicit relationship between doctors and the pharmaceutical industry, which leads to a responsibility to respond to gifts [14].
Advertising has a significant role in the marketing of medicine. Pharmaceutical companies spend a lot of money to advertise in medical and pharmaceutical magazines, which are read by a lot of general practitioners and clinical specialists. Medical journals in India would perish if pharmaceutical companies did not advertise in them. The advertising of pharmaceuticals is strictly monitored, and if there is any false information, harsh action is taken. Drug information should be accurate, current, and balanced, according to the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) and The Association of the British Pharmaceutical Industry (ABPI) guidelines. The IFPMA code must be followed by all members of the Organization of Pharmaceutical Producers of India (OPPI). Internal codes and promotional material for the pharmaceutical producers of India must be approved by medical advisers, according to the organization. A Promotional Quality Improvement and Assurance Committee also performs a thorough study of these promotional materials. Furthermore, this committee makes recommendations for marketing enhancements.
Irrational prescription and its consequences are heavily influenced by pharmaceutical marketing and promotional activities. The Medical Council of India has issued a new code of ethics for practitioners who receive any sort of compensation from pharmaceutical companies. New legislation in Rajasthan, India, states that a doctor must only put the generic name of a medicine on a prescription [14].
With the advent of clinical pharmacy, which provides high-quality treatment and assistance to patients, a pharmacist\'s job has been expanded. Pharmacists now provide drug and toxicity information, manage anticoagulation clinics, and administer smoking cessation programs, among other things.
The paramedic education system has been supply-driven, with no regard for industry demand. Allied healthcare providers are the most crucial because, if a patient has a hundred interactions at a hospital, allied healthcare workers account for 80 of those encounters. In India, healthcare is the third most important source of employment. It is broken down into three categories: Doctors make up 10–15% of the healthcare workforce, nurses make up 20–25% of the workforce, and paramedics, also known as allied healthcare professionals or healthcare technicians, make up the largest segment of the healthcare workforce. The doctor-to-allied healthcare-professional ratio in India is 1:4. The advanced countries, such as the United States and the United Kingdom, have a 1:20 ratio. India already employs over 10 million allied healthcare workers, but to meet the 1:20 ratio, we will need to increase this number to 40–50 million in the next few years. Diagnostic, curative, and rehabilitative allied healthcare professions are categorized into three groups. The diagnostic and therapeutic industries in India have been expanding. Allied healthcare professionals such as X-ray technicians and medical app technicians work in diagnostic. Technicians such as OT technicians and emergency medical technicians work in Curative. The difficulty is that in India, only about 7% of these allied healthcare professionals are certified because there was no centralized authority to certify them until the NSTC was established. Before NSTC, each state certified them at their own level, and the biggest problem today is for quality healthcare services, allied healthcare professionals are the most important because if a patient has a hundred interactions in a hospital, 80 of those interactions are with allied healthcare professionals, and the biggest challenge in India is that there are less than a hundred allied healthcare professionals. Until 2008, there was no centralized body. One of the most significant issues is that, in general, education in India has been supply-driven, with no connection to industry needs. As a result, when compared to worldwide norms, we are one of the least prepared for the workforce. What needs to be done is for education to be driven by demand. It must be presented from the standpoint of the company and how these individuals will work in the sector. To do so, we must recognize three factors—technical training, practical training, and soft skills and grooming training, all of which must be provided so that these individuals are prepared to fully contribute to the workforce in a productive manner when they enter the workforce. Mr. Narendra Modi, Prime Minister of India, believes that ongoing training of the workforce required to combat the COVID 19 crisis is critical. He recommended officials and doctors to hold training sessions and webinars, particularly for paramedics and doctors who work in rural areas. He also requested that the officials endeavor to reduce vaccination waste in the district. Interacting with Varanasi doctors and administrators via video chat Prime Minister Narendra Modi paid a heartfelt tribute to those who died because of COVID-19. He emphasized the necessity of ongoing training for those fighting COVID, advising officials and doctors to hold training sessions and webinars, particularly for paramedics and doctors functioning in remote areas. He also requested that the officials endeavor to reduce vaccination waste in the district. "Jahan Bimar Wahan Upchar," is the new slogan in COVID management in terms of delivering therapy to the patient\'s doorstep that will minimize the strain on the health system. The doctors from Varanasi updated the other doctors through video conference on the measures made in the last month to restrict the spread of COVID, vaccination status, and ongoing steps and strategies to prepare the district for future difficulties. They stated that they have been vigilant in their response to the threat of mucormycosis and have already taken action and established facilities to handle the condition. Our Prime Minister also praised the microcontainment zones project and praised the home distribution of medicines, and he urged health professionals to make the campaign as widespread as possible in rural areas. He praised the physicians, nurses, technicians, ward boys, ambulance drivers, and other Kashi frontline health professionals for their efforts. He praised the medical staff in Kashi for their efforts in controlling the pandemic to a large extent, but warned against complacency, urging them to fight a lengthy battle right now by focusing on the rural districts of Banaras and Purvanchal. PM emphasized the critical role of Accredited Social Health Activists (ASHAs) and Auxiliary Nursing Midwifery (ANMs) sisters in the ongoing village campaign against COVID-19 and urged health officials to use their potential and experience. The main reason is if the frontline employees had already been vaccinated, they were able to serve the people safely during the second wave. We need to encourage everyone to get the vaccine when it is their turn, that is what has currently been done.
Diverse countries and continents, including emerging, transitional, and industrialized countries, have different pharmaceutical practices. The World Health Organization (WHO)/International Pharmaceutical Federation (FIP) joint guideline of good pharmacy practice (GPP), which was updated in 2011, is meant to account for these changes in practice. The pharmacy profession is rapidly expanding, with new responsibilities being offered and announced not only by pharmacists but also by other medical professionals, national organizations, and institutions. The GPP\'s guideline is progressive and adaptable, and it must remain relevant when new positions develop. Standardizing many parts of pharmacies is one of the most important techniques of quality control for medications and pharmaceutical services for the public. The GPP Guide is a significant step toward bettering pharmacy services [12]. The GPP guideline is designed for use by national professional pharmaceutical associations, as well as national authorities and other relevant agencies responsible for drafting relevant documents and related laws and regulations in their countries, according to the WHO and FIP. It is not a clear national standard, but it does provide guidance on certain tasks, responsibilities, and actions that help pharmacists to fulfill their mission. Professional issues and attitudes are given specific attention throughout the guideline\'s content, and the patient\'s well-being is given priority. However, it should be noted that this is the first time that a legal, economic, and labor framework has been introduced in the context of the GPP structure, and it comes at an appropriate time given global debates on the economic aspects of medicines, access to quality medicines, access to skilled medical workers, the global workforce failure, the increased cost of medical care, and new models of healthcare [13]. The GPP is defined by the WHO and the FIP as a pharmacy practice that satisfies the needs of people who use pharmacists\' services to deliver optimal medical care based on evidence-based medicine principles. To support this approach, a national framework of quality standards and guidelines is required. The goal of this project is to investigate the historical stages of development of GPP requirements, as well as to examine modern normative texts proposed by FIP for use in global pharmaceutical practice, as well as to investigate the current state of this issue around the world. The study included the generalization of information material and system analysis methods. The WHO and the FIP have been working together since the late 1980s to define pharmacist duties and functions, as well as produce guidelines for the GPP as a framework for pharmacological care. The WHO amended the medicines strategy, which was accepted by the World Health Assembly in 1986, and two meetings on the function of pharmacists were held in accordance with it. The inaugural meeting was held in Delhi, India, in 1988 [15]. The FIP produced criteria for pharmaceutical services in 1992, and the WHO Information Centers disseminated the approach of good pharmaceutical practice in March 1993. The standards of pharmacy services entitled "GPP in Public and Hospital Pharmacies" were officially issued during the convention in Tokyo, Japan [15]. Under the framework of the Tokyo declaration on quality standards of pharmaceutical services, the FIP congress accepted the FIP/GPP text. The FIP has asked pharmaceutical companies and governments to work together to implement GPP standards or to amend current national standards in countries where they currently exist, according to this paper. Then, in May 1994, the World Health Assembly adopted a resolution on the role of the pharmacist in support of the WHO\'s new pharmaceuticals strategy. In 1994, a version of the GPP was also presented to the WHO Expert Committee on Pharmaceutical Medicine Specifications in Geneva. In 1999, a joint document of the WHO/FIP of the GPP was published in a series of technical reports of the WHO Expert Committee on concerns of pharmaceutical medicine specification, following the recommendations of the WHO Expert Committee and the approval of the Board of the FIP in 1997. This gave the GPP more formal standing and assured that it was widely distributed around the world [16]. A Soon after, the WHO convened two more meetings on the pharmacist\'s role, one in 1997 in Vancouver, Canada, and the other in 1998 in The Hague, Netherlands. These gatherings reinforced the necessity for reforming pharmacy education programs and highlighted the pharmacist\'s role in self-help and self-healing. The European Union\'s (EU) pharmaceutical group prepared a paper containing the GPP for Europe in 1998, with special emphasis dedicated to EU countries—"the GPP in Europe." [17]. The “GPP in the New Independent States” was established in 2001. The Copenhagen Center for Drug Policy and Development of Pharmaceutical Practice developed “Guidelines for the creation and implementation of standards” in Denmark. The document examined the state of pharmacy practice and focused on issues such as health education and morbidity prevention, the provision of prescription drugs and their use, self-treatment, the effects of prescription and use of drugs, as well as the method of implementing proper pharmacy practices in developing countries. The WHO experts recommended that European standards for pharmacies be implemented on a par with existing national standards to regulate various aspects of pharmaceutical activity, including the quality of prescription data received by the pharmacist, the development of medical forms, the building of contacts with doctors based on individual recipes, and the evaluation of data on the use of medical products [18]. There is a strategy for establishing national GPP standards, according to FIP recommendations. To begin, fundamental pharmaceutical services must be established, for which a regulatory framework and relevant standards must be created. The secondary and higher education systems in pharmacy should be revised after that because pharmacists will require a more in-depth understanding of pharmacotherapy, pharmacopeia, and communications skills. The provision of more complex professional pharmaceutical services is the ultimate stage. The FIP highlights GPP elements that demonstrate that the pharmacy provides high-quality service and adheres to strict guidelines: The presence of a zone in the pharmacy with information about healthy lifestyles; availability of a pharmacy for people with disabilities and elderly patients; availability of a comfortable waiting area; the possibility of a private conversation between a pharmacist and a patient, including those with disabilities; and the presence of a pharmacist on call. The pharmacist\'s responsibility in providing successful drug therapy, according to FIP\'s recommendations, is as follows: Management of therapy, monitoring of treatment success, and disseminating information on the safe and effective use of medications. The pharmacist should evaluate the client\'s health and needs, taking into consideration his unique qualities. Professional collaboration between the pharmacist and the doctor is an important part of GPP. Each patient\'s medical and pharmacological information (diagnosis and laboratory data) should be in the first one. It is also crucial to keep track of whether GPP standards are being followed. It can be internal and/or external; it can also be necessary or simply for accreditation/certification purposes. This will disclose the drawbacks of meeting GPP requirements as well as ideas for how to avoid them. One of the simplest ways to ensure that a pharmacy\'s work is of high quality is to assess customer satisfaction with the service. In 2006, FIP and WHO collaborated to publish the handbook "Developing Pharmacy Practice—A Patient-Centered Approach." This guide introduces the new pharmacy practice paradigm and the approach to pharmaceutical assistance. The FIP has taken the initiative to explore the possibilities of providing technical assistance to its member organizations in Cambodia, Moldova, Mongolia, Paraguay, Thailand, Uruguay, and Vietnam in developing national standards of the GPP in a pilot project to improve standards and practice of medicine distribution and use with the help of the WHO/FIP setting with the GPP as the framework. The “Bangkok declaration of the GPP in public pharmacies” was adopted across Southeast Asia in 2007, and member associations pledged to improve the quality of pharmacy services and professional practice [19]. Significant advances in practice applied science and technology, and pharmaceutical policy has happened since the GPP guideline was accepted in community and hospital settings. Despite changes that have occurred since the GPP\'s previous guidance in pharmaceutical policy, practice, and applied science was adopted in 2007, FIP was established to investigate the problem of updating the GPP\'s guiding principles to reflect current standards and professional thinking peculiarities [20]. During the 68th World Congress in Basel, Switzerland, in 2008, the FIP convened expert consultations for this aim. A total of 50 people attended the meeting, including members of the working group (WG), FIP of the GPP, WHO headquarters staff, representatives from the WHO regional office for the Eastern Mediterranean countries, medicines advisers from Ghana, Nigeria, and the United Republic of Tanzania, presidents, and secretaries of six Regional Pharmaceutical Forums, FIP member organizations, and several NGOs [21]. Following these consultations, the FIP GPP working group performed a detailed examination of current national standards for GPP in at least 37 countries and developed a time zone that could allow for adequate consultations with all 120 national associations, relevant experts, and the WHO. In October 2008, a proposal for this project was given to the WHO Expert Committee on concerns of pharmaceutical medicine specification at its 43rd meeting, and an updated report was provided to the Committee of Experts at its 44th meeting in October 2009. Simultaneously, in late 2008, the Pan-American Health Organization prepared “the guide for pharmaceutical services in primary health care” with the help of a group of experts from various pharmaceutical organizations, with the goal of highlighting the role of pharmaceutical experts in Latin America\'s health system. Following discussion with 120 national members of the FIP in 2011 and changes in the pharmaceutical industry, the GPP recommendations were adopted and updated by the approval of a joint guideline FIP/WHO titled "the GPP: Standards of the quality of pharmacy services." This general guideline was released as new standards of pharmacy service quality in the WHO Expert Committee\'s 45th report. In addition, this document encourages national pharmacy professional associations to embrace these standards and propose some GPP-specific norms [22]. The GPP establishes standards that are usually higher than the requirements of a country\'s pharmaceutical legislation. In the modified version of the GPP, pharmacists play many roles:
Medical product manufacturing, receiving, storage, security, distribution, usage, release, and disposal.
Ensuring that the pharmacological therapy is properly managed.
Continuation and enhancement of professional activity.
Encouraging the system of medical care and health to become more effective [20].
Depending on the duties that each pharmacist does, these positions may differ. Only through national pharmacy professional associations may specific GPP standards be defined. This recommendation is made in the form of a set of professional goals that must consider the needs of patients and other pharmaceutical stakeholders.
In comparison to the previously authorized concept of the GPP, the present updated version reinforces the requirements for the GPP\'s well-known primary aspects and identifies functions in each pharmacist\'s position for which minimum national standards should be established. Different countries have different versions of the GPP rules. There are holistic papers in some countries that cover both requirements for the material-technical base, infrastructure, personnel, and standards for the provision of pharmacological treatment. These rules and regulations are spelled out in numerous documents in other countries. The standards for pharmacists in France, for example, are established in several guidelines. In Austria, on the other hand, nearly all the requirements for pharmacists are encapsulated in a single piece of legislation. There is also a guideline for pharmacists\' work, which includes standards for a quality management system in addition to the typical criteria for premises, equipment, and staff. The GPP standards have a recommended status in industrialized countries. As a result, the Norwegian pharmaceutical association\'s standards of pharmacy practice, created in partnership with other professional groups, include requirements for pharmacy activities that are utilized by pharmacy owners to conduct internal quality control of pharmacy services. The government adopts legislation acts that provide the minimum standards for the functioning of pharmacies [23]. The Pharmaceutical Society of Ireland published a guideline on pharmacy practice to help pharmacists meet legal and regulatory requirements when providing pharmaceutical services [24]. In addition, the GPP is adopted in CIS countries. Belarus has implemented a pharmacy classification system. The GPP was adopted in Kazakhstan in 2006, and the provisions of the GPP of the customs union are currently approved in the Russian Federation. It should be noted that the GPP standard and guidance on the implementation of proper pharmacy practices serve as the foundation for implementing the total quality management (TQM) concept and the international standard of ISO quality management at pharmaceutical companies, both of which have been in use for more than 30 years. The understanding of the existence of an inextricable link between the quality management system and the organization\'s management system, as well as the understanding that this is an essential tool for continuous improvement and increasing the pharmacy organization\'s competitiveness in any market, is the foundation of TQM [25]. As a result, by enhancing the requirements to assure the quality of public services, the GPP standards are a significant step toward the expansion and enhancement of pharmacy operations. Despite improvements in pharmaceutical research and practice, the development and implementation of GPP criteria into pharmacy practice is a long-term and ongoing process. The standardization of pharmacists\' activity in providing people with medications and medical items receives a lot of attention in GPP guides of all years. Because national regulation of pharmacy practice differs widely among nations, the establishment of GPP standards should be handled at the level of public professional organizations. The results of the study will be used to design and apply GPP national standards around the world, according to future scientific research.
A recent countrywide survey done by final year postgraduate diploma in management students from Indian Institute of Health Management & Research, Bangalore finds that out of 107 hospitals 66 hospitals only follow the WHO/FIP GPP 2011 or Indian Pharmacy Practice Regulations 2015 which is merely 62% of the entire sample.
Students were asked to conduct a brief analysis and report on the top five hospitals or community pharmacy dept. in their area or where they did train/observer ship whether these guidelines are followed or not and where are the loopholes in following this guideline. There were two kinds of data generated, such as
The graphical representation of the quantitative survey data is illustrated as follows:
The qualitative observational/survey data is represented as follows:
Qualitative survey result | Observations |
---|---|
Narayana Health City | While working in a Pharmacy Department of the Hospital, many things are founded like:
There should be a proper space in the IP pharmacy. Pharmacists should be provided with more space with more no of counters. Expired medicine should be categorized separately. Medicine should be categorized on a monthly basis so that it may return on time. Calls should be attended properly by the staff. The pharmacy should categorize the drugs, injections, medical consumables in an order so that anyone can find it quickly. Drinking water facilities should be there. There should be proper lighting facilities. The pharmacy should be hygienic. |
Dr. Agarwal\'s Eye Hospital Chain, S V Hospital & C M N Hospital |
|
Sagar Hospital | Most common loopholes and challenges found in the hospital pharmacy. As hospitals have a pharmacy, they mostly followed the FIP guidelines but there are some challenges and loopholes faced by the hospital pharmacy. The challenges related to the pharmacist include the inadequacy of service promotion, absence of service continuity, poor DIC service, and lack of commitment, communication, and confidence among clinical pharmacists. Most respondents declared that poor attitude toward the services, conflict of interest due to the unclear scope of practice, and absence of cooperation are the challenges that radiate from health practitioners such as nurses and physicians. Some respondents also described challenges that arise from the hospital management and its set-up. The challenges they mentioned include lack of training, shortage of skilled manpower, lack of incentives, absence of facilities in the ward for clinical pharmacists, and collaboration between academics and hospital clinical pharmacists. The other challenges stated by the respondents were due to the academic policy and the curriculum itself. This encompasses some gaps of the curriculum; absence of clear job description and working guidelines; and documentation system. The major challenges for clinical pharmacy services described were a lack of support from hospital management, absence of clearly defined roles and responsibilities for the clinical pharmacists, a shortage of pharmacy workforce and staff turnover, a lack of follow-up from responsible bodies, and a lack of enough salaries and incentives for the healthcare providers. |
Aditya Netralaya |
|
Mithra Hospital |
|
General | Many of the hospitals do not have an assigned clinical pharmacist, which makes the difficulty in practicing Rule number 2 of the standards of GPP. Workforce shortage during peak OPD hours there should be a training of pharmacists and associated personnel on regular basis. Updating newer guidelines. Sometimes when too much workload is there, pharmacists are unable to properly counsel the patients/attendants regarding doses, their uses, drug interactions, etc. Shortage of time for EWS pharmacy. Because medications are not always available, it is extremely inconvenient for patients to return after time. The room does not have adequate light and ventilation. There is a lack of adequate space for the storage area of the pharmacy. No trained personnel in pharmacy, that is, the staff is from nonpharmaceutical or nonmedical backgrounds. No proper support is seen in abiding by policies of government related to health outcomes as per the guidelines of Role 4. Drug availability is not meet the needs of patients. No proper record is maintained in any aspects related to dispensing or storing of drugs. |
No proper follow-up of patient turnaround time at the pharmacy | |
Narayana Health City | Missing of personnel in the pharmacy increases the patient waiting time |
Omni R K Hospital | No trained personnel in pharmacy, that is, staff from nonpharmaceutical or nonmedical background |
Gayathri Hospital | No trained personnel in pharmacy, that is, staff from non-pharmaceutical or non-medical background |
Pharmacy practice, which includes clinical, community, and hospital pharmacy, is referred to as healthcare in the true sense. PPs establish a vital link between doctors, nurses, and patients in a social community group, with the goal of improving patient welfare and safety [26]. Pharmacists must provide more than only distribution; they must also provide services to society, such as patient counseling, guidance, and the organization of drug data for human services, suppliers, and patients [27]. For example, before the product patent was implemented in India in the early 2000s, the pharma industry thrived successfully after the amendment of new monetary reforms in India in the mid-1990s until the early 2000s [28]. In terms of educational outcomes, the degree of student achievement in pharmacy has improved from 2012 to 2020 and is predicted to continue to climb due to its scope. Many pharmacy graduates have expressed an interest in medication discovery and innovation through research [29]. It has been suggested that pharmacies play an important role in strengthening social security because they work around the clock to maintain a chain of elegant integrity on drugs, particularly during the COVID-19 pandemic. From the standpoint of regulatory authorities, PPs play a variety of roles and duties in the execution of new recommendations based on situational faults [30].
It entails the implementation, evaluation, and interpretation of pharmacy orders as well as the dispensing of prescriptions. Pharmacists are responsible for providing patient counseling, legislation, and social services to promote pharmaceutical treatment as primary care in all areas of patient health [31]. They are also in charge of segregating and labeling pharmaceuticals and medical devices, as well as guaranteeing the safety of medication and device storage and maintaining adequate records [32].
The Pharmacy Act is a nonconstitutional statute.
There cannot be two regulators at the same time.
The AICTE Act is a broad statute.
The Pharmacy Act is a unique piece of legislation.
The Pharmacy Act is a comprehensive code that includes pharmacy specialists.
Only the Pharmacy Council of India (PCI) has the authority to set pharmacist qualifications.
Only PCI has the authority to set standards for pharmacies.
PCI will be solely responsible for approval and admission to institutes.
The Pharmacy Act has the power to govern not just pharmacy education but also the profession [33].
In India, there are two types of pharmacists—those who work in hospitals and those who work in
Pharmaceutical industry
Pharmacies in the community
Pharmacovigilance is a term that refers to the monitoring of pharmaceuticals.
Pharmacy schooling
Pharmacovigilance procedures
Bengal Chemical and Pharmaceuticals Ltd. was founded in 1892 as an individual initiative by the "Father of Indian Chemistry," Acharya Prafulla Chandra Ray, and is considered the country\'s first pharmaceutical enterprise. For the first time in more than six decades, Bengal chemicals and medicines Ltd. made a profit in 2016–17 [34].
For the manufacture, distribution, and sale of medications, India has the harshest rules and regulations in the world. The ability of law enforcement is not just determined by good legislation; it also requires stringent regulations and the acceptance of successful challenges. According to the Mashelkar committee\'s recommendations, one drug inspector should be assigned to every 50 manufacturing units and one to every 200 distribution outlets. In most states, 30–50% of positions are vacant, and the number of positions available is insufficient to expand the pharmaceutical sector. According to the Mashelkar committee report, one drug inspector is assigned to every 200 retailers, and the data from the All-India Organization of Chemists and Druggists (AIOCD) indicates that there are approximately 8.5 lakh pharmacies to be considered, implying that more than 4250 drug inspectors are required to manage the retail pharmacy segment [35].
CDSCO and SDRA have different roles.
Pre-manufacturing is the process of preparing a product for manufacture.
Expert panels help the Central Drugs Standard Control Organization (CDSCO) to regulate premanufacturing. The following is their primary role in dealing with the two major criteria:
Clinical studies (clinical trial registry, GCP, inspections, ethics committee, and significant adverse events)
Import and marketing license approvals for new drugs [36].
The State Drug Regulatory Authority (SDRA) oversees regulating drug product manufacturing in the states, while CDSCO oversees union territories. In some circumstances, the CDSCO and SDRAs undertake joint inspections [37]. The terms listed below are required for the manufacture of pharmaceutical products.
Permit (generic and marketing license)
GMP (good manufacturing practices) inspection
Drug testing and noncompliance penalties [31].
The SDRAs oversee regulating the distribution and sale of drugs in the states, while the CDSCO oversees the union territories. The terms listed below are required for the distribution and sale of pharmaceutical items.
Permit (sale and distribution practices)
Good Distribution Practices Inspection (GDP)
Drug testing and noncompliance penalties [38].
The current state of pharmacy education, authority functions, and future difficulties of pharmacists in all aspects was discussed, particularly considering the COVID-19 epidemic. During the development phase, it must overcome numerous obstacles, including regulations, duration, process controls, legal stumbling blocks, and situational flaws [39]. Table 3 summarized the educational updates.
Pharmacy program | Number of institutions | Annual intake |
---|---|---|
D Pharm | 3022 | 180,770 |
B Pharm | 1961 | 125,524 |
Pharm D | 267 | 8010 |
M Pharm | 792 | 24,465 |
Ph. D. in Pharmacy | 31 | 1240 |
Statistics of pharmacy education program in India.
From June 2, 2020, the PLI Scheme will be open for 4 months, allowing investors to propose the construction of Greenfield facilities for any of the 53 important drug intermediates and bulk pharmaceuticals that are now barely made in India [40]. The list contains important chemicals found in regularly given medications such as paracetamol, aspirin, metformin, atorvastatin, and others. The whole planned incentive package is worth Rs. 13,760 Crore, which is divided between bulk medicines and medical devices as shown in Figure 1.
COVID-19 PPs
Millions of people around the world are affected
Insight into no cure
Online (digital) education
Evaluate Indian strategy and tactics.
India\'s pharmaceutical industry\'s expectations in terms of global visibility
Opportunities with challenges
Across the several layers of regulatory and enforcement procedures, this industry suffers from knowledge asymmetry. Because each state has its own regulations, there is a lot of variation in the quality of drug regulation across the country [41]. India\'s drug inspectors, who are crucial players in drug regulation, should be highly qualified and adequately compensated to reflect the dignity that comes with such a large duty. The agency has a budget limit when it comes to implementing innovative methods of regulatory monitoring [39].
There is a great deal of anticipation, price pressure, and caution in the development of vaccines, particularly (Covaxin, Covishield, or Sputnik) for the treatment of COVID-19, which is still in Phase I and II clinical trials in India. There is a potential that poor data will emerge in a Phase III study, as several countries have done in the past, leading to vaccine development and outcome failure [42]. Nowadays, one of the most pressing issues in the management of process controls during the formulation of pharmaceuticals is the formation of impurities in the form of genotoxic and carcinogenic impurities, which are extremely toxic and harmful to patients taking medication for diabetes, gastric ulcers, and psychosis [43]. There is also a compensation challenge in India due to the loss of fixed-dose combination (FDC) drugs, as many of the 344 drugs in this category were banned and withdrawn because they were therapeutically irrational and caused toxicity in patients when used to treat chronic diseases like tuberculosis and HIV. As a result, there are still hopes of bringing FDCs to market for patient benefit with assurances of safety and efficacy [44]. If the financial expenditure is not increased, the quality of research, drug discovery, and development will suffer.
According to Holon IQ global education intelligence, the current $6 trillion education market will grow to $10 trillion by 2030. Digital platforms account for only 3% of worldwide education spending, and by 2025, they will account for $325 billion, or less than 5% of total spending [45, 46]. Although this will go a long way toward solving the country\'s educational challenges, the government\'s present worries include guaranteeing smooth delivery of education on the post-Covid road of digital education [47]. The UGC is now working on a game-changing regulation that will allow universities with a high “NAAC” score in the top 100 NIRF rankings to offer online programs. This will be a game-changer since educational jurisdiction will become worldwide, and only equipped universities will survive [48].
The following recommendations were implemented for the PPs based on the unique circumstance faced by each country because of COVID-19:
The pharmaceutical business must shift its focus away from COVID-19 and onto the needs of the country, as well as ideas for overcoming governmental and regulatory obstacles.
The government should provide adequate funds to PPs researchers for the development of novel drugs and the conduct of clinical trials.
To achieve the required results, the pharmaceutical business should learn to invest in quality staff and move its attention from the product to the patient [49].
Application of state and federal norms to protect public health and disease prevention.
Strengthening the regulations governing healthcare administration and professionals, requiring them to adhere to severe state-based rules.
There should not be a large reliance on API procurement from China; instead, actions should be done to ensure API supply from within the country.
Enabling workflow changes in principles while dealing with emergencies
To raise awareness and develop educational training programs to protect people\'s physical and mental health during the pandemic.
To combat COVID-19 as a naturopathy-based treatment, the pharmacognosy and phytopharmacy department should focus on herbal and ayurvedic formulation development.
Positive, credible, and evidence-based marketing to be made by PPs on the conventional way of using AYUSH-based drugs to combat COVID-19.
The general public should consume “Kapasura kudineer,” which is widely available in retail pharmacies, particularly in south India, and contains many combinations of herbs that can combat the coronavirus and other microorganisms. This has shown promising results, as many people have been benefited and relieved from COVID-19 in asymptomatic reported positive cases.
Steps to be done for e-learning/webinar programs in order to receive additional updates from the WHO and the health advisory council for pharmaceutical development and public health protection.
In the event of an emergency, the use of PPs as second-line healers or physicians to diagnose the patient\'s ailment [50].
During the COVID-19 epidemic, enabling e-prescriptions and home delivery of medicines to self-isolated individuals and older people by guaranteeing preventive steps and safety.
Advocacy with policymakers and stakeholders must be strengthened in order to create the optimal regulatory framework for the pharmaceutical industry to thrive.
The devastating second wave of the COVID-19 outbreak has brought strangers together offline and online to assist one another in any way they can. Even terrible stories of death and loss have not deterred some people from engaging in unethical and immoral actions including black-marketing medical life-saving medicines, hoarding, and defrauding in the name of COVID-19 medical supplies, and charging exorbitant prices for ambulance service. The Delhi Police recently raided a fine-dining restaurant in Lodhi Colony and seized 419 oxygen concentrators. These were being sold at an astronomical price of 69,999, complete with bogus MRP labels. About 96 oxygen concentrators were seized from Khan Chacha, owner of a famous food joint in Khan Market. When Delhi-NCR is in the midst of the biggest crisis in its history, notable figures in the city urge tough punishments for anyone who engages in such unlawful and inhumane activities. In connection with a Rs 450 crore medical equipment maintenance scam, Andhra Pradesh\'s Crime Investigation Department (CID) has filed a complaint against Bengaluru-based TBS India Telematic & Biomedical Services Private Limited, private individuals, and health department employees. The case was filed under the sections of the Indian Penal Code dealing with cheating, criminal conspiracy, and criminal breach of trust. Price increases, inflated bills for nonexisting equipment, and increased invoices for equipment in government hospitals in AP are among the irregularities. Over 300 doses of anti-COVID vaccination were taken from a hospital in Jaipur during a spike in coronavirus illness, forcing authorities to file a criminal complaint. According to agency reports citing a Centre RTI response, Tamil Nadu recorded 12.10% vaccine wastage, followed by Haryana (9.74%), Punjab (8.12%), Manipur (7.80%), and Telangana (7.80%) (7.55%). Vaccine wastage in Tamil Nadu is up to 13% for Covaxin and 9% for Covishield, according to data from the state directorate of public health, which distributes vaccines and regulates its use. Between January 16 and April 17, 7.14 lakh doses of Covaxin and 44.80 lakh doses of Covishield were sent to drug retailers, according to state authorities. A vial must be used within 4 h of being opened and stored at a temperature between 2 and 8°C. The state has used 47.05 lakh dosages by April 17, including 40.5 lakh Covishield. Health staff was under pressure to vaccinate as many individuals as possible. Even though there were not enough individuals, they opened bottles of 20 and 10 dosages. We will now be able to expand immunizations due to an increase in cases and stock. On Friday, as a new day dawned over Delhi, a somber narrative surfaced from Sir Ganga Ram Hospital, one of the capital\'s most prestigious institutions. In the last 24 h, at least 25 COVID-19 patients had perished there. Physical ventilation—occasional6manual compression of a gas-filled reservoir bag to drive the gas into a patient\'s lungs—has been used on occasion to ensure that patients on ventilator assistance survive. The burning question is how to treat patients when key supplies are not available. As per specialist doctors without oxygen, a patient who requires ventilator assistance can die in minutes. Many other hospitals were in a similar situation. The hospitals then devised a plan to have two patients share a cylinder by using connectors. But also, according to doctors, those on a ventilator can die in minutes if their oxygen supply is cut off. Doctors face a significant hurdle because of this. Despite government pledges and rules, the black market for Remdesivir, a crucial COVID-19 medicine, is thriving in Chennai, with many pharma dealers asking up to Rs 14,000 per 100-mg vial. Even though the Tamil Nadu government has promised to assist them in obtaining the drug, many private hospitals have thrown in the towel, leaving numerous COVID-19 patients in their care without treatment. A private COVID panel hospital has been charged with overbilling by the Kanpur district administration. On Monday, the complainant filed a complaint alleging that he was overcharged by Rs 3.50 lakh in the previous 7 days, and on Tuesday, the district administration issued a notice to the hospital\'s management after completing a preliminary investigation. The charges were confirmed to be accurate after a preliminary investigation by the extra city magistrate and a government doctor. When the hospital\'s management failed to respond satisfactorily, district magistrate Alok Tiwari issued an order to register an FIR against it on Tuesday. The administration has appointed static magistrates and sector magistrates to investigate overbilling issues in private panel hospitals, according to the district magistrate. Furthermore, the government has already circulated cell phone numbers for the public to use to report any overbilling complaints. Despite threats of severe consequences for overbilling, private panel hospitals are seizing every opportunity to overcharge patients. Prices of oxygen concentrators, oximeters, and nebulizers have risen by 50–100% in the last 10 days, owing to a massive demand-supply mismatch as the coronavirus epidemic enters its second wave. Even as the organized medical device sector, legal entities, and consumers pressed for enforcing pricing control over these products, e-commerce giant Amazon stated it has begun removing listings of accounts selling these products beyond MRP. Over the last 7 days, the price of oxygen concentrators, which generate oxygen from the air, has nearly doubled, while the price of oximeters has increased by Rs 1000–2000. Prices have risen in both physical businesses and online marketplaces such as Amazon and Flipkart. The government set a price cap on certain products last year, but some vendors, companies, and importers are not following it. A spokesman for Amazon India stated the business is taking urgent action to stop the surge pricing. Hundreds of tweets from customers have gone viral, claiming that they had to pay more than Rs 1 lakh for oxygen concentrators that would normally cost Rs 45,000. The device\'s monthly rentals have also increased from Rs 5000 to Rs 10,000–20,000. Many sellers and importers have boosted costs of COVID-essential medical supplies by two to four times in just a week, even on online markets like Amazon and Flipkart. The problem is large with imported products by opportunistic dealers who import these products at low costs and then continuously raise prices to profit from the scenario while blaming it on their suppliers.
Since the pharmaceutical industry\'s exponential rise, there has been a need to regulate the interaction between pharmaceutical firms and medical practitioners. The Indian Medical Council (Professional Conduct, Etiquette, and Ethics) Regulations, 2002, as revised until February 1, 2016, ("MCI Regulations") were enacted with this in mind. The MCI Regulations, Regulation 6 (Unethical Acts), establishes a code of conduct for medical practitioners in their interactions with the pharmaceutical and allied healthcare industries. The MCI Regulations, on the other hand, apply only to medical practitioners. As a result, on December 12, 2014, the Department of Pharmaceuticals ("DoP") declared the Uniform Code of Pharmaceuticals Marketing Practices ("UCPMP") effective on January 1, 2015, for a 6-month period of voluntary adoption. When the DoP announced UCPMP, it stated that it was a voluntary code for the Indian pharmaceutical industry, but warned that if it is discovered that the pharma associations/companies have not implemented it successfully, the government may consider making it a statutory code. The DoP then extended UCPMP until further orders on August 30, 2016. Despite the fact that the UCPMP was the first of its kind and contained substantial regulations, the DoP attempted to replace the voluntary code with mandatory recommendations since it was optional. As a result, the DoP transmitted the draught Essential Commodities (Control of Unethical Practices in Drug Marketing) Order, 2017 ("Order") to the Law Ministry in July 2017 for final approval. The Law Ministry, on the other hand, is concerned about the Order, which is now being sought to be issued under the Essential Commodities Act, 1955. It is worth noting that the Order is beyond the scope of the Vital Commodities Act of 1955 ("Act"), whose goals are to control the manufacture, supply, and distribution of essential commodities rather than to oversee medication marketing. In 2015, the UCPMP was expanded to include the medical devices business, which is worth more than Rs 25,000 crore annually. The Order indicates that it will not apply to medical devices because the DoP is in the process of creating and releasing a separate code of marketing practices for the medical device industry (which would be voluntary for 6 months). The Order, like the UCPMP, prohibits pharmaceutical corporations from presenting cash, gifts, or sponsorship to doctors, chemists, or pharmacists, as well as giving travel facilities or paid vacations. Any pharmaceutical firm or its representatives are prohibited from giving presents, cash cards, hampers, or any other item that may produce monetary benefit or allow profits in kind to a medical practitioner, a retail chemist, or pharmacists, or their "family members" under paragraph 3 of the Order. It does, however, allow for the financing of academic conferences organized by medical groups, as well as the organization of screening camps or awareness campaigns in government-owned healthcare institutions, with the caveat that these cannot be used as surrogate advertising. A pharmaceutical business or its agent is also prohibited from providing free samples to any medical practitioner under the terms of the Order. Allowing pharmaceutical companies to distribute free samples up to a full course of medicines for a maximum of three patients has created an exemption to this norm. Three, on the other hand, is a modest amount for any medical professional to comprehend and analyze the effects of a new drug on patients. It is important to note that the term "Agent" is defined very broadly in paragraph 2(b) of the Order, and includes any person, company, society, nongovernmental organization, or other institution who has been hired or authorized by a third party to call on any healthcare facility to promote a pharmaceutical company\'s drugs. The Order further states that a company\'s MD or CEO is accountable for ensuring that the Order is followed. All complaints involving violations of the Order shall be investigated by an Ethics Compliance Officer (ECO) designated by the Government of India, who shall not be below the rank of a Joint Secretary to the Government of India, according to paragraph 5 of the Order. It should be noted that a firm or its agent who fails to comply with the terms of subparagraphs (a) (b) (c) or (d) of paragraph 3 of the Order will face a penalty under paragraph 4 of the Order. Furthermore, paragraph 5(4) of the Order lays out the mechanism for imposing a penalty by prohibiting the breaching corporation from marketing its best-selling product for the previous 12 months for a period of three to one year. The Order also states that corporations can pay a penalty ranging from Rs 5 lakh to Rs 10 lakh to have the marketing prohibition lifted. According to the Order, the DoP Secretary will be the appellate authority, and appeals from the Appellate authority\'s orders will be handled by the court.
There is an utmost necessity to relook and re-establish the standards of pharmacy practice in healthcare setups available in each and every corner of the country in line with guidelines provided by the World Health Organization (WHO) and International Pharmaceutical Federation (FIP). For that, the dependency and responsibilities are very high on healthcare professionals, particularly in this pandemic situation. The pharmacy zone is adaptable, evolving, and increasingly diverse, offering a wide range of work and management opportunities to execute [27]. PPs are human service professionals whose responsibilities include safeguarding individuals by dispensing medications based on prescriptions [28]. Representing the world\'s third-largest medicinal services with active gathering, and in India, there are over 1,000,000 (1 million) enrolled PPs employed in various capacities and readily contributing to the country\'s well-being [51]. Pharmacy practice, which includes clinical, community, and hospital pharmacy, is referred to as total healthcare in its true sense. Through adaptation and implementation of GPP in healthcare setup, PPs form an essential link between physicians, nurses, and patients in the social community group, with an ultimate emphasis on patient well-being and protection [30].
There should be country-wise GPP training programs are specifically aimed to gain rapid insights from World Health Organization (WHO) and International Pharmaceutical Federation (FIP) joint guidelines for advancing pharmacy practice worldwide and especially in India. In the view of current COVID-19 crisis, this initiative should be the first of its kind training program being offered in India. This training program mainly focuses on experiential training while promoting the GPP concept among healthcare professionals in India. This course will help the participants to get easy access to the guidelines, provides opportunities for peer discussions, and eventually be influential in improving pharmacy practices.
There should be a very focused approach for the same as follows
To understand the roles of pharmacists, national pharmaceutical organizations, and healthcare systems in developing GPP standards.
To understand the role of the pharmacist as a part of healthcare and the requirements of this role.
To understand the methodology and principles of quality management.
Be able to set standards, measure the quality and use the principle of continual improvement in one’s own working environment.
This course mainly explores and discusses the WHO/FIP GPP guidelines, the model of GPP in the hospital setting, and aseptic preparations.
Additionally, focus on WHO, MoH & FW, ICMR & NCDC guidelines for handling, treatment, and disposal of biomedical waste at healthcare facilities.
Across the globe, pharmacy is one of the most important, dynamic, and versatile segments of the healthcare industry. The pharmacy zone has become adaptable, evolving, increasingly diverse, adhering to the quality standards. However, the importance of ensuring appropriate quality to every patient has taken a center stage in this pandemic, especially in India. In such time, it is important to understand and execute the methodology and principles of quality management and set standards, for continual improvement in one’s own working environment, while realizing the emerging roles of pharmacists, national pharmaceutical organizations, and healthcare systems in developing good pharmacy practice (GPP) standards in this pandemic era.
The International Pharmaceutical Federation and World Health Organization define good pharmacy practice (GPP) as practices that meet the personal needs of patients or those using pharmacy services by offering appropriate evidence-based care. In developed countries, pharmaceutical assistance is defined as a pharmaceutical practice model that involves attitudes, ethical values, behaviors, skills, appointments, and co-responsibility to prevent diseases, promote and recovery health in an integrated manner as part of the healthcare process, highlighting, among other, the requirement that the institution fully adopts the GPP. The program should be designed to take care of the Indian healthcare system and its context of adoption of “new normal” due to the unprecedented event of COVID 19 and the importance of GPP for the healthcare professionals in same.
This kind of training program should be opened to
Health, Health IT, Hospital & Pharma Management Students & Professionals.
Medical, Dental, Physiotherapy, Nursing, Pharma, Paramedical Students.
Any Graduate student/Professional who wants to pursue a career in healthcare.
Today, the forms of care are shifting from secondary care providers to primary care providers to patients (Figure 2). This trend has already started in developed countries, such as the behind-the-counter drug option in European countries that was already endorsed by the FDA. The FDA showed positive signs toward boosting the numbers of nonprescription drug statuses to over-the-counter statuses. The healthcare delivery system is coming closer to the patient due to knowledge and understanding, as well as better diagnostic tools and monitoring devices [52] (Figure 2).
The healthcare delivery status of 2007 and 2020. Source: PricewaterhouseCoopers.
The use of simulation and related technology in healthcare education will continue to grow in the next years, and this methodology has a collective role within the pharmacy curriculum. It is expected that increasing the quantity of simulation in pharmacy curricula will have a good impact on pharmacy student education and training, resulting in favorable outcomes for patients and the healthcare team. The obvious goal of incorporating simulation techniques into the pharmacy student training curriculum is to increase pharmacist education and training with the ultimate goal of enhancing patient care and safety. Simulation experiences will never be able to replace real-world clinical experiences, but they do have the ability to supplement clinical education and serve as a tool for developing the skills necessary for a successful pharmacist. Simulation approaches have been utilized in pharmacy education to address broad cognitive and social skills, particularly communication, decision-making, ethical dilemmas, prioritization, and teamwork, in addition to the development of technical skills such as procedural and clinical abilities. Simulated learning environments could provide a more systematic approach to both clinical skill training and pharmacy programs that aim to provide an opportunity for theoretical knowledge to be applied to a real clinical situation. Basic sciences, dispensing, and drug supply all benefit from simulation\'s constant, predictable experience. In an ideal world, simulation training would be integrated into all levels of pharmacy education and training.
Types of simulation technology used in healthcare education [53, 54].
1. | High-fidelity patient simulator or mannequin—able to mimic human actions and physiology and respond to physiologic and pharmacologic interventions |
2. | Task trainer —designed to help learners practice, specific skills and do not have the extensive programming capabilities of high-fidelity models. It can be considered as |
3. | Standardized patients—live people who are coached to portray patients, usually referred to as simulated patients |
4. | Virtual reality simulator—in which a computer display simulates the physical world and user interactions are with the computer within that simulated (virtual) world |
5. | Full environment simulation—it involves the incorporation of high-fidelity mannequins, standardized patients, healthcare professionals, and ancillary equipment to recreate a real-life clinical environment |
Serves to increase efficiency and accuracy of dispensing
Re-direct staff time away from routine technical tasks and toward more direct patient care activities
Featured Systems: ADC, place medications much closer to the user, but still allow electronic verification
Pharmacy Robot: Reduced preparation and check time for medications, minimizations of potential contamination in sterile product preparation
Bar coded medication administration
Computerized prescriber order entry systems (CPOE)
Smart pumps
Clinical decision support system (CDSS)
Predictive population risk stratification
Patient self-management tools
list of contributors in who gpp 2011/ippr 2015 regulation adherence survey | |
---|---|
All publications on this website are published under the Open Access model, without any subscription, registration, or access fees required from the user or his/her institution. In accordance with the Budapest Open Access Initiative's (BOAI) definition of Open Access, users are allowed to read, download, copy, distribute, print, search, and link to the full text versions of all Chapters. To read more about our Open Access Statement click here.
\n\nFor Editorial Policies for journals please consult individual journal pages.
',metaTitle:"Editorial policies",metaDescription:"Editorial policies",metaKeywords:null,canonicalURL:"/page/editorial-policies",contentRaw:'[{"type":"htmlEditorComponent","content":"All published Book Chapters are licensed under a Creative Commons Attribution 3.0 Unported License. Monographs are licensed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license granted to all others. Our Copyright Policy aims to guarantee that original material is published while at the same time giving significant freedom to our Authors. IntechOpen upholds a flexible Copyright Policy meaning that there is no copyright transfer to the publisher and Authors hold exclusive copyright to their work.
\\n\\n\\n\\nWith the purpose of protecting our Authors' copyright and the transparent reuse of Open Access content, IntechOpen has developed an Attribution Policy for works published under Creative Commons licenses.
\\n\\n\\n\\nIntechOpen is committed to disseminating high-quality scientific research in a manner that exemplifies the best practice in scholarly publishing. IntechOpen is an official member of the Committee on Publication Ethics (COPE), which advocates the maintenance of the highest ethical standards for all parties involved in the act of publishing, including Authors, Academic Editors of the book, Peer Reviewers, the publisher and Societies, where applicable.
\\n\\nIn line with publication ethics practices recommended by COPE, ICMJE, and other similar organizations, IntechOpen's contributing Authors, Academic Editors, and Peer Reviewers are required to declare fully all possible conflicts of interest.
\\n\\n\\n\\nIntechOpen's Authorship Policy is based on ICMJE criteria for authorship. In order to be identified as an Author, the following requirements must be met:
\\n\\nAll scientific works are subject to Peer Review prior to publishing. IntechOpen is a member of the Committee on Publication Ethics (COPE) and all participating referees and Academic Editors are expected to review submitted scientific works in line with the COPE Ethical Guidelines for Peer Reviewers where applicable.
\\n\\n\\n\\nThe Internet has changed the dynamics of scholarly communication and publishing which is why we find it necessary to clearly indicate our stance on what we consider to be a published scientific work. A significant number of working papers, early drafts, and similar works in progress are shared openly online between members of the scientific community. It has become common practice for researchers to announce their work on a personal website or a blog in order to gather comments and suggestions from other researchers. Such works and online postings are ‘published’ in the sense that they are made publicly available, but this does not mean that if submitted for publication by IntechOpen they are not original works. We differentiate between reviewed and non-reviewed works when determining whether a work is original and has been published in a scholarly sense or not.
\\n\\n\\n\\nTo identify instances of fraud and misconduct during the publishing process, IntechOpen implements a robust policy governing such occurrences. In line with our general commitment to openness, and in order to maintain the highest scientific standards, we are committed to transparency about our editorial policy regarding retractions and corrections.
\\n\\n\\n\\nWhen faced with potential misconduct, IntechOpen accepts its responsibility to maintain the integrity of the academic record. For particularly complex cases, IntechOpen might ask for the assistance of formal industry bodies or seek advice from an appropriate team of advisors.
\\n\\nIntechOpen's advisors are professionals and scholars with broad knowledge and understanding of different aspects of the scientific publishing process: editorial, authorship, and reviewing roles; publication ethics, copyright, and general legal issues; as well as bibliographic and technical standards.
\\n\\nIn order to provide us with unbiased insights, without compromising the privacy of third parties, IntechOpen presents problematic cases to its advisors in an anonymized format.
\\n\\nIntechOpen publishes books in the English language. If you are interested in the translation of Book Chapters, please check IntechOpen's Translation Policy.
\\n\\n\\n\\nIn line with the Principles of Transparency and Best Practice in Scholarly Publishing, you can access a more detailed description of IntechOpen's Advertising Policy.
\\n\\n\\n\\nAt IntechOpen we realize that exceptional circumstances can occur, resulting in a request for a refund. We will honor all justified requests in the specific instances outlined in our Refund Policy.
\\n\\n\\n\\nAll chapters will be published via IntechOpen's 'Online First' service meaning chapters will be published individually, immediately after review and before the entire book is ready for publication, allowing content to be shared, searched and cited straightaway, thereby generating early stage interest and momentum for your research
\\n\\nOnline First Chapters are considered published on the day they are posted and are citable from that date.
\\n\\nChapters will remain listed as Online First until the final versions of the books are published online. Following publication of the full monograph, Chapters will be redirected from the Online First version and will be available only through the final link of the official published page.
\\n\\nYou are invited to download, use, reproduce, make derivative works of, display, distribute and cite the Online First works. You can find "How to Cite and Reference" by following the link at the end of each online book chapter. Please be aware that it is possible that further editing and changes might be made before the final release of the book.
\\n\\nIf there are supplemental materials to the chapter, these will be published at the time the final book is published online.
\\n\\nReaders and Authors can notify us if they find any errors in the works published under Online First. All major errors will be accompanied by a separate correction notice, erratum or corrigendum (Retraction and Correction Policy.)
\\n\\nIntechOpen books are available online by accessing all published content on a chapter level.
\\n\\n\\n\\nIntechOpen publishes different types of publications.
\\n\\n\\n\\n\\n"}]'},components:[{type:"htmlEditorComponent",content:'
All published Book Chapters are licensed under a Creative Commons Attribution 3.0 Unported License. Monographs are licensed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license granted to all others. Our Copyright Policy aims to guarantee that original material is published while at the same time giving significant freedom to our Authors. IntechOpen upholds a flexible Copyright Policy meaning that there is no copyright transfer to the publisher and Authors hold exclusive copyright to their work.
\n\n\n\nWith the purpose of protecting our Authors' copyright and the transparent reuse of Open Access content, IntechOpen has developed an Attribution Policy for works published under Creative Commons licenses.
\n\n\n\nIntechOpen is committed to disseminating high-quality scientific research in a manner that exemplifies the best practice in scholarly publishing. IntechOpen is an official member of the Committee on Publication Ethics (COPE), which advocates the maintenance of the highest ethical standards for all parties involved in the act of publishing, including Authors, Academic Editors of the book, Peer Reviewers, the publisher and Societies, where applicable.
\n\nIn line with publication ethics practices recommended by COPE, ICMJE, and other similar organizations, IntechOpen's contributing Authors, Academic Editors, and Peer Reviewers are required to declare fully all possible conflicts of interest.
\n\n\n\nIntechOpen's Authorship Policy is based on ICMJE criteria for authorship. In order to be identified as an Author, the following requirements must be met:
\n\nAll scientific works are subject to Peer Review prior to publishing. IntechOpen is a member of the Committee on Publication Ethics (COPE) and all participating referees and Academic Editors are expected to review submitted scientific works in line with the COPE Ethical Guidelines for Peer Reviewers where applicable.
\n\n\n\nThe Internet has changed the dynamics of scholarly communication and publishing which is why we find it necessary to clearly indicate our stance on what we consider to be a published scientific work. A significant number of working papers, early drafts, and similar works in progress are shared openly online between members of the scientific community. It has become common practice for researchers to announce their work on a personal website or a blog in order to gather comments and suggestions from other researchers. Such works and online postings are ‘published’ in the sense that they are made publicly available, but this does not mean that if submitted for publication by IntechOpen they are not original works. We differentiate between reviewed and non-reviewed works when determining whether a work is original and has been published in a scholarly sense or not.
\n\n\n\nTo identify instances of fraud and misconduct during the publishing process, IntechOpen implements a robust policy governing such occurrences. In line with our general commitment to openness, and in order to maintain the highest scientific standards, we are committed to transparency about our editorial policy regarding retractions and corrections.
\n\n\n\nWhen faced with potential misconduct, IntechOpen accepts its responsibility to maintain the integrity of the academic record. For particularly complex cases, IntechOpen might ask for the assistance of formal industry bodies or seek advice from an appropriate team of advisors.
\n\nIntechOpen's advisors are professionals and scholars with broad knowledge and understanding of different aspects of the scientific publishing process: editorial, authorship, and reviewing roles; publication ethics, copyright, and general legal issues; as well as bibliographic and technical standards.
\n\nIn order to provide us with unbiased insights, without compromising the privacy of third parties, IntechOpen presents problematic cases to its advisors in an anonymized format.
\n\nIntechOpen publishes books in the English language. If you are interested in the translation of Book Chapters, please check IntechOpen's Translation Policy.
\n\n\n\nIn line with the Principles of Transparency and Best Practice in Scholarly Publishing, you can access a more detailed description of IntechOpen's Advertising Policy.
\n\n\n\nAt IntechOpen we realize that exceptional circumstances can occur, resulting in a request for a refund. We will honor all justified requests in the specific instances outlined in our Refund Policy.
\n\n\n\nAll chapters will be published via IntechOpen's 'Online First' service meaning chapters will be published individually, immediately after review and before the entire book is ready for publication, allowing content to be shared, searched and cited straightaway, thereby generating early stage interest and momentum for your research
\n\nOnline First Chapters are considered published on the day they are posted and are citable from that date.
\n\nChapters will remain listed as Online First until the final versions of the books are published online. Following publication of the full monograph, Chapters will be redirected from the Online First version and will be available only through the final link of the official published page.
\n\nYou are invited to download, use, reproduce, make derivative works of, display, distribute and cite the Online First works. You can find "How to Cite and Reference" by following the link at the end of each online book chapter. Please be aware that it is possible that further editing and changes might be made before the final release of the book.
\n\nIf there are supplemental materials to the chapter, these will be published at the time the final book is published online.
\n\nReaders and Authors can notify us if they find any errors in the works published under Online First. All major errors will be accompanied by a separate correction notice, erratum or corrigendum (Retraction and Correction Policy.)
\n\nIntechOpen books are available online by accessing all published content on a chapter level.
\n\n\n\nIntechOpen publishes different types of publications.
\n\n\n\n\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{},profiles:[{id:"396",title:"Dr.",name:"Vedran",middleName:null,surname:"Kordic",slug:"vedran-kordic",fullName:"Vedran Kordic",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/396/images/7281_n.png",biography:"After obtaining his Master's degree in Mechanical Engineering he continued his education at the Vienna University of Technology where he obtained his PhD degree in 2004. He worked as a researcher at the Automation and Control Institute, Faculty of Electrical Engineering, Vienna University of Technology until 2008. His studies in robotics lead him not only to a PhD degree but also inspired him to co-found and build the International Journal of Advanced Robotic Systems - world's first Open Access journal in the field of robotics.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"441",title:"Ph.D.",name:"Jaekyu",middleName:null,surname:"Park",slug:"jaekyu-park",fullName:"Jaekyu Park",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/441/images/1881_n.jpg",biography:null,institutionString:null,institution:{name:"LG Corporation (South Korea)",country:{name:"Korea, South"}}},{id:"465",title:"Dr.",name:"Christian",middleName:null,surname:"Martens",slug:"christian-martens",fullName:"Christian Martens",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Rheinmetall (Germany)",country:{name:"Germany"}}},{id:"479",title:"Dr.",name:"Valentina",middleName:null,surname:"Colla",slug:"valentina-colla",fullName:"Valentina Colla",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/479/images/358_n.jpg",biography:null,institutionString:null,institution:{name:"Sant'Anna School of Advanced Studies",country:{name:"Italy"}}},{id:"494",title:"PhD",name:"Loris",middleName:null,surname:"Nanni",slug:"loris-nanni",fullName:"Loris Nanni",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/494/images/system/494.jpg",biography:"Loris Nanni received his Master Degree cum laude on June-2002 from the University of Bologna, and the April 26th 2006 he received his Ph.D. in Computer Engineering at DEIS, University of Bologna. On September, 29th 2006 he has won a post PhD fellowship from the university of Bologna (from October 2006 to October 2008), at the competitive examination he was ranked first in the industrial engineering area. He extensively served as referee for several international journals. He is author/coauthor of more than 100 research papers. He has been involved in some projects supported by MURST and European Community. His research interests include pattern recognition, bioinformatics, and biometric systems (fingerprint classification and recognition, signature verification, face recognition).",institutionString:null,institution:null},{id:"496",title:"Dr.",name:"Carlos",middleName:null,surname:"Leon",slug:"carlos-leon",fullName:"Carlos Leon",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Seville",country:{name:"Spain"}}},{id:"512",title:"Dr.",name:"Dayang",middleName:null,surname:"Jawawi",slug:"dayang-jawawi",fullName:"Dayang Jawawi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Technology Malaysia",country:{name:"Malaysia"}}},{id:"528",title:"Dr.",name:"Kresimir",middleName:null,surname:"Delac",slug:"kresimir-delac",fullName:"Kresimir Delac",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/528/images/system/528.jpg",biography:"K. Delac received his B.Sc.E.E. degree in 2003 and is currentlypursuing a Ph.D. degree at the University of Zagreb, Faculty of Electrical Engineering andComputing. His current research interests are digital image analysis, pattern recognition andbiometrics.",institutionString:null,institution:{name:"University of Zagreb",country:{name:"Croatia"}}},{id:"557",title:"Dr.",name:"Andon",middleName:"Venelinov",surname:"Topalov",slug:"andon-topalov",fullName:"Andon Topalov",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/557/images/1927_n.jpg",biography:"Dr. Andon V. Topalov received the MSc degree in Control Engineering from the Faculty of Information Systems, Technologies, and Automation at Moscow State University of Civil Engineering (MGGU) in 1979. He then received his PhD degree in Control Engineering from the Department of Automation and Remote Control at Moscow State Mining University (MGSU), Moscow, in 1984. From 1985 to 1986, he was a Research Fellow in the Research Institute for Electronic Equipment, ZZU AD, Plovdiv, Bulgaria. In 1986, he joined the Department of Control Systems, Technical University of Sofia at the Plovdiv campus, where he is presently a Full Professor. He has held long-term visiting Professor/Scholar positions at various institutions in South Korea, Turkey, Mexico, Greece, Belgium, UK, and Germany. And he has coauthored one book and authored or coauthored more than 80 research papers in conference proceedings and journals. His current research interests are in the fields of intelligent control and robotics.",institutionString:null,institution:{name:"Technical University of Sofia",country:{name:"Bulgaria"}}},{id:"585",title:"Prof.",name:"Munir",middleName:null,surname:"Merdan",slug:"munir-merdan",fullName:"Munir Merdan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/585/images/system/585.jpg",biography:"Munir Merdan received the M.Sc. degree in mechanical engineering from the Technical University of Sarajevo, Bosnia and Herzegovina, in 2001, and the Ph.D. degree in electrical engineering from the Vienna University of Technology, Vienna, Austria, in 2009.Since 2005, he has been at the Automation and Control Institute, Vienna University of Technology, where he is currently a Senior Researcher. His research interests include the application of agent technology for achieving agile control in the manufacturing environment.",institutionString:null,institution:null},{id:"605",title:"Prof",name:"Dil",middleName:null,surname:"Hussain",slug:"dil-hussain",fullName:"Dil Hussain",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/605/images/system/605.jpg",biography:"Dr. Dil Muhammad Akbar Hussain is a professor of Electronics Engineering & Computer Science at the Department of Energy Technology, Aalborg University Denmark. Professor Akbar has a Master degree in Digital Electronics from Govt. College University, Lahore Pakistan and a P-hD degree in Control Engineering from the School of Engineering and Applied Sciences, University of Sussex United Kingdom. Aalborg University has Two Satellite Campuses, one in Copenhagen (Aalborg University Copenhagen) and the other in Esbjerg (Aalborg University Esbjerg).\n· He is a member of prestigious IEEE (Institute of Electrical and Electronics Engineers), and IAENG (International Association of Engineers) organizations. \n· He is the chief Editor of the Journal of Software Engineering.\n· He is the member of the Editorial Board of International Journal of Computer Science and Software Technology (IJCSST) and International Journal of Computer Engineering and Information Technology. \n· He is also the Editor of Communication in Computer and Information Science CCIS-20 by Springer.\n· Reviewer For Many Conferences\nHe is the lead person in making collaboration agreements between Aalborg University and many universities of Pakistan, for which the MOU’s (Memorandum of Understanding) have been signed.\nProfessor Akbar is working in Academia since 1990, he started his career as a Lab demonstrator/TA at the University of Sussex. After finishing his P. hD degree in 1992, he served in the Industry as a Scientific Officer and continued his academic career as a visiting scholar for a number of educational institutions. In 1996 he joined National University of Science & Technology Pakistan (NUST) as an Associate Professor; NUST is one of the top few universities in Pakistan. In 1999 he joined an International Company Lineo Inc, Canada as Manager Compiler Group, where he headed the group for developing Compiler Tool Chain and Porting of Operating Systems for the BLACKfin processor. The processor development was a joint venture by Intel and Analog Devices. In 2002 Lineo Inc., was taken over by another company, so he joined Aalborg University Denmark as an Assistant Professor.\nProfessor Akbar has truly a multi-disciplined career and he continued his legacy and making progress in many areas of his interests both in teaching and research. He has contributed in stochastic estimation of control area especially, in the Multiple Target Tracking and Interactive Multiple Model (IMM) research, Ball & Beam Control Problem, Robotics, Levitation Control. He has contributed in developing Algorithms for Fingerprint Matching, Computer Vision and Face Recognition. He has been supervising Pattern Recognition, Formal Languages and Distributed Processing projects for several years. He has reviewed many books on Management, Computer Science. Currently, he is an active and permanent reviewer for many international conferences and symposia and the program committee member for many international conferences.\nIn teaching he has taught the core computer science subjects like, Digital Design, Real Time Embedded System Programming, Operating Systems, Software Engineering, Data Structures, Databases, Compiler Construction. In the Engineering side, Digital Signal Processing, Computer Architecture, Electronics Devices, Digital Filtering and Engineering Management.\nApart from his Academic Interest and activities he loves sport especially, Cricket, Football, Snooker and Squash. He plays cricket for Esbjerg city in the second division team as an opener wicket keeper batsman. He is a very good player of squash but has not played squash since his arrival in Denmark.",institutionString:null,institution:null},{id:"611",title:"Prof.",name:"T",middleName:null,surname:"Nagarajan",slug:"t-nagarajan",fullName:"T Nagarajan",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universiti Teknologi Petronas",country:{name:"Malaysia"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:13404},{group:"region",caption:"Middle and South America",value:2,count:11681},{group:"region",caption:"Africa",value:3,count:4213},{group:"region",caption:"Asia",value:4,count:22423},{group:"region",caption:"Australia and Oceania",value:5,count:2020},{group:"region",caption:"Europe",value:6,count:33699}],offset:12,limit:12,total:135704},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{hasNoEditors:"0",sort:"dateEndThirdStepPublish",src:"R-SLS"},books:[{type:"book",id:"11369",title:"RNA Viruses Infection",subtitle:null,isOpenForSubmission:!0,hash:"52f8a3a1486912beae40b34ac557fed3",slug:null,bookSignature:"Ph.D. Yogendra Shah",coverURL:"https://cdn.intechopen.com/books/images_new/11369.jpg",editedByType:null,editors:[{id:"278914",title:"Ph.D.",name:"Yogendra",surname:"Shah",slug:"yogendra-shah",fullName:"Yogendra Shah"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11027",title:"Basics of Hypoglycemia",subtitle:null,isOpenForSubmission:!0,hash:"98ebc1e36d02be82c204b8fd5d24f97a",slug:null,bookSignature:"Dr. Alok Raghav",coverURL:"https://cdn.intechopen.com/books/images_new/11027.jpg",editedByType:null,editors:[{id:"334465",title:"Dr.",name:"Alok",surname:"Raghav",slug:"alok-raghav",fullName:"Alok Raghav"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11124",title:"Next-Generation Textiles",subtitle:null,isOpenForSubmission:!0,hash:"093f9e26bb829b8d414d13626aea1086",slug:null,bookSignature:"Dr. Hassan Ibrahim",coverURL:"https://cdn.intechopen.com/books/images_new/11124.jpg",editedByType:null,editors:[{id:"90645",title:"Dr.",name:"Hassan",surname:"Ibrahim",slug:"hassan-ibrahim",fullName:"Hassan Ibrahim"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11610",title:"New Insights in Herbicide Science",subtitle:null,isOpenForSubmission:!0,hash:"eb3830b8176caf3d1fd52c32313c5168",slug:null,bookSignature:"Ph.D. Kassio Ferreira Mendes",coverURL:"https://cdn.intechopen.com/books/images_new/11610.jpg",editedByType:null,editors:[{id:"197720",title:"Ph.D.",name:"Kassio",surname:"Ferreira Mendes",slug:"kassio-ferreira-mendes",fullName:"Kassio Ferreira Mendes"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11561",title:"Zeolite From Wastes - New Perspectives on Innovative Resources and Their Valorization Process",subtitle:null,isOpenForSubmission:!0,hash:"3ed0dfd842de9cd1143212415903e6ad",slug:null,bookSignature:"Dr. Claudia Belviso",coverURL:"https://cdn.intechopen.com/books/images_new/11561.jpg",editedByType:null,editors:[{id:"61457",title:"Dr.",name:"Claudia",surname:"Belviso",slug:"claudia-belviso",fullName:"Claudia Belviso"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11814",title:"Liposomes - Recent Advances, New Perspectives and Applications",subtitle:null,isOpenForSubmission:!0,hash:"62d8542d18b8cddcf507f7948b2ae74b",slug:null,bookSignature:"Dr. Rajeev K. Tyagi",coverURL:"https://cdn.intechopen.com/books/images_new/11814.jpg",editedByType:null,editors:[{id:"269120",title:"Dr.",name:"Rajeev",surname:"Tyagi",slug:"rajeev-tyagi",fullName:"Rajeev Tyagi"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11778",title:"Correctional Facilities and Correctional Treatment - International Perspectives",subtitle:null,isOpenForSubmission:!0,hash:"a933550a6966a04e4677a4c0aea8f5b2",slug:null,bookSignature:"Prof. Rui Abrunhosa Gonçalves",coverURL:"https://cdn.intechopen.com/books/images_new/11778.jpg",editedByType:null,editors:[{id:"198691",title:"Prof.",name:"Rui",surname:"Abrunhosa Gonçalves",slug:"rui-abrunhosa-goncalves",fullName:"Rui Abrunhosa Gonçalves"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11709",title:"Type 1 Diabetes Mellitus",subtitle:null,isOpenForSubmission:!0,hash:"cc0e61f864a2a8a9595f4975ce301f70",slug:null,bookSignature:"Dr. Shilpa Mehta",coverURL:"https://cdn.intechopen.com/books/images_new/11709.jpg",editedByType:null,editors:[{id:"342545",title:"Dr.",name:"Shilpa",surname:"Mehta",slug:"shilpa-mehta",fullName:"Shilpa Mehta"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11889",title:"Sexual Disorders and Dysfunctions",subtitle:null,isOpenForSubmission:!0,hash:"b988fda30a4e2364ee9d47e417bd0ba9",slug:null,bookSignature:"Dr. Dhastagir Sultan Sheriff",coverURL:"https://cdn.intechopen.com/books/images_new/11889.jpg",editedByType:null,editors:[{id:"167875",title:"Dr.",name:"Dhastagir Sultan",surname:"Sheriff",slug:"dhastagir-sultan-sheriff",fullName:"Dhastagir Sultan Sheriff"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11867",title:"Echocardiography",subtitle:null,isOpenForSubmission:!0,hash:"d9159ce31733bf78cc2a79b18c225994",slug:null,bookSignature:"Dr. Gabriel Cismaru",coverURL:"https://cdn.intechopen.com/books/images_new/11867.jpg",editedByType:null,editors:[{id:"191888",title:"Dr.",name:"Gabriel",surname:"Cismaru",slug:"gabriel-cismaru",fullName:"Gabriel Cismaru"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11513",title:"Gas Sensors",subtitle:null,isOpenForSubmission:!0,hash:"8eeb7ab232fa8d5c723b61e0da251857",slug:null,bookSignature:"Dr. Soumen Dhara and Dr. Gorachand Dutta",coverURL:"https://cdn.intechopen.com/books/images_new/11513.jpg",editedByType:null,editors:[{id:"196334",title:"Dr.",name:"Soumen",surname:"Dhara",slug:"soumen-dhara",fullName:"Soumen Dhara"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12107",title:"Contemporary Topics in Patient Safety - Volume 2",subtitle:null,isOpenForSubmission:!0,hash:"3fe674b93710773f0db746ca96d6e048",slug:null,bookSignature:"Dr. Philip Salen and Dr. Stanislaw P. Stawicki",coverURL:"https://cdn.intechopen.com/books/images_new/12107.jpg",editedByType:null,editors:[{id:"217603",title:"Dr.",name:"Philip",surname:"Salen",slug:"philip-salen",fullName:"Philip Salen"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:22},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:6},{group:"topic",caption:"Business, Management and Economics",value:7,count:4},{group:"topic",caption:"Chemistry",value:8,count:15},{group:"topic",caption:"Computer and Information Science",value:9,count:18},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:8},{group:"topic",caption:"Engineering",value:11,count:37},{group:"topic",caption:"Environmental Sciences",value:12,count:5},{group:"topic",caption:"Immunology and Microbiology",value:13,count:8},{group:"topic",caption:"Materials Science",value:14,count:15},{group:"topic",caption:"Mathematics",value:15,count:8},{group:"topic",caption:"Medicine",value:16,count:61},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:2},{group:"topic",caption:"Neuroscience",value:18,count:2},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:7},{group:"topic",caption:"Physics",value:20,count:5},{group:"topic",caption:"Psychology",value:21,count:5},{group:"topic",caption:"Robotics",value:22,count:2},{group:"topic",caption:"Social Sciences",value:23,count:8},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:2}],offset:12,limit:12,total:240},popularBooks:{featuredBooks:[{type:"book",id:"10827",title:"Oral Health Care",subtitle:"An Important Issue of the Modern Society",isOpenForSubmission:!1,hash:"9a0ceb9ced4598aea3f3723f6dc4ea04",slug:"oral-health-care-an-important-issue-of-the-modern-society",bookSignature:"Lavinia Cosmina Ardelean and Laura Cristina Rusu",coverURL:"https://cdn.intechopen.com/books/images_new/10827.jpg",editors:[{id:"180569",title:"Dr.",name:"Lavinia",middleName:null,surname:"Ardelean",slug:"lavinia-ardelean",fullName:"Lavinia Ardelean"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10808",title:"Current Concepts in Dental Implantology",subtitle:"From Science to Clinical Research",isOpenForSubmission:!1,hash:"4af8830e463f89c57515c2da2b9777b0",slug:"current-concepts-in-dental-implantology-from-science-to-clinical-research",bookSignature:"Dragana Gabrić and Marko Vuletić",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",editors:[{id:"26946",title:"Prof.",name:"Dragana",middleName:null,surname:"Gabrić",slug:"dragana-gabric",fullName:"Dragana Gabrić"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10780",title:"Current Trends in Orthodontics",subtitle:null,isOpenForSubmission:!1,hash:"badce0e23eb5176fd653b049d5295c0a",slug:"current-trends-in-orthodontics",bookSignature:"Farid Bourzgui",coverURL:"https://cdn.intechopen.com/books/images_new/10780.jpg",editors:[{id:"52177",title:"Prof.",name:"Farid",middleName:null,surname:"Bourzgui",slug:"farid-bourzgui",fullName:"Farid Bourzgui"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8452",title:"Organizational Conflict",subtitle:"New Insights",isOpenForSubmission:!1,hash:"96bdaaba38a7850a7e7379aa5a505748",slug:"organizational-conflict-new-insights",bookSignature:"Josiane Fahed-Sreih",coverURL:"https://cdn.intechopen.com/books/images_new/8452.jpg",editors:[{id:"103784",title:"Dr.",name:"Josiane",middleName:null,surname:"Fahed-Sreih",slug:"josiane-fahed-sreih",fullName:"Josiane Fahed-Sreih"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10206",title:"Terahertz Technology",subtitle:null,isOpenForSubmission:!1,hash:"2cdb79bf6297623f1d6202ef11f099c4",slug:"terahertz-technology",bookSignature:"Borwen You and Ja-Yu Lu",coverURL:"https://cdn.intechopen.com/books/images_new/10206.jpg",editors:[{id:"191131",title:"Dr.",name:"Borwen",middleName:null,surname:"You",slug:"borwen-you",fullName:"Borwen You"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11331",title:"Secondary Metabolites",subtitle:"Trends and Reviews",isOpenForSubmission:!1,hash:"7d6274f42d5441e537c5fa744bc84523",slug:"secondary-metabolites-trends-and-reviews",bookSignature:"Ramasamy Vijayakumar and Suresh Selvapuram Sudalaimuthu Raja",coverURL:"https://cdn.intechopen.com/books/images_new/11331.jpg",editors:[{id:"176044",title:"Dr.",name:"Ramasamy",middleName:null,surname:"Vijayakumar",slug:"ramasamy-vijayakumar",fullName:"Ramasamy Vijayakumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10793",title:"Molecular Mechanisms in Cancer",subtitle:null,isOpenForSubmission:!1,hash:"3ed2817275edb3de6f5683602314706e",slug:"molecular-mechanisms-in-cancer",bookSignature:"Metin Budak and Rajamanickam Rajkumar",coverURL:"https://cdn.intechopen.com/books/images_new/10793.jpg",editors:[{id:"226275",title:"Ph.D.",name:"Metin",middleName:null,surname:"Budak",slug:"metin-budak",fullName:"Metin Budak"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10957",title:"Liquid Crystals",subtitle:null,isOpenForSubmission:!1,hash:"7a2d81fa4893fcf74e7b3823a3e4f385",slug:"liquid-crystals",bookSignature:"Pankaj Kumar Choudhury and Abdel-Baset M.A. Ibrahim",coverURL:"https://cdn.intechopen.com/books/images_new/10957.jpg",editors:[{id:"205744",title:"Dr.",name:"Pankaj",middleName:null,surname:"Kumar Choudhury",slug:"pankaj-kumar-choudhury",fullName:"Pankaj Kumar Choudhury"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7827",title:"Interpersonal Relationships",subtitle:null,isOpenForSubmission:!1,hash:"ebf41f4d17c75010eb3294cc8cac3d47",slug:"interpersonal-relationships",bookSignature:"Martha Peaslee Levine",coverURL:"https://cdn.intechopen.com/books/images_new/7827.jpg",editors:[{id:"186919",title:"Dr.",name:"Martha",middleName:null,surname:"Peaslee Levine",slug:"martha-peaslee-levine",fullName:"Martha Peaslee Levine"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10652",title:"Information Extraction and Object Tracking in Digital Video",subtitle:null,isOpenForSubmission:!1,hash:"d13718b2d986d058d55cf91e69bf21c0",slug:"information-extraction-and-object-tracking-in-digital-video",bookSignature:"Antonio José Ribeiro Neves and Francisco Javier Gallegos-Funes",coverURL:"https://cdn.intechopen.com/books/images_new/10652.jpg",editors:[{id:"1177",title:"Prof.",name:"António",middleName:"J. R.",surname:"José Ribeiro Neves",slug:"antonio-jose-ribeiro-neves",fullName:"António José Ribeiro Neves"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10820",title:"Data Clustering",subtitle:null,isOpenForSubmission:!1,hash:"086d299ffd05aacd2311c3ca4ebf0d3a",slug:"data-clustering",bookSignature:"Niansheng Tang",coverURL:"https://cdn.intechopen.com/books/images_new/10820.jpg",editors:[{id:"221831",title:"Prof.",name:"Niansheng",middleName:null,surname:"Tang",slug:"niansheng-tang",fullName:"Niansheng Tang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10728",title:"Blood Groups",subtitle:"More than Inheritance of Antigenic Substances",isOpenForSubmission:!1,hash:"b5e79b54a382651f3130c9ee5ab862b4",slug:"blood-groups-more-than-inheritance-of-antigenic-substances",bookSignature:"Kaneez Fatima Shad",coverURL:"https://cdn.intechopen.com/books/images_new/10728.jpg",editors:[{id:"31988",title:"Prof.",name:"Kaneez",middleName:null,surname:"Fatima Shad",slug:"kaneez-fatima-shad",fullName:"Kaneez Fatima Shad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:4802},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"10827",title:"Oral Health Care",subtitle:"An Important Issue of the Modern Society",isOpenForSubmission:!1,hash:"9a0ceb9ced4598aea3f3723f6dc4ea04",slug:"oral-health-care-an-important-issue-of-the-modern-society",bookSignature:"Lavinia Cosmina Ardelean and Laura Cristina Rusu",coverURL:"https://cdn.intechopen.com/books/images_new/10827.jpg",publishedDate:"August 17th 2022",numberOfDownloads:2310,editors:[{id:"180569",title:"Dr.",name:"Lavinia",middleName:null,surname:"Ardelean",slug:"lavinia-ardelean",fullName:"Lavinia Ardelean"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10808",title:"Current Concepts in Dental Implantology",subtitle:"From Science to Clinical Research",isOpenForSubmission:!1,hash:"4af8830e463f89c57515c2da2b9777b0",slug:"current-concepts-in-dental-implantology-from-science-to-clinical-research",bookSignature:"Dragana Gabrić and Marko Vuletić",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",publishedDate:"August 17th 2022",numberOfDownloads:2095,editors:[{id:"26946",title:"Prof.",name:"Dragana",middleName:null,surname:"Gabrić",slug:"dragana-gabric",fullName:"Dragana Gabrić"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10780",title:"Current Trends in Orthodontics",subtitle:null,isOpenForSubmission:!1,hash:"badce0e23eb5176fd653b049d5295c0a",slug:"current-trends-in-orthodontics",bookSignature:"Farid Bourzgui",coverURL:"https://cdn.intechopen.com/books/images_new/10780.jpg",publishedDate:"August 17th 2022",numberOfDownloads:2079,editors:[{id:"52177",title:"Prof.",name:"Farid",middleName:null,surname:"Bourzgui",slug:"farid-bourzgui",fullName:"Farid Bourzgui"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8452",title:"Organizational Conflict",subtitle:"New Insights",isOpenForSubmission:!1,hash:"96bdaaba38a7850a7e7379aa5a505748",slug:"organizational-conflict-new-insights",bookSignature:"Josiane Fahed-Sreih",coverURL:"https://cdn.intechopen.com/books/images_new/8452.jpg",publishedDate:"August 17th 2022",numberOfDownloads:1987,editors:[{id:"103784",title:"Dr.",name:"Josiane",middleName:null,surname:"Fahed-Sreih",slug:"josiane-fahed-sreih",fullName:"Josiane Fahed-Sreih"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10206",title:"Terahertz Technology",subtitle:null,isOpenForSubmission:!1,hash:"2cdb79bf6297623f1d6202ef11f099c4",slug:"terahertz-technology",bookSignature:"Borwen You and Ja-Yu Lu",coverURL:"https://cdn.intechopen.com/books/images_new/10206.jpg",publishedDate:"August 17th 2022",numberOfDownloads:1528,editors:[{id:"191131",title:"Dr.",name:"Borwen",middleName:null,surname:"You",slug:"borwen-you",fullName:"Borwen You"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11331",title:"Secondary Metabolites",subtitle:"Trends and Reviews",isOpenForSubmission:!1,hash:"7d6274f42d5441e537c5fa744bc84523",slug:"secondary-metabolites-trends-and-reviews",bookSignature:"Ramasamy Vijayakumar and Suresh Selvapuram Sudalaimuthu Raja",coverURL:"https://cdn.intechopen.com/books/images_new/11331.jpg",publishedDate:"August 17th 2022",numberOfDownloads:932,editors:[{id:"176044",title:"Dr.",name:"Ramasamy",middleName:null,surname:"Vijayakumar",slug:"ramasamy-vijayakumar",fullName:"Ramasamy Vijayakumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10793",title:"Molecular Mechanisms in Cancer",subtitle:null,isOpenForSubmission:!1,hash:"3ed2817275edb3de6f5683602314706e",slug:"molecular-mechanisms-in-cancer",bookSignature:"Metin Budak and Rajamanickam Rajkumar",coverURL:"https://cdn.intechopen.com/books/images_new/10793.jpg",publishedDate:"August 17th 2022",numberOfDownloads:700,editors:[{id:"226275",title:"Ph.D.",name:"Metin",middleName:null,surname:"Budak",slug:"metin-budak",fullName:"Metin Budak"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10957",title:"Liquid Crystals",subtitle:null,isOpenForSubmission:!1,hash:"7a2d81fa4893fcf74e7b3823a3e4f385",slug:"liquid-crystals",bookSignature:"Pankaj Kumar Choudhury and Abdel-Baset M.A. Ibrahim",coverURL:"https://cdn.intechopen.com/books/images_new/10957.jpg",publishedDate:"August 17th 2022",numberOfDownloads:676,editors:[{id:"205744",title:"Dr.",name:"Pankaj",middleName:null,surname:"Kumar Choudhury",slug:"pankaj-kumar-choudhury",fullName:"Pankaj Kumar Choudhury"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7827",title:"Interpersonal Relationships",subtitle:null,isOpenForSubmission:!1,hash:"ebf41f4d17c75010eb3294cc8cac3d47",slug:"interpersonal-relationships",bookSignature:"Martha Peaslee Levine",coverURL:"https://cdn.intechopen.com/books/images_new/7827.jpg",publishedDate:"July 27th 2022",numberOfDownloads:7215,editors:[{id:"186919",title:"Dr.",name:"Martha",middleName:null,surname:"Peaslee Levine",slug:"martha-peaslee-levine",fullName:"Martha Peaslee Levine"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10652",title:"Information Extraction and Object Tracking in Digital Video",subtitle:null,isOpenForSubmission:!1,hash:"d13718b2d986d058d55cf91e69bf21c0",slug:"information-extraction-and-object-tracking-in-digital-video",bookSignature:"Antonio José Ribeiro Neves and Francisco Javier Gallegos-Funes",coverURL:"https://cdn.intechopen.com/books/images_new/10652.jpg",publishedDate:"August 17th 2022",numberOfDownloads:602,editors:[{id:"1177",title:"Prof.",name:"António",middleName:"J. R.",surname:"José Ribeiro Neves",slug:"antonio-jose-ribeiro-neves",fullName:"António José Ribeiro Neves"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"8452",title:"Organizational Conflict",subtitle:"New Insights",isOpenForSubmission:!1,hash:"96bdaaba38a7850a7e7379aa5a505748",slug:"organizational-conflict-new-insights",bookSignature:"Josiane Fahed-Sreih",coverURL:"https://cdn.intechopen.com/books/images_new/8452.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"103784",title:"Dr.",name:"Josiane",middleName:null,surname:"Fahed-Sreih",slug:"josiane-fahed-sreih",fullName:"Josiane Fahed-Sreih"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10778",title:"Model-Based Control Engineering",subtitle:"Recent Design and Implementations for Varied Applications",isOpenForSubmission:!1,hash:"e39a567d9b6d2a45d0a1d927362c9005",slug:"model-based-control-engineering-recent-design-and-implementations-for-varied-applications",bookSignature:"Umar Zakir Abdul Hamid and Ahmad `Athif Mohd Faudzi",coverURL:"https://cdn.intechopen.com/books/images_new/10778.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"268173",title:"Dr.",name:"Umar Zakir Abdul",middleName:null,surname:"Hamid",slug:"umar-zakir-abdul-hamid",fullName:"Umar Zakir Abdul Hamid"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10780",title:"Current Trends in Orthodontics",subtitle:null,isOpenForSubmission:!1,hash:"badce0e23eb5176fd653b049d5295c0a",slug:"current-trends-in-orthodontics",bookSignature:"Farid Bourzgui",coverURL:"https://cdn.intechopen.com/books/images_new/10780.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"52177",title:"Prof.",name:"Farid",middleName:null,surname:"Bourzgui",slug:"farid-bourzgui",fullName:"Farid Bourzgui"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10793",title:"Molecular Mechanisms in Cancer",subtitle:null,isOpenForSubmission:!1,hash:"3ed2817275edb3de6f5683602314706e",slug:"molecular-mechanisms-in-cancer",bookSignature:"Metin Budak and Rajamanickam Rajkumar",coverURL:"https://cdn.intechopen.com/books/images_new/10793.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"226275",title:"Ph.D.",name:"Metin",middleName:null,surname:"Budak",slug:"metin-budak",fullName:"Metin Budak"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11308",title:"Selected Topics on Infant Feeding",subtitle:null,isOpenForSubmission:!1,hash:"213c3e403327a2919eca1dc5e82a0ec3",slug:"selected-topics-on-infant-feeding",bookSignature:"Isam Jaber AL-Zwaini and Haider Hadi AL-Musawi",coverURL:"https://cdn.intechopen.com/books/images_new/11308.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"30993",title:"Prof.",name:"Isam Jaber",middleName:null,surname:"Al-Zwaini",slug:"isam-jaber-al-zwaini",fullName:"Isam Jaber Al-Zwaini"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10808",title:"Current Concepts in Dental Implantology",subtitle:"From Science to Clinical Research",isOpenForSubmission:!1,hash:"4af8830e463f89c57515c2da2b9777b0",slug:"current-concepts-in-dental-implantology-from-science-to-clinical-research",bookSignature:"Dragana Gabrić and Marko Vuletić",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"26946",title:"Prof.",name:"Dragana",middleName:null,surname:"Gabrić",slug:"dragana-gabric",fullName:"Dragana Gabrić"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11331",title:"Secondary Metabolites",subtitle:"Trends and Reviews",isOpenForSubmission:!1,hash:"7d6274f42d5441e537c5fa744bc84523",slug:"secondary-metabolites-trends-and-reviews",bookSignature:"Ramasamy Vijayakumar and Suresh Selvapuram Sudalaimuthu Raja",coverURL:"https://cdn.intechopen.com/books/images_new/11331.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"176044",title:"Dr.",name:"Ramasamy",middleName:null,surname:"Vijayakumar",slug:"ramasamy-vijayakumar",fullName:"Ramasamy Vijayakumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10820",title:"Data Clustering",subtitle:null,isOpenForSubmission:!1,hash:"086d299ffd05aacd2311c3ca4ebf0d3a",slug:"data-clustering",bookSignature:"Niansheng Tang",coverURL:"https://cdn.intechopen.com/books/images_new/10820.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"221831",title:"Prof.",name:"Niansheng",middleName:null,surname:"Tang",slug:"niansheng-tang",fullName:"Niansheng Tang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10827",title:"Oral Health Care",subtitle:"An Important Issue of the Modern Society",isOpenForSubmission:!1,hash:"9a0ceb9ced4598aea3f3723f6dc4ea04",slug:"oral-health-care-an-important-issue-of-the-modern-society",bookSignature:"Lavinia Cosmina Ardelean and Laura Cristina Rusu",coverURL:"https://cdn.intechopen.com/books/images_new/10827.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"180569",title:"Dr.",name:"Lavinia",middleName:null,surname:"Ardelean",slug:"lavinia-ardelean",fullName:"Lavinia Ardelean"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11139",title:"Geochemistry and Mineral Resources",subtitle:null,isOpenForSubmission:!1,hash:"928cebbdce21d9b3f081267b24f12dfb",slug:"geochemistry-and-mineral-resources",bookSignature:"Hosam M. Saleh and Amal I. Hassan",coverURL:"https://cdn.intechopen.com/books/images_new/11139.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"144691",title:"Prof.",name:"Hosam M.",middleName:null,surname:"Saleh",slug:"hosam-m.-saleh",fullName:"Hosam M. Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"29",title:"Agronomy",slug:"agronomy",parent:{id:"5",title:"Agricultural and Biological Sciences",slug:"agricultural-and-biological-sciences"},numberOfBooks:55,numberOfSeries:0,numberOfAuthorsAndEditors:1532,numberOfWosCitations:1638,numberOfCrossrefCitations:1306,numberOfDimensionsCitations:2860,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicId:"29",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"11357",title:"Sustainable Crop Production",subtitle:"Recent Advances",isOpenForSubmission:!1,hash:"ee41e09e4ad6a336ca9f0e5462da3904",slug:"sustainable-crop-production-recent-advances",bookSignature:"Vijay Singh Meena, Mahipal Choudhary, Ram Prakash Yadav and Sunita Kumari Meena",coverURL:"https://cdn.intechopen.com/books/images_new/11357.jpg",editedByType:"Edited by",editors:[{id:"420235",title:"Dr.",name:"Vijay",middleName:null,surname:"Meena",slug:"vijay-meena",fullName:"Vijay Meena"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10774",title:"Model Organisms in Plant Genetics",subtitle:null,isOpenForSubmission:!1,hash:"f6624b58571ac10c9b636c5d85ec5e54",slug:"model-organisms-in-plant-genetics",bookSignature:"Ibrokhim Y. Abdurakhmonov",coverURL:"https://cdn.intechopen.com/books/images_new/10774.jpg",editedByType:"Edited by",editors:[{id:"213344",title:"Prof.",name:"Ibrokhim Y.",middleName:null,surname:"Abdurakhmonov",slug:"ibrokhim-y.-abdurakhmonov",fullName:"Ibrokhim Y. Abdurakhmonov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9670",title:"Current Trends in Wheat Research",subtitle:null,isOpenForSubmission:!1,hash:"89d795987f1747a76eee532700d2093d",slug:"current-trends-in-wheat-research",bookSignature:"Mahmood-ur-Rahman Ansari",coverURL:"https://cdn.intechopen.com/books/images_new/9670.jpg",editedByType:"Edited by",editors:[{id:"185476",title:"Dr.",name:"Mahmood-ur-Rahman",middleName:null,surname:"Ansari",slug:"mahmood-ur-rahman-ansari",fullName:"Mahmood-ur-Rahman Ansari"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10896",title:"Integrative Advances in Rice Research",subtitle:null,isOpenForSubmission:!1,hash:"47659401ffe512c28313440110c0a903",slug:"integrative-advances-in-rice-research",bookSignature:"Min Huang",coverURL:"https://cdn.intechopen.com/books/images_new/10896.jpg",editedByType:"Edited by",editors:[{id:"189829",title:"Dr.",name:"Min",middleName:null,surname:"Huang",slug:"min-huang",fullName:"Min Huang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11571",title:"Cereal Grains",subtitle:"Volume 2",isOpenForSubmission:!1,hash:"2c4003ff225208126f1e2386eefa4d5a",slug:"cereal-grains-volume-2",bookSignature:"Aakash Kumar Goyal",coverURL:"https://cdn.intechopen.com/books/images_new/11571.jpg",editedByType:"Edited by",editors:[{id:"97604",title:"Dr.",name:"Aakash K.",middleName:null,surname:"Goyal",slug:"aakash-k.-goyal",fullName:"Aakash K. Goyal"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10499",title:"Next-Generation Greenhouses for Food Security",subtitle:null,isOpenForSubmission:!1,hash:"456f82c97eafad5734cd36c48e167781",slug:"next-generation-greenhouses-for-food-security",bookSignature:"Redmond R. Shamshiri",coverURL:"https://cdn.intechopen.com/books/images_new/10499.jpg",editedByType:"Edited by",editors:[{id:"203413",title:"Dr.",name:"Redmond R.",middleName:null,surname:"Shamshiri",slug:"redmond-r.-shamshiri",fullName:"Redmond R. Shamshiri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9643",title:"Agrometeorology",subtitle:null,isOpenForSubmission:!1,hash:"492510d45d202e73a8a7d6eb6cc60be8",slug:"agrometeorology",bookSignature:"Ram Swaroop Meena",coverURL:"https://cdn.intechopen.com/books/images_new/9643.jpg",editedByType:"Edited by",editors:[{id:"315343",title:"Dr.",name:"Ram Swaroop",middleName:null,surname:"Meena",slug:"ram-swaroop-meena",fullName:"Ram Swaroop Meena"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9685",title:"Agroecosystems",subtitle:"Very Complex Environmental Systems",isOpenForSubmission:!1,hash:"c44f7b43a9f9610c243dc32300d37df6",slug:"agroecosystems-very-complex-environmental-systems",bookSignature:"Marcelo L. Larramendy and Sonia Soloneski",coverURL:"https://cdn.intechopen.com/books/images_new/9685.jpg",editedByType:"Edited by",editors:[{id:"14764",title:"Dr.",name:"Marcelo L.",middleName:null,surname:"Larramendy",slug:"marcelo-l.-larramendy",fullName:"Marcelo L. Larramendy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9669",title:"Recent Advances in Rice Research",subtitle:null,isOpenForSubmission:!1,hash:"12b06cc73e89af1e104399321cc16a75",slug:"recent-advances-in-rice-research",bookSignature:"Mahmood-ur- Rahman Ansari",coverURL:"https://cdn.intechopen.com/books/images_new/9669.jpg",editedByType:"Edited by",editors:[{id:"185476",title:"Dr.",name:"Mahmood-ur-Rahman",middleName:null,surname:"Ansari",slug:"mahmood-ur-rahman-ansari",fullName:"Mahmood-ur-Rahman Ansari"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9711",title:"Pests, Weeds and Diseases in Agricultural Crop and Animal Husbandry Production",subtitle:null,isOpenForSubmission:!1,hash:"12cf675f1e433135dd5bf5df7cec124f",slug:"pests-weeds-and-diseases-in-agricultural-crop-and-animal-husbandry-production",bookSignature:"Dimitrios Kontogiannatos, Anna Kourti and Kassio Ferreira Mendes",coverURL:"https://cdn.intechopen.com/books/images_new/9711.jpg",editedByType:"Edited by",editors:[{id:"196691",title:"Dr.",name:"Dimitrios",middleName:null,surname:"Kontogiannatos",slug:"dimitrios-kontogiannatos",fullName:"Dimitrios Kontogiannatos"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10134",title:"Organic Agriculture",subtitle:null,isOpenForSubmission:!1,hash:"a9866f9df52191cc505b27fb2abdc687",slug:"organic-agriculture",bookSignature:"Shaon Kumar Das",coverURL:"https://cdn.intechopen.com/books/images_new/10134.jpg",editedByType:"Edited by",editors:[{id:"182210",title:"Dr.",name:"Shaon Kumar",middleName:null,surname:"Das",slug:"shaon-kumar-das",fullName:"Shaon Kumar Das"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9712",title:"Genetic Transformation in Crops",subtitle:null,isOpenForSubmission:!1,hash:"c111fe32d4d7e3988e4ef2fd6775a265",slug:"genetic-transformation-in-crops",bookSignature:"Kin-Ying To",coverURL:"https://cdn.intechopen.com/books/images_new/9712.jpg",editedByType:"Edited by",editors:[{id:"310646",title:"Dr.",name:"Kin-Ying",middleName:null,surname:"To",slug:"kin-ying-to",fullName:"Kin-Ying To"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:55,seriesByTopicCollection:[],seriesByTopicTotal:0,mostCitedChapters:[{id:"40178",doi:"10.5772/52583",title:"Molecular Markers and Marker-Assisted Breeding in Plants",slug:"molecular-markers-and-marker-assisted-breeding-in-plants",totalDownloads:23146,totalCrossrefCites:85,totalDimensionsCites:153,abstract:null,book:{id:"3060",slug:"plant-breeding-from-laboratories-to-fields",title:"Plant Breeding from Laboratories to Fields",fullTitle:"Plant Breeding from Laboratories to Fields"},signatures:"Guo-Liang Jiang",authors:[{id:"158810",title:"Dr.",name:"Guo-Liang",middleName:null,surname:"Jiang",slug:"guo-liang-jiang",fullName:"Guo-Liang Jiang"}]},{id:"33765",doi:"10.5772/37578",title:"Nutrient Solutions for Hydroponic Systems",slug:"nutrient-solutions-for-hydroponic-systems",totalDownloads:71763,totalCrossrefCites:11,totalDimensionsCites:68,abstract:null,book:{id:"1781",slug:"hydroponics-a-standard-methodology-for-plant-biological-researches",title:"Hydroponics",fullTitle:"Hydroponics - A Standard Methodology for Plant Biological Researches"},signatures:"Libia I. Trejo-Téllez and Fernando C. Gómez-Merino",authors:[{id:"113365",title:"Dr.",name:"Libia I.",middleName:null,surname:"Trejo-Téllez",slug:"libia-i.-trejo-tellez",fullName:"Libia I. Trejo-Téllez"},{id:"113414",title:"Dr.",name:"Fernando C.",middleName:null,surname:"Gómez-Merino",slug:"fernando-c.-gomez-merino",fullName:"Fernando C. Gómez-Merino"}]},{id:"45745",doi:"10.5772/56824",title:"Current Advances on Genetic Resistance to Rice Blast Disease",slug:"current-advances-on-genetic-resistance-to-rice-blast-disease",totalDownloads:4543,totalCrossrefCites:27,totalDimensionsCites:60,abstract:null,book:{id:"3554",slug:"rice-germplasm-genetics-and-improvement",title:"Rice",fullTitle:"Rice - Germplasm, Genetics and Improvement"},signatures:"Xueyan Wang, Seonghee Lee, Jichun Wang, Jianbing Ma, Tracy\nBianco and Yulin Jia",authors:[{id:"168971",title:"Dr.",name:"Yulin",middleName:null,surname:"Jia",slug:"yulin-jia",fullName:"Yulin Jia"}]},{id:"68945",doi:"10.5772/intechopen.88434",title:"Effect of Abiotic Stress on Crops",slug:"effect-of-abiotic-stress-on-crops",totalDownloads:1549,totalCrossrefCites:31,totalDimensionsCites:52,abstract:"Crop yield is mainly influenced by climatic factors, agronomic factors, pests and nutrient availability in the soil. Stress is any adverse environmental condition that hampers proper growth of plant. Abiotic stress creates adverse effect on multiple procedures of morphology, biochemistry and physiology that are directly connected with growth and yield of plant. Abiotic stress are quantitative trait hence genes linked to these traits can be identified and used to select desirable alleles responsible for tolerance in plant. Plants can initiate a number of molecular, cellular and physiological modifications to react to and adapt to abiotic stress. Crop productivity is significantly affected by drought, salinity and cold. Abiotic stress reduce water availability to plant roots by increasing water soluble salts in soil and plants suffer from increased osmotic pressure outside the root. Physiological changes include lowering of leaf osmotic potential, water potential and relative water content, creation of nutritional imbalance, enhancing relative stress injury or one or more combination of these factors. Morphological and biochemical changes include changes in root and shoot length, number of leaves, secondary metabolite (glycine betaine, proline, MDA, abscisic acid) accumulation in plant, source and sink ratio. Proposed chapter will concentrate on enhancing plant response to abiotic stress and contemporary breeding application to increasing stress tolerance.",book:{id:"9345",slug:"sustainable-crop-production",title:"Sustainable Crop Production",fullTitle:"Sustainable Crop Production"},signatures:"Summy Yadav, Payal Modi, Akanksha Dave, Akdasbanu Vijapura, Disha Patel and Mohini Patel",authors:[{id:"186963",title:"Dr.",name:"Summy",middleName:null,surname:"Yadav",slug:"summy-yadav",fullName:"Summy Yadav"},{id:"308004",title:"Ms.",name:"Payal",middleName:null,surname:"Modi",slug:"payal-modi",fullName:"Payal Modi"},{id:"308005",title:"Ms.",name:"Akanksha",middleName:null,surname:"Dave",slug:"akanksha-dave",fullName:"Akanksha Dave"},{id:"308006",title:"Ms.",name:"Akdasbanu",middleName:null,surname:"Vijapara",slug:"akdasbanu-vijapara",fullName:"Akdasbanu Vijapara"},{id:"308007",title:"Ms.",name:"Disha",middleName:null,surname:"Patel",slug:"disha-patel",fullName:"Disha Patel"},{id:"308008",title:"Ms.",name:"Mohini",middleName:null,surname:"Patel",slug:"mohini-patel",fullName:"Mohini Patel"}]},{id:"45540",doi:"10.5772/56621",title:"Genes and QTLs for Rice Grain Quality Improvement",slug:"genes-and-qtls-for-rice-grain-quality-improvement",totalDownloads:3772,totalCrossrefCites:21,totalDimensionsCites:49,abstract:null,book:{id:"3554",slug:"rice-germplasm-genetics-and-improvement",title:"Rice",fullTitle:"Rice - Germplasm, Genetics and Improvement"},signatures:"Jinsong Bao",authors:[{id:"52135",title:"Dr.",name:"Jinsong",middleName:null,surname:"Bao",slug:"jinsong-bao",fullName:"Jinsong Bao"}]}],mostDownloadedChaptersLast30Days:[{id:"70658",title:"Factors Affecting Yield of Crops",slug:"factors-affecting-yield-of-crops",totalDownloads:4179,totalCrossrefCites:31,totalDimensionsCites:46,abstract:"A good understanding of dynamics involved in food production is critical for the improvement of food security. It has been demonstrated that an increase in crop yields significantly reduces poverty. Yield, the mass of harvest crop product in a specific area, is influenced by several factors. These factors are grouped in three basic categories known as technological (agricultural practices, managerial decision, etc.), biological (diseases, insects, pests, weeds) and environmental (climatic condition, soil fertility, topography, water quality, etc.). These factors account for yield differences from one region to another worldwide. The current chapter will discuss each of these three basic factors as well as providing some recommendations for overcoming them. In addition, it will provide the importance of climate-smart agriculture in the increase of crop yields while facilitating the achievement of crop production in safe environment. This goes in line with the second goal of 2030 Agenda for Sustainable Development of United Nations in transforming our world formulated as end hunger, achieve food security, improve nutrition and promote sustainable agriculture.",book:{id:"8153",slug:"agronomy-climate-change-food-security",title:"Agronomy",fullTitle:"Agronomy - Climate Change & Food Security"},signatures:"Tandzi Ngoune Liliane and Mutengwa Shelton Charles",authors:[{id:"313819",title:"Dr.",name:"Liliane",middleName:null,surname:"Tandzi",slug:"liliane-tandzi",fullName:"Liliane Tandzi"},{id:"314316",title:"Prof.",name:"Charles Shelton",middleName:null,surname:"Mutengwa",slug:"charles-shelton-mutengwa",fullName:"Charles Shelton Mutengwa"}]},{id:"40178",title:"Molecular Markers and Marker-Assisted Breeding in Plants",slug:"molecular-markers-and-marker-assisted-breeding-in-plants",totalDownloads:23145,totalCrossrefCites:85,totalDimensionsCites:153,abstract:null,book:{id:"3060",slug:"plant-breeding-from-laboratories-to-fields",title:"Plant Breeding from Laboratories to Fields",fullTitle:"Plant Breeding from Laboratories to Fields"},signatures:"Guo-Liang Jiang",authors:[{id:"158810",title:"Dr.",name:"Guo-Liang",middleName:null,surname:"Jiang",slug:"guo-liang-jiang",fullName:"Guo-Liang Jiang"}]},{id:"60074",title:"Pollen Germination in vitro",slug:"pollen-germination-in-vitro",totalDownloads:2819,totalCrossrefCites:1,totalDimensionsCites:1,abstract:"Pollen germination in vitro is a reliable method to test the pollen viability. It also addresses many basic questions in sexual reproduction and particularly useful in wide hybridization. Many pollen germination medium ranging from simple sugars to complex one having vitamins, growth regulators, etc. in addition to various minerals have been standardized to germinate pollen artificially. The different media, successful pollen germination methods, procedures from pollen germination studies with wheat, rye, brinjal, pigeonpea and its wild relatives are discussed.",book:{id:"6659",slug:"pollination-in-plants",title:"Pollination in Plants",fullTitle:"Pollination in Plants"},signatures:"Jayaprakash P",authors:[{id:"235465",title:"Dr.",name:"Jayaprakash",middleName:null,surname:"P",slug:"jayaprakash-p",fullName:"Jayaprakash P"}]},{id:"62376",title:"Genotype × Environment Interaction: A Prerequisite for Tomato Variety Development",slug:"genotype-environment-interaction-a-prerequisite-for-tomato-variety-development",totalDownloads:2347,totalCrossrefCites:2,totalDimensionsCites:7,abstract:"Tomato (Solanum lycopersicum L.) is the second most important vegetable crop in the world due to its high level of nutrition particularly in vitamins and antioxidants. It is grown in several ecologies of the world due to its adaptability and ease of cultivation. Besides field conditions, tomatoes are grown in controlled environments which range from hydroponics and simple high tunnel structures to highly automated screen houses in advanced countries. However, the yield and quality of the fruits are highly influenced by the environment. This results in unpredictable performances in different growing environments in terms of quality, a phenomenon known as genotype by environment (G × E) interaction which confounds selection efficiency. Various approaches are employed by plant breeders to evaluate and address the challenges posed by genotype by environment interaction. This chapter discusses various field and controlled environments for growing tomatoes and the effect of these environments on the performance of the crop. The various types of genotype × environment interactions and their effect of the tomato plant are discussed. Finally, efforts are made to suggest ways and methods of mitigating the confounding effects of genotype × environment interaction including statistical approaches.",book:{id:"6422",slug:"recent-advances-in-tomato-breeding-and-production",title:"Recent Advances in Tomato Breeding and Production",fullTitle:"Recent Advances in Tomato Breeding and Production"},signatures:"Michael Kwabena Osei, Benjamin Annor, Joseph Adjebeng-\nDanquah, Agyemang Danquah, Eric Danquah, Essie Blay and Hans\nAdu-Dapaah",authors:[{id:"204223",title:"Dr.",name:"Agyemang",middleName:null,surname:"Danquah",slug:"agyemang-danquah",fullName:"Agyemang Danquah"},{id:"217531",title:"M.Sc.",name:"Michael Kwabena",middleName:null,surname:"Osei",slug:"michael-kwabena-osei",fullName:"Michael Kwabena Osei"},{id:"217760",title:"Dr.",name:"Joseph",middleName:null,surname:"Adjebeng-Danquah",slug:"joseph-adjebeng-danquah",fullName:"Joseph Adjebeng-Danquah"},{id:"217768",title:"MSc.",name:"Benjamin",middleName:null,surname:"Annor",slug:"benjamin-annor",fullName:"Benjamin Annor"},{id:"247378",title:"Dr.",name:"Eric Y.",middleName:null,surname:"Danquah",slug:"eric-y.-danquah",fullName:"Eric Y. Danquah"},{id:"248095",title:"Prof.",name:"Essie",middleName:null,surname:"Blay",slug:"essie-blay",fullName:"Essie Blay"},{id:"248096",title:"Prof.",name:"Hans",middleName:null,surname:"Adu-Dapaah",slug:"hans-adu-dapaah",fullName:"Hans Adu-Dapaah"}]},{id:"45153",title:"Irrigation of Sandy Soils, Basics and Scheduling",slug:"irrigation-of-sandy-soils-basics-and-scheduling",totalDownloads:5648,totalCrossrefCites:5,totalDimensionsCites:11,abstract:null,book:{id:"3357",slug:"crop-production",title:"Crop Production",fullTitle:"Crop Production"},signatures:"Mohamed S. Alhammadi and Ali M. Al-Shrouf",authors:[{id:"78245",title:"Dr.",name:"Mohamed",middleName:"Salman",surname:"Alhammadi",slug:"mohamed-alhammadi",fullName:"Mohamed Alhammadi"},{id:"159904",title:"Mr.",name:"Ali",middleName:null,surname:"Al-Shrouf",slug:"ali-al-shrouf",fullName:"Ali Al-Shrouf"}]}],onlineFirstChaptersFilter:{topicId:"29",limit:6,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},subscriptionForm:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[],offset:8,limit:8,total:0},allSeries:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:11,numberOfPublishedChapters:91,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:109,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:33,numberOfPublishedChapters:333,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:14,numberOfPublishedChapters:145,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:11,numberOfPublishedChapters:144,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:126,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:113,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:23,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:13,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:"2753-6580",doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],testimonialsList:[{id:"13",text:"The collaboration with and support of the technical staff of IntechOpen is fantastic. The whole process of submitting an article and editing of the submitted article goes extremely smooth and fast, the number of reads and downloads of chapters is high, and the contributions are also frequently cited.",author:{id:"55578",name:"Antonio",surname:"Jurado-Navas",institutionString:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",slug:"antonio-jurado-navas",institution:{id:"720",name:"University of Malaga",country:{id:null,name:"Spain"}}}},{id:"6",text:"It is great to work with the IntechOpen to produce a worthwhile collection of research that also becomes a great educational resource and guide for future research endeavors.",author:{id:"259298",name:"Edward",surname:"Narayan",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",slug:"edward-narayan",institution:{id:"3",name:"University of Queensland",country:{id:null,name:"Australia"}}}}]},series:{item:{id:"7",title:"Biomedical Engineering",doi:"10.5772/intechopen.71985",issn:"2631-5343",scope:"Biomedical Engineering is one of the fastest-growing interdisciplinary branches of science and industry. The combination of electronics and computer science with biology and medicine has improved patient diagnosis, reduced rehabilitation time, and helped to facilitate a better quality of life. Nowadays, all medical imaging devices, medical instruments, or new laboratory techniques result from the cooperation of specialists in various fields. The series of Biomedical Engineering books covers such areas of knowledge as chemistry, physics, electronics, medicine, and biology. This series is intended for doctors, engineers, and scientists involved in biomedical engineering or those wanting to start working in this field.",coverUrl:"https://cdn.intechopen.com/series/covers/7.jpg",latestPublicationDate:"August 20th, 2022",hasOnlineFirst:!0,numberOfPublishedBooks:12,editor:{id:"50150",title:"Prof.",name:"Robert",middleName:null,surname:"Koprowski",slug:"robert-koprowski",fullName:"Robert Koprowski",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYTYNQA4/Profile_Picture_1630478535317",biography:"Robert Koprowski, MD (1997), PhD (2003), Habilitation (2015), is an employee of the University of Silesia, Poland, Institute of Computer Science, Department of Biomedical Computer Systems. For 20 years, he has studied the analysis and processing of biomedical images, emphasizing the full automation of measurement for a large inter-individual variability of patients. Dr. Koprowski has authored more than a hundred research papers with dozens in impact factor (IF) journals and has authored or co-authored six books. Additionally, he is the author of several national and international patents in the field of biomedical devices and imaging. Since 2011, he has been a reviewer of grants and projects (including EU projects) in biomedical engineering.",institutionString:null,institution:{name:"University of Silesia",institutionURL:null,country:{name:"Poland"}}},editorTwo:null,editorThree:null},subseries:{paginationCount:3,paginationItems:[{id:"7",title:"Bioinformatics and Medical Informatics",coverUrl:"https://cdn.intechopen.com/series_topics/covers/7.jpg",isOpenForSubmission:!0,editor:{id:"351533",title:"Dr.",name:"Slawomir",middleName:null,surname:"Wilczynski",slug:"slawomir-wilczynski",fullName:"Slawomir Wilczynski",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000035U1loQAC/Profile_Picture_1630074514792",biography:"Professor Sławomir Wilczyński, Head of the Chair of Department of Basic Biomedical Sciences, Faculty of Pharmaceutical Sciences, Medical University of Silesia in Katowice, Poland. His research interests are focused on modern imaging methods used in medicine and pharmacy, including in particular hyperspectral imaging, dynamic thermovision analysis, high-resolution ultrasound, as well as other techniques such as EPR, NMR and hemispheric directional reflectance. Author of over 100 scientific works, patents and industrial designs. Expert of the Polish National Center for Research and Development, Member of the Investment Committee in the Bridge Alfa NCBiR program, expert of the Polish Ministry of Funds and Regional Policy, Polish Medical Research Agency. Editor-in-chief of the journal in the field of aesthetic medicine and dermatology - Aesthetica.",institutionString:null,institution:{name:"Medical University of Silesia",institutionURL:null,country:{name:"Poland"}}},editorTwo:null,editorThree:null},{id:"8",title:"Bioinspired Technology and Biomechanics",coverUrl:"https://cdn.intechopen.com/series_topics/covers/8.jpg",isOpenForSubmission:!0,editor:{id:"144937",title:"Prof.",name:"Adriano",middleName:"De Oliveira",surname:"Andrade",slug:"adriano-andrade",fullName:"Adriano Andrade",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRC8QQAW/Profile_Picture_1625219101815",biography:"Dr. Adriano de Oliveira Andrade graduated in Electrical Engineering at the Federal University of Goiás (Brazil) in 1997. He received his MSc and PhD in Biomedical Engineering respectively from the Federal University of Uberlândia (UFU, Brazil) in 2000 and from the University of Reading (UK) in 2005. He completed a one-year Post-Doctoral Fellowship awarded by the DFAIT (Foreign Affairs and International Trade Canada) at the Institute of Biomedical Engineering of the University of New Brunswick (Canada) in 2010. Currently, he is Professor in the Faculty of Electrical Engineering (UFU). He has authored and co-authored more than 200 peer-reviewed publications in Biomedical Engineering. He has been a researcher of The National Council for Scientific and Technological Development (CNPq-Brazil) since 2009. He has served as an ad-hoc consultant for CNPq, CAPES (Coordination for the Improvement of Higher Education Personnel), FINEP (Brazilian Innovation Agency), and other funding bodies on several occasions. He was the Secretary of the Brazilian Society of Biomedical Engineering (SBEB) from 2015 to 2016, President of SBEB (2017-2018) and Vice-President of SBEB (2019-2020). He was the head of the undergraduate program in Biomedical Engineering of the Federal University of Uberlândia (2015 - June/2019) and the head of the Centre for Innovation and Technology Assessment in Health (NIATS/UFU) since 2010. He is the head of the Postgraduate Program in Biomedical Engineering (UFU, July/2019 - to date). He was the secretary of the Parkinson's Disease Association of Uberlândia (2018-2019). Dr. Andrade's primary area of research is focused towards getting information from the neuromuscular system to understand its strategies of organization, adaptation and controlling in the context of motor neuron diseases. His research interests include Biomedical Signal Processing and Modelling, Assistive Technology, Rehabilitation Engineering, Neuroengineering and Parkinson's Disease.",institutionString:null,institution:{name:"Federal University of Uberlândia",institutionURL:null,country:{name:"Brazil"}}},editorTwo:null,editorThree:null},{id:"9",title:"Biotechnology - Biosensors, Biomaterials and Tissue Engineering",coverUrl:"https://cdn.intechopen.com/series_topics/covers/9.jpg",isOpenForSubmission:!0,editor:{id:"126286",title:"Dr.",name:"Luis",middleName:"Jesús",surname:"Villarreal-Gómez",slug:"luis-villarreal-gomez",fullName:"Luis Villarreal-Gómez",profilePictureURL:"https://mts.intechopen.com/storage/users/126286/images/system/126286.jpg",biography:"Dr. Luis Villarreal is a research professor from the Facultad de Ciencias de la Ingeniería y Tecnología, Universidad Autónoma de Baja California, Tijuana, Baja California, México. Dr. Villarreal is the editor in chief and founder of the Revista de Ciencias Tecnológicas (RECIT) (https://recit.uabc.mx/) and is a member of several editorial and reviewer boards for numerous international journals. He has published more than thirty international papers and reviewed more than ninety-two manuscripts. His research interests include biomaterials, nanomaterials, bioengineering, biosensors, drug delivery systems, and tissue engineering.",institutionString:null,institution:{name:"Autonomous University of Baja California",institutionURL:null,country:{name:"Mexico"}}},editorTwo:null,editorThree:null}]},overviewPageOFChapters:{paginationCount:28,paginationItems:[{id:"83185",title:"Perspective Chapter: Design and Characterization of Natural and Synthetic Soft Polymeric Materials with Biomimetic 3D Microarchitecture for Tissue Engineering and Medical Applications",doi:"10.5772/intechopen.106471",signatures:"Ching-Cheng Huang and Masashi Shiotsuki",slug:"perspective-chapter-design-and-characterization-of-natural-and-synthetic-soft-polymeric-materials-wi",totalDownloads:0,totalCrossrefCites:null,totalDimensionsCites:null,authors:null,book:{title:"Biomimetics - Bridging the Gap",coverURL:"https://cdn.intechopen.com/books/images_new/11453.jpg",subseries:{id:"8",title:"Bioinspired Technology and Biomechanics"}}},{id:"83092",title:"Novel Composites for Bone Tissue Engineering",doi:"10.5772/intechopen.106255",signatures:"Pugalanthipandian Sankaralingam, Poornimadevi Sakthivel and Vijayakumar Chinnaswamy Thangavel",slug:"novel-composites-for-bone-tissue-engineering",totalDownloads:7,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Biomimetics - Bridging the Gap",coverURL:"https://cdn.intechopen.com/books/images_new/11453.jpg",subseries:{id:"8",title:"Bioinspired Technology and Biomechanics"}}},{id:"82800",title:"Repurposing Drugs as Potential Therapeutics for the SARS-Cov-2 Viral Infection: Automatizing a Blind Molecular Docking High-throughput Pipeline",doi:"10.5772/intechopen.105792",signatures:"Aldo Herrera-Rodulfo, Mariana Andrade-Medina and Mauricio Carrillo-Tripp",slug:"repurposing-drugs-as-potential-therapeutics-for-the-sars-cov-2-viral-infection-automatizing-a-blind-",totalDownloads:10,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Molecular Docking - Recent Advances",coverURL:"https://cdn.intechopen.com/books/images_new/11451.jpg",subseries:{id:"7",title:"Bioinformatics and Medical Informatics"}}},{id:"82582",title:"Protecting Bioelectric Signals from Electromagnetic Interference in a Wireless World",doi:"10.5772/intechopen.105951",signatures:"David Marcarian",slug:"protecting-bioelectric-signals-from-electromagnetic-interference-in-a-wireless-world",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Biosignal Processing",coverURL:"https://cdn.intechopen.com/books/images_new/11153.jpg",subseries:{id:"7",title:"Bioinformatics and Medical Informatics"}}}]},overviewPagePublishedBooks:{paginationCount:12,paginationItems:[{type:"book",id:"6692",title:"Medical and Biological Image Analysis",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/6692.jpg",slug:"medical-and-biological-image-analysis",publishedDate:"July 4th 2018",editedByType:"Edited by",bookSignature:"Robert Koprowski",hash:"e75f234a0fc1988d9816a94e4c724deb",volumeInSeries:1,fullTitle:"Medical and Biological Image Analysis",editors:[{id:"50150",title:"Prof.",name:"Robert",middleName:null,surname:"Koprowski",slug:"robert-koprowski",fullName:"Robert Koprowski",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYTYNQA4/Profile_Picture_1630478535317",biography:"Robert Koprowski, MD (1997), PhD (2003), Habilitation (2015), is an employee of the University of Silesia, Poland, Institute of Computer Science, Department of Biomedical Computer Systems. For 20 years, he has studied the analysis and processing of biomedical images, emphasizing the full automation of measurement for a large inter-individual variability of patients. Dr. Koprowski has authored more than a hundred research papers with dozens in impact factor (IF) journals and has authored or co-authored six books. Additionally, he is the author of several national and international patents in the field of biomedical devices and imaging. Since 2011, he has been a reviewer of grants and projects (including EU projects) in biomedical engineering.",institutionString:null,institution:{name:"University of Silesia",institutionURL:null,country:{name:"Poland"}}}]},{type:"book",id:"7218",title:"OCT",subtitle:"Applications in Ophthalmology",coverURL:"https://cdn.intechopen.com/books/images_new/7218.jpg",slug:"oct-applications-in-ophthalmology",publishedDate:"September 19th 2018",editedByType:"Edited by",bookSignature:"Michele Lanza",hash:"e3a3430cdfd6999caccac933e4613885",volumeInSeries:2,fullTitle:"OCT - Applications in Ophthalmology",editors:[{id:"240088",title:"Prof.",name:"Michele",middleName:null,surname:"Lanza",slug:"michele-lanza",fullName:"Michele Lanza",profilePictureURL:"https://mts.intechopen.com/storage/users/240088/images/system/240088.png",biography:"Michele Lanza is Associate Professor of Ophthalmology at Università della Campania, Luigi Vanvitelli, Napoli, Italy. His fields of interest are anterior segment disease, keratoconus, glaucoma, corneal dystrophies, and cataracts. His research topics include\nintraocular lens power calculation, eye modification induced by refractive surgery, glaucoma progression, and validation of new diagnostic devices in ophthalmology. \nHe has published more than 100 papers in international and Italian scientific journals, more than 60 in journals with impact factors, and chapters in international and Italian books. He has also edited two international books and authored more than 150 communications or posters for the most important international and Italian ophthalmology conferences.",institutionString:'University of Campania "Luigi Vanvitelli"',institution:{name:'University of Campania "Luigi Vanvitelli"',institutionURL:null,country:{name:"Italy"}}}]},{type:"book",id:"7560",title:"Non-Invasive Diagnostic Methods",subtitle:"Image Processing",coverURL:"https://cdn.intechopen.com/books/images_new/7560.jpg",slug:"non-invasive-diagnostic-methods-image-processing",publishedDate:"December 19th 2018",editedByType:"Edited by",bookSignature:"Mariusz Marzec and Robert Koprowski",hash:"d92fd8cf5a90a47f2b8a310837a5600e",volumeInSeries:3,fullTitle:"Non-Invasive Diagnostic Methods - Image Processing",editors:[{id:"253468",title:"Dr.",name:"Mariusz",middleName:null,surname:"Marzec",slug:"mariusz-marzec",fullName:"Mariusz Marzec",profilePictureURL:"https://mts.intechopen.com/storage/users/253468/images/system/253468.png",biography:"An assistant professor at Department of Biomedical Computer Systems, at Institute of Computer Science, Silesian University in Katowice. Scientific interests: computer analysis and processing of images, biomedical images, databases and programming languages. He is an author and co-author of scientific publications covering analysis and processing of biomedical images and development of database systems.",institutionString:"University of Silesia",institution:{name:"University of Silesia",institutionURL:null,country:{name:"Poland"}}}]},{type:"book",id:"6843",title:"Biomechanics",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/6843.jpg",slug:"biomechanics",publishedDate:"January 30th 2019",editedByType:"Edited by",bookSignature:"Hadi Mohammadi",hash:"85132976010be1d7f3dbd88662b785e5",volumeInSeries:4,fullTitle:"Biomechanics",editors:[{id:"212432",title:"Prof.",name:"Hadi",middleName:null,surname:"Mohammadi",slug:"hadi-mohammadi",fullName:"Hadi Mohammadi",profilePictureURL:"https://mts.intechopen.com/storage/users/212432/images/system/212432.jpeg",biography:"Dr. Hadi Mohammadi is a biomedical engineer with hands-on experience in the design and development of many engineering structures and medical devices through various projects that he has been involved in over the past twenty years. Dr. Mohammadi received his BSc. and MSc. degrees in Mechanical Engineering from Sharif University of Technology, Tehran, Iran, and his PhD. degree in Biomedical Engineering (biomaterials) from the University of Western Ontario. He was a postdoctoral trainee for almost four years at University of Calgary and Harvard Medical School. He is an industry innovator having created the technology to produce lifelike synthetic platforms that can be used for the simulation of almost all cardiovascular reconstructive surgeries. He’s been heavily involved in the design and development of cardiovascular devices and technology for the past 10 years. He is currently an Assistant Professor with the University of British Colombia, Canada.",institutionString:"University of British Columbia",institution:{name:"University of British Columbia",institutionURL:null,country:{name:"Canada"}}}]}]},openForSubmissionBooks:{paginationCount:2,paginationItems:[{id:"11673",title:"Stem Cell Research",coverURL:"https://cdn.intechopen.com/books/images_new/11673.jpg",hash:"13092df328080c762dd9157be18ca38c",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"July 13th 2022",isOpenForSubmission:!0,editors:[{id:"203598",title:"Ph.D.",name:"Diana",surname:"Kitala",slug:"diana-kitala",fullName:"Diana Kitala"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"12215",title:"Cell Death and Disease",coverURL:"https://cdn.intechopen.com/books/images_new/12215.jpg",hash:"dfd456a29478fccf4ebd3294137eb1e3",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"July 29th 2022",isOpenForSubmission:!0,editors:[{id:"59529",title:"Dr.",name:"Ke",surname:"Xu",slug:"ke-xu",fullName:"Ke Xu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},onlineFirstChapters:{paginationCount:16,paginationItems:[{id:"82135",title:"Carotenoids in Cassava (Manihot esculenta Crantz)",doi:"10.5772/intechopen.105210",signatures:"Lovina I. Udoh, Josephine U. Agogbua, Eberechi R. Keyagha and Itorobong I. Nkanga",slug:"carotenoids-in-cassava-manihot-esculenta-crantz",totalDownloads:15,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Carotenoids - New Perspectives and Application",coverURL:"https://cdn.intechopen.com/books/images_new/10836.jpg",subseries:{id:"13",title:"Plant Physiology"}}},{id:"82112",title:"Comparative Senescence and Lifespan",doi:"10.5772/intechopen.105137",signatures:"Hassan M. Heshmati",slug:"comparative-senescence-and-lifespan",totalDownloads:17,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Hassan M.",surname:"Heshmati"}],book:{title:"Mechanisms and Management of Senescence",coverURL:"https://cdn.intechopen.com/books/images_new/10935.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81796",title:"Apoptosis-Related Diseases and Peroxisomes",doi:"10.5772/intechopen.105052",signatures:"Meimei Wang, Yakun Liu, Ni Chen, Juan Wang and Ye Zhao",slug:"apoptosis-related-diseases-and-peroxisomes",totalDownloads:11,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"The Metabolic Role of Peroxisome in Health and Disease",coverURL:"https://cdn.intechopen.com/books/images_new/10837.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81723",title:"Peroxisomal Modulation as Therapeutic Alternative for Tackling Multiple Cancers",doi:"10.5772/intechopen.104873",signatures:"Shazia Usmani, Shadma Wahab, Abdul Hafeez, Shabana Khatoon and Syed Misbahul Hasan",slug:"peroxisomal-modulation-as-therapeutic-alternative-for-tackling-multiple-cancers",totalDownloads:18,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"The Metabolic Role of Peroxisome in Health and Disease",coverURL:"https://cdn.intechopen.com/books/images_new/10837.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81638",title:"Aging and Neuropsychiatric Disease: A General Overview of Prevalence and Trends",doi:"10.5772/intechopen.103102",signatures:"Jelena Milić",slug:"aging-and-neuropsychiatric-disease-a-general-overview-of-prevalence-and-trends",totalDownloads:30,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Mechanisms and Management of Senescence",coverURL:"https://cdn.intechopen.com/books/images_new/10935.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81576",title:"Carotenoids in Thermal Adaptation of Plants and Animals",doi:"10.5772/intechopen.104537",signatures:"Ivan M. Petyaev",slug:"carotenoids-in-thermal-adaptation-of-plants-and-animals",totalDownloads:28,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Ivan",surname:"Petyaev"}],book:{title:"Carotenoids - New Perspectives and Application",coverURL:"https://cdn.intechopen.com/books/images_new/10836.jpg",subseries:{id:"13",title:"Plant Physiology"}}},{id:"81358",title:"New Insights on Carotenoid Production by Gordonia alkanivorans Strain 1B",doi:"10.5772/intechopen.103919",signatures:"Tiago P. Silva, Susana M. Paixão, Ana S. Fernandes, José C. Roseiro and Luís Alves",slug:"new-insights-on-carotenoid-production-by-gordonia-alkanivorans-strain-1b",totalDownloads:22,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Carotenoids - New Perspectives and Application",coverURL:"https://cdn.intechopen.com/books/images_new/10836.jpg",subseries:{id:"13",title:"Plant Physiology"}}},{id:"81290",title:"Musculoskeletal Abnormalities Caused by Cystic Fibrosis",doi:"10.5772/intechopen.104591",signatures:"Mark Lambrechts",slug:"musculoskeletal-abnormalities-caused-by-cystic-fibrosis",totalDownloads:30,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Advances in Skeletal Muscle Health and Disease",coverURL:"https://cdn.intechopen.com/books/images_new/11675.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81246",title:"Role of Carotenoids in Cardiovascular Disease",doi:"10.5772/intechopen.102750",signatures:"Arslan Ahmad, Sakhawat Riaz, Muhammad Shahzaib Nadeem, Umber Mubeen and Khadija Maham",slug:"role-of-carotenoids-in-cardiovascular-disease",totalDownloads:44,totalCrossrefCites:1,totalDimensionsCites:1,authors:null,book:{title:"Carotenoids - New Perspectives and Application",coverURL:"https://cdn.intechopen.com/books/images_new/10836.jpg",subseries:{id:"13",title:"Plant Physiology"}}},{id:"81226",title:"Computational Methods for the Study of Peroxisomes in Health and Disease",doi:"10.5772/intechopen.103178",signatures:"Naomi van Wijk and Michal Linial",slug:"computational-methods-for-the-study-of-peroxisomes-in-health-and-disease",totalDownloads:32,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"The Metabolic Role of Peroxisome in Health and Disease",coverURL:"https://cdn.intechopen.com/books/images_new/10837.jpg",subseries:{id:"11",title:"Cell Physiology"}}}]},subseriesFiltersForOFChapters:[{caption:"Plant Physiology",value:13,count:6,group:"subseries"},{caption:"Cell Physiology",value:11,count:10,group:"subseries"}],publishedBooks:{paginationCount:11,paginationItems:[{type:"book",id:"10664",title:"Animal Reproduction",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10664.jpg",slug:"animal-reproduction",publishedDate:"May 25th 2022",editedByType:"Edited by",bookSignature:"Yusuf Bozkurt and Mustafa Numan Bucak",hash:"2d66af42fb17d0a6556bb9ef28e273c7",volumeInSeries:11,fullTitle:"Animal Reproduction",editors:[{id:"90846",title:"Prof.",name:"Yusuf",middleName:null,surname:"Bozkurt",slug:"yusuf-bozkurt",fullName:"Yusuf Bozkurt",profilePictureURL:"https://mts.intechopen.com/storage/users/90846/images/system/90846.jpg",institutionString:"İskenderun Technical University",institution:{name:"İskenderun Technical University",institutionURL:null,country:{name:"Turkey"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10830",title:"Animal Feed Science and Nutrition",subtitle:"Production, Health and Environment",coverURL:"https://cdn.intechopen.com/books/images_new/10830.jpg",slug:"animal-feed-science-and-nutrition-production-health-and-environment",publishedDate:"May 18th 2022",editedByType:"Edited by",bookSignature:"Amlan Kumar Patra",hash:"79944fc8fbbaa329aed6fde388154832",volumeInSeries:10,fullTitle:"Animal Feed Science and Nutrition - Production, Health and Environment",editors:[{id:"310962",title:"Dr.",name:"Amlan",middleName:"Kumar",surname:"Patra",slug:"amlan-patra",fullName:"Amlan Patra",profilePictureURL:"https://mts.intechopen.com/storage/users/310962/images/system/310962.jpg",institutionString:null,institution:{name:"West Bengal University of Animal and Fishery Sciences",institutionURL:null,country:{name:"India"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8737",title:"Rabies Virus at the Beginning of 21st Century",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8737.jpg",slug:"rabies-virus-at-the-beginning-of-21st-century",publishedDate:"May 11th 2022",editedByType:"Edited by",bookSignature:"Sergey Tkachev",hash:"49cce3f548da548c718c865feb343509",volumeInSeries:9,fullTitle:"Rabies Virus at the Beginning of 21st Century",editors:[{id:"61139",title:"Dr.",name:"Sergey",middleName:null,surname:"Tkachev",slug:"sergey-tkachev",fullName:"Sergey Tkachev",profilePictureURL:"https://mts.intechopen.com/storage/users/61139/images/system/61139.png",institutionString:"Russian Academy of Sciences",institution:{name:"Russian Academy of Sciences",institutionURL:null,country:{name:"Russia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10496",title:"Advanced Studies in the 21st Century Animal Nutrition",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10496.jpg",slug:"advanced-studies-in-the-21st-century-animal-nutrition",publishedDate:"December 8th 2021",editedByType:"Edited by",bookSignature:"László Babinszky, Juliana Oliveira and Edson Mauro Santos",hash:"8ffe43a82ac48b309abc3632bbf3efd0",volumeInSeries:8,fullTitle:"Advanced Studies in the 21st Century Animal Nutrition",editors:[{id:"53998",title:"Prof.",name:"László",middleName:null,surname:"Babinszky",slug:"laszlo-babinszky",fullName:"László Babinszky",profilePictureURL:"https://mts.intechopen.com/storage/users/53998/images/system/53998.png",institutionString:"University of Debrecen",institution:{name:"University of Debrecen",institutionURL:null,country:{name:"Hungary"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10497",title:"Canine Genetics, Health and Medicine",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10497.jpg",slug:"canine-genetics-health-and-medicine",publishedDate:"June 2nd 2021",editedByType:"Edited by",bookSignature:"Catrin Rutland",hash:"b91512e31ce34032e560362e6cbccc1c",volumeInSeries:7,fullTitle:"Canine Genetics, Health and Medicine",editors:[{id:"202192",title:"Dr.",name:"Catrin",middleName:null,surname:"Rutland",slug:"catrin-rutland",fullName:"Catrin Rutland",profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",institutionString:null,institution:{name:"University of Nottingham",institutionURL:null,country:{name:"United Kingdom"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8545",title:"Animal Reproduction in Veterinary Medicine",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8545.jpg",slug:"animal-reproduction-in-veterinary-medicine",publishedDate:"January 20th 2021",editedByType:"Edited by",bookSignature:"Faruk Aral, Rita Payan-Carreira and Miguel Quaresma",hash:"13aaddf5fdbbc78387e77a7da2388bf6",volumeInSeries:6,fullTitle:"Animal Reproduction in Veterinary Medicine",editors:[{id:"25600",title:"Prof.",name:"Faruk",middleName:null,surname:"Aral",slug:"faruk-aral",fullName:"Faruk Aral",profilePictureURL:"https://mts.intechopen.com/storage/users/25600/images/system/25600.jpg",institutionString:"Independent Researcher",institution:{name:"Harran University",institutionURL:null,country:{name:"Turkey"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9081",title:"Equine Science",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9081.jpg",slug:"equine-science",publishedDate:"September 23rd 2020",editedByType:"Edited by",bookSignature:"Catrin Rutland and Albert Rizvanov",hash:"ac415ef2f5450fa80fdb9cf6cf32cd2d",volumeInSeries:5,fullTitle:"Equine Science",editors:[{id:"202192",title:"Dr.",name:"Catrin",middleName:null,surname:"Rutland",slug:"catrin-rutland",fullName:"Catrin Rutland",profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",institutionString:null,institution:{name:"University of Nottingham",institutionURL:null,country:{name:"United Kingdom"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8460",title:"Reproductive Biology and Technology in Animals",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8460.jpg",slug:"reproductive-biology-and-technology-in-animals",publishedDate:"April 15th 2020",editedByType:"Edited by",bookSignature:"Juan Carlos Gardón Poggi and Katy Satué Ambrojo",hash:"32ef5fe73998dd723d308225d756fa1e",volumeInSeries:4,fullTitle:"Reproductive Biology and Technology in Animals",editors:[{id:"251314",title:"Dr.",name:"Juan Carlos",middleName:null,surname:"Gardón Poggi",slug:"juan-carlos-gardon-poggi",fullName:"Juan Carlos Gardón Poggi",profilePictureURL:"https://mts.intechopen.com/storage/users/251314/images/system/251314.jpeg",institutionString:null,institution:{name:"Valencia Catholic University Saint Vincent Martyr",institutionURL:null,country:{name:"Spain"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8524",title:"Lactation in Farm Animals",subtitle:"Biology, Physiological Basis, Nutritional Requirements, and Modelization",coverURL:"https://cdn.intechopen.com/books/images_new/8524.jpg",slug:"lactation-in-farm-animals-biology-physiological-basis-nutritional-requirements-and-modelization",publishedDate:"January 22nd 2020",editedByType:"Edited by",bookSignature:"Naceur M'Hamdi",hash:"2aa2a9a0ec13040bbf0455e34625504e",volumeInSeries:3,fullTitle:"Lactation in Farm Animals - Biology, Physiological Basis, Nutritional Requirements, and Modelization",editors:[{id:"73376",title:"Dr.",name:"Naceur",middleName:null,surname:"M'Hamdi",slug:"naceur-m'hamdi",fullName:"Naceur M'Hamdi",profilePictureURL:"https://mts.intechopen.com/storage/users/73376/images/system/73376.jpg",institutionString:null,institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7144",title:"Veterinary Anatomy and Physiology",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7144.jpg",slug:"veterinary-anatomy-and-physiology",publishedDate:"March 13th 2019",editedByType:"Edited by",bookSignature:"Catrin Sian Rutland and Valentina Kubale",hash:"75cdacb570e0e6d15a5f6e69640d87c9",volumeInSeries:2,fullTitle:"Veterinary Anatomy and Physiology",editors:[{id:"202192",title:"Dr.",name:"Catrin",middleName:null,surname:"Rutland",slug:"catrin-rutland",fullName:"Catrin Rutland",profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",institutionString:null,institution:{name:"University of Nottingham",institutionURL:null,country:{name:"United Kingdom"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7233",title:"New Insights into Theriogenology",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7233.jpg",slug:"new-insights-into-theriogenology",publishedDate:"December 5th 2018",editedByType:"Edited by",bookSignature:"Rita Payan-Carreira",hash:"74f4147e3fb214dd050e5edd3aaf53bc",volumeInSeries:1,fullTitle:"New Insights into Theriogenology",editors:[{id:"38652",title:"Prof.",name:"Rita",middleName:null,surname:"Payan-Carreira",slug:"rita-payan-carreira",fullName:"Rita Payan-Carreira",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRiFPQA0/Profile_Picture_1614601496313",institutionString:null,institution:{name:"University of Évora",institutionURL:null,country:{name:"Portugal"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},subseriesFiltersForPublishedBooks:[{group:"subseries",caption:"Animal Nutrition",value:20,count:2},{group:"subseries",caption:"Animal Reproductive Biology and Technology",value:28,count:4},{group:"subseries",caption:"Animal Science",value:19,count:5}],publicationYearFilters:[{group:"publicationYear",caption:"2022",value:2022,count:3},{group:"publicationYear",caption:"2021",value:2021,count:3},{group:"publicationYear",caption:"2020",value:2020,count:3},{group:"publicationYear",caption:"2019",value:2019,count:1},{group:"publicationYear",caption:"2018",value:2018,count:1}],authors:{paginationCount:303,paginationItems:[{id:"280338",title:"Dr.",name:"Yutaka",middleName:null,surname:"Tsutsumi",slug:"yutaka-tsutsumi",fullName:"Yutaka Tsutsumi",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/280338/images/7961_n.jpg",biography:null,institutionString:null,institution:{name:"Fujita Health University",country:{name:"Japan"}}},{id:"116250",title:"Dr.",name:"Nima",middleName:null,surname:"Rezaei",slug:"nima-rezaei",fullName:"Nima Rezaei",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/116250/images/system/116250.jpg",biography:"Professor Nima Rezaei obtained an MD from Tehran University of Medical Sciences, Iran. He also obtained an MSc in Molecular and Genetic Medicine, and a Ph.D. in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also completed a short-term fellowship in Pediatric Clinical Immunology and Bone Marrow Transplantation at Newcastle General Hospital, England. Dr. Rezaei is a Full Professor of Immunology and Vice Dean of International Affairs and Research, at the School of Medicine, Tehran University of Medical Sciences, and the co-founder and head of the Research Center for Immunodeficiencies. He is also the founding president of the Universal Scientific Education and Research Network (USERN). Dr. Rezaei has directed more than 100 research projects and has designed and participated in several international collaborative projects. He is an editor, editorial assistant, or editorial board member of more than forty international journals. He has edited more than 50 international books, presented more than 500 lectures/posters in congresses/meetings, and published more than 1,100 scientific papers in international journals.",institutionString:"Tehran University of Medical Sciences",institution:{name:"Tehran University of Medical Sciences",country:{name:"Iran"}}},{id:"180733",title:"Dr.",name:"Jean",middleName:null,surname:"Engohang-Ndong",slug:"jean-engohang-ndong",fullName:"Jean Engohang-Ndong",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/180733/images/system/180733.png",biography:"Dr. Jean Engohang-Ndong was born and raised in Gabon. After obtaining his Associate Degree of Science at the University of Science and Technology of Masuku, Gabon, he continued his education in France where he obtained his BS, MS, and Ph.D. in Medical Microbiology. He worked as a post-doctoral fellow at the Public Health Research Institute (PHRI), Newark, NJ for four years before accepting a three-year faculty position at Brigham Young University-Hawaii. Dr. Engohang-Ndong is a tenured faculty member with the academic rank of Full Professor at Kent State University, Ohio, where he teaches a wide range of biological science courses and pursues his research in medical and environmental microbiology. Recently, he expanded his research interest to epidemiology and biostatistics of chronic diseases in Gabon.",institutionString:"Kent State University",institution:{name:"Kent State University",country:{name:"United States of America"}}},{id:"188773",title:"Prof.",name:"Emmanuel",middleName:null,surname:"Drouet",slug:"emmanuel-drouet",fullName:"Emmanuel Drouet",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/188773/images/system/188773.png",biography:"Emmanuel Drouet, PharmD, is a Professor of Virology at the Faculty of Pharmacy, the University Grenoble-Alpes, France. As a head scientist at the Institute of Structural Biology in Grenoble, Dr. Drouet’s research investigates persisting viruses in humans (RNA and DNA viruses) and the balance with our host immune system. He focuses on these viruses’ effects on humans (both their impact on pathology and their symbiotic relationships in humans). He has an excellent track record in the herpesvirus field, and his group is engaged in clinical research in the field of Epstein-Barr virus diseases. He is the editor of the online Encyclopedia of Environment and he coordinates the Universal Health Coverage education program for the BioHealth Computing Schools of the European Institute of Science.",institutionString:null,institution:{name:"Grenoble Alpes University",country:{name:"France"}}},{id:"131400",title:"Prof.",name:"Alfonso J.",middleName:null,surname:"Rodriguez-Morales",slug:"alfonso-j.-rodriguez-morales",fullName:"Alfonso J. Rodriguez-Morales",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/131400/images/system/131400.png",biography:"Dr. Rodriguez-Morales is an expert in tropical and emerging diseases, particularly zoonotic and vector-borne diseases (especially arboviral diseases). He is the president of the Travel Medicine Committee of the Pan-American Infectious Diseases Association (API), as well as the president of the Colombian Association of Infectious Diseases (ACIN). He is a member of the Committee on Tropical Medicine, Zoonoses, and Travel Medicine of ACIN. He is a vice-president of the Latin American Society for Travel Medicine (SLAMVI) and a Member of the Council of the International Society for Infectious Diseases (ISID). Since 2014, he has been recognized as a Senior Researcher, at the Ministry of Science of Colombia. He is a professor at the Faculty of Medicine of the Fundacion Universitaria Autonoma de las Americas, in Pereira, Risaralda, Colombia. He is an External Professor, Master in Research on Tropical Medicine and International Health, Universitat de Barcelona, Spain. He is also a professor at the Master in Clinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima, Peru. In 2021 he has been awarded the “Raul Isturiz Award” Medal of the API. Also, in 2021, he was awarded with the “Jose Felix Patiño” Asclepius Staff Medal of the Colombian Medical College, due to his scientific contributions to COVID-19 during the pandemic. He is currently the Editor in Chief of the journal Travel Medicine and Infectious Diseases. His Scopus H index is 47 (Google Scholar H index, 68).",institutionString:"Institución Universitaria Visión de las Américas, Colombia",institution:null},{id:"332819",title:"Dr.",name:"Chukwudi Michael",middleName:"Michael",surname:"Egbuche",slug:"chukwudi-michael-egbuche",fullName:"Chukwudi Michael Egbuche",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/332819/images/14624_n.jpg",biography:"I an Dr. Chukwudi Michael Egbuche. I am a Senior Lecturer in the Department of Parasitology and Entomology, Nnamdi Azikiwe University, Awka.",institutionString:null,institution:{name:"Nnamdi Azikiwe University",country:{name:"Nigeria"}}},{id:"284232",title:"Mr.",name:"Nikunj",middleName:"U",surname:"Tandel",slug:"nikunj-tandel",fullName:"Nikunj Tandel",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/284232/images/8275_n.jpg",biography:'Mr. Nikunj Tandel has completed his Master\'s degree in Biotechnology from VIT University, India in the year of 2012. He is having 8 years of research experience especially in the field of malaria epidemiology, immunology, and nanoparticle-based drug delivery system against the infectious diseases, autoimmune disorders and cancer. He has worked for the NIH funded-International Center of Excellence in Malaria Research project "Center for the study of complex malaria in India (CSCMi)" in collaboration with New York University. The preliminary objectives of the study are to understand and develop the evidence-based tools and interventions for the control and prevention of malaria in different sites of the INDIA. Alongside, with the help of next-generation genomics study, the team has studied the antimalarial drug resistance in India. Further, he has extended his research in the development of Humanized mice for the study of liver-stage malaria and identification of molecular marker(s) for the Artemisinin resistance. At present, his research focuses on understanding the role of B cells in the activation of CD8+ T cells in malaria. Received the CSIR-SRF (Senior Research Fellow) award-2018, FIMSA (Federation of Immunological Societies of Asia-Oceania) Travel Bursary award to attend the IUIS-IIS-FIMSA Immunology course-2019',institutionString:"Nirma University",institution:{name:"Nirma University",country:{name:"India"}}},{id:"334383",title:"Ph.D.",name:"Simone",middleName:"Ulrich",surname:"Ulrich Picoli",slug:"simone-ulrich-picoli",fullName:"Simone Ulrich Picoli",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/334383/images/15919_n.jpg",biography:"Graduated in Pharmacy from Universidade Luterana do Brasil (1999), Master in Agricultural and Environmental Microbiology from Federal University of Rio Grande do Sul (2002), Specialization in Clinical Microbiology from Universidade de São Paulo, USP (2007) and PhD in Sciences in Gastroenterology and Hepatology (2012). She is currently an Adjunct Professor at Feevale University in Medicine and Biomedicine courses and a permanent professor of the Academic Master\\'s Degree in Virology. She has experience in the field of Microbiology, with an emphasis on Bacteriology, working mainly on the following topics: bacteriophages, bacterial resistance, clinical microbiology and food microbiology.",institutionString:null,institution:{name:"Universidade Feevale",country:{name:"Brazil"}}},{id:"229220",title:"Dr.",name:"Amjad",middleName:"Islam",surname:"Aqib",slug:"amjad-aqib",fullName:"Amjad Aqib",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/229220/images/system/229220.png",biography:"Dr. Amjad Islam Aqib obtained a DVM and MSc (Hons) from University of Agriculture Faisalabad (UAF), Pakistan, and a PhD from the University of Veterinary and Animal Sciences Lahore, Pakistan. Dr. Aqib joined the Department of Clinical Medicine and Surgery at UAF for one year as an assistant professor where he developed a research laboratory designated for pathogenic bacteria. Since 2018, he has been Assistant Professor/Officer in-charge, Department of Medicine, Manager Research Operations and Development-ORIC, and President One Health Club at Cholistan University of Veterinary and Animal Sciences, Bahawalpur, Pakistan. He has nearly 100 publications to his credit. His research interests include epidemiological patterns and molecular analysis of antimicrobial resistance and modulation and vaccine development against animal pathogens of public health concern.",institutionString:"Cholistan University of Veterinary and Animal Sciences",institution:{name:"University of Agriculture Faisalabad",country:{name:"Pakistan"}}},{id:"333753",title:"Dr.",name:"Rais",middleName:null,surname:"Ahmed",slug:"rais-ahmed",fullName:"Rais Ahmed",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/333753/images/20168_n.jpg",biography:null,institutionString:null,institution:{name:"University of Agriculture Faisalabad",country:{name:"Pakistan"}}},{id:"62900",title:"Prof.",name:"Fethi",middleName:null,surname:"Derbel",slug:"fethi-derbel",fullName:"Fethi Derbel",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62900/images/system/62900.jpeg",biography:"Professor Fethi Derbel was born in 1960 in Tunisia. He received his medical degree from the Sousse Faculty of Medicine at Sousse, University of Sousse, Tunisia. He completed his surgical residency in General Surgery at the University Hospital Farhat Hached of Sousse and was a member of the Unit of Liver Transplantation in the University of Rennes, France. He then worked in the Department of Surgery at the Sahloul University Hospital in Sousse. Professor Derbel is presently working at the Clinique les Oliviers, Sousse, Tunisia. His hospital activities are mostly concerned with laparoscopic, colorectal, pancreatic, hepatobiliary, and gastric surgery. He is also very interested in hernia surgery and performs ventral hernia repairs and inguinal hernia repairs. He has been a member of the GREPA and Tunisian Hernia Society (THS). During his residency, he managed patients suffering from diabetic foot, and he was very interested in this pathology. For this reason, he decided to coordinate a book project dealing with the diabetic foot. Professor Derbel has published many articles in journals and collaborates intensively with IntechOpen Access Publisher as an editor.",institutionString:"Clinique les Oliviers",institution:null},{id:"300144",title:"Dr.",name:"Meriem",middleName:null,surname:"Braiki",slug:"meriem-braiki",fullName:"Meriem Braiki",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/300144/images/system/300144.jpg",biography:"Dr. Meriem Braiki is a specialist in pediatric surgeon from Tunisia. She was born in 1985. She received her medical degree from the University of Medicine at Sousse, Tunisia. She achieved her surgical residency training periods in Pediatric Surgery departments at University Hospitals in Monastir, Tunis and France.\r\nShe is currently working at the Pediatric surgery department, Sidi Bouzid Hospital, Tunisia. Her hospital activities are mostly concerned with laparoscopic, parietal, urological and digestive surgery. She has published several articles in diffrent journals.",institutionString:"Sidi Bouzid Regional Hospital",institution:null},{id:"229481",title:"Dr.",name:"Erika M.",middleName:"Martins",surname:"de Carvalho",slug:"erika-m.-de-carvalho",fullName:"Erika M. de Carvalho",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/229481/images/6397_n.jpg",biography:null,institutionString:null,institution:{name:"Oswaldo Cruz Foundation",country:{name:"Brazil"}}},{id:"186537",title:"Prof.",name:"Tonay",middleName:null,surname:"Inceboz",slug:"tonay-inceboz",fullName:"Tonay Inceboz",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/186537/images/system/186537.jfif",biography:"I was graduated from Ege University of Medical Faculty (Turkey) in 1988 and completed his Med. PhD degree in Medical Parasitology at the same university. I became an Associate Professor in 2008 and Professor in 2014. I am currently working as a Professor at the Department of Medical Parasitology at Dokuz Eylul University, Izmir, Turkey.\n\nI have given many lectures, presentations in different academic meetings. I have more than 60 articles in peer-reviewed journals, 18 book chapters, 1 book editorship.\n\nMy research interests are Echinococcus granulosus, Echinococcus multilocularis (diagnosis, life cycle, in vitro and in vivo cultivation), and Trichomonas vaginalis (diagnosis, PCR, and in vitro cultivation).",institutionString:"Dokuz Eylül University",institution:{name:"Dokuz Eylül University",country:{name:"Turkey"}}},{id:"71812",title:"Prof.",name:"Hanem Fathy",middleName:"Fathy",surname:"Khater",slug:"hanem-fathy-khater",fullName:"Hanem Fathy Khater",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/71812/images/1167_n.jpg",biography:"Prof. Khater is a Professor of Parasitology at Benha University, Egypt. She studied for her doctoral degree, at the Department of Entomology, College of Agriculture, Food and Natural Resources, University of Missouri, Columbia, USA. She has completed her Ph.D. degrees in Parasitology in Egypt, from where she got the award for “the best scientific Ph.D. dissertation”. She worked at the School of Biological Sciences, Bristol, England, the UK in controlling insects of medical and veterinary importance as a grant from Newton Mosharafa, the British Council. Her research is focused on searching of pesticides against mosquitoes, house flies, lice, green bottle fly, camel nasal botfly, soft and hard ticks, mites, and the diamondback moth as well as control of several parasites using safe and natural materials to avoid drug resistances and environmental contamination.",institutionString:null,institution:{name:"Banha University",country:{name:"Egypt"}}},{id:"99780",title:"Prof.",name:"Omolade",middleName:"Olayinka",surname:"Okwa",slug:"omolade-okwa",fullName:"Omolade Okwa",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/99780/images/system/99780.jpg",biography:"Omolade Olayinka Okwa is presently a Professor of Parasitology at Lagos State University, Nigeria. She has a PhD in Parasitology (1997), an MSc in Cellular Parasitology (1992), and a BSc (Hons) Zoology (1990) all from the University of Ibadan, Nigeria. She teaches parasitology at the undergraduate and postgraduate levels. She was a recipient of a Commonwealth fellowship supported by British Council tenable at the Centre for Entomology and Parasitology (CAEP), Keele University, United Kingdom between 2004 and 2005. She was awarded an Honorary Visiting Research Fellow at the same university from 2005 to 2007. \nShe has been an external examiner to the Department of Veterinary Microbiology and Parasitology, University of Ibadan, MSc programme between 2010 and 2012. She is a member of the Nigerian Society of Experimental Biology (NISEB), Parasitology and Public Health Society of Nigeria (PPSN), Science Association of Nigeria (SAN), Zoological Society of Nigeria (ZSN), and is Vice Chairperson of the Organisation of Women in Science (OWSG), LASU chapter. She served as Head of Department of Zoology and Environmental Biology, Lagos State University from 2007 to 2010 and 2014 to 2016. She is a reviewer for several local and international journals such as Unilag Journal of Science, Libyan Journal of Medicine, Journal of Medicine and Medical Sciences, and Annual Research and Review in Science. \nShe has authored 45 scientific research publications in local and international journals, 8 scientific reviews, 4 books, and 3 book chapters, which includes the books “Malaria Parasites” and “Malaria” which are IntechOpen access publications.",institutionString:"Lagos State University",institution:{name:"Lagos State University",country:{name:"Nigeria"}}},{id:"273100",title:"Dr.",name:"Vijay",middleName:null,surname:"Gayam",slug:"vijay-gayam",fullName:"Vijay Gayam",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/273100/images/system/273100.jpeg",biography:"Dr. Vijay Bhaskar Reddy Gayam is currently practicing as an internist at Interfaith Medical Center in Brooklyn, New York, USA. He is also a Clinical Assistant Professor at the SUNY Downstate University Hospital and Adjunct Professor of Medicine at the American University of Antigua. He is a holder of an M.B.B.S. degree bestowed to him by Osmania Medical College and received his M.D. at Interfaith Medical Center. His career goals thus far have heavily focused on direct patient care, medical education, and clinical research. He currently serves in two leadership capacities; Assistant Program Director of Medicine at Interfaith Medical Center and as a Councilor for the American\r\nFederation for Medical Research. As a true academician and researcher, he has more than 50 papers indexed in international peer-reviewed journals. He has also presented numerous papers in multiple national and international scientific conferences. His areas of research interest include general internal medicine, gastroenterology and hepatology. He serves as an editor, editorial board member and reviewer for multiple international journals. His research on Hepatitis C has been very successful and has led to multiple research awards, including the 'Equity in Prevention and Treatment Award” from the New York Department of Health Viral Hepatitis Symposium (2018) and the 'Presidential Poster Award” awarded to him by the American College of Gastroenterology (2018). He was also awarded 'Outstanding Clinician in General Medicine” by Venus International Foundation for his extensive research expertise and services, perform over and above the standard expected in the advancement of healthcare, patient safety and quality of care.",institutionString:"Interfaith Medical Center",institution:{name:"Interfaith Medical Center",country:{name:"United States of America"}}},{id:"93517",title:"Dr.",name:"Clement",middleName:"Adebajo",surname:"Meseko",slug:"clement-meseko",fullName:"Clement Meseko",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/93517/images/system/93517.jpg",biography:"Dr. Clement Meseko obtained DVM and PhD degree in Veterinary Medicine and Virology respectively. He has worked for over 20 years in both private and public sectors including the academia, contributing to knowledge and control of infectious disease. Through the application of epidemiological skill, classical and molecular virological skills, he investigates viruses of economic and public health importance for the mitigation of the negative impact on people, animal and the environment in the context of Onehealth. \r\nDr. Meseko’s field experience on animal and zoonotic diseases and pathogen dynamics at the human-animal interface over the years shaped his carrier in research and scientific inquiries. He has been part of the investigation of Highly Pathogenic Avian Influenza incursions in sub Saharan Africa and monitors swine Influenza (Pandemic influenza Virus) agro-ecology and potential for interspecies transmission. He has authored and reviewed a number of journal articles and book chapters.",institutionString:"National Veterinary Research Institute",institution:{name:"National Veterinary Research Institute",country:{name:"Nigeria"}}},{id:"158026",title:"Prof.",name:"Shailendra K.",middleName:null,surname:"Saxena",slug:"shailendra-k.-saxena",fullName:"Shailendra K. Saxena",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRET3QAO/Profile_Picture_2022-05-10T10:10:26.jpeg",biography:"Professor Dr. Shailendra K. Saxena is a vice dean and professor at King George's Medical University, Lucknow, India. His research interests involve understanding the molecular mechanisms of host defense during human viral infections and developing new predictive, preventive, and therapeutic strategies for them using Japanese encephalitis virus (JEV), HIV, and emerging viruses as a model via stem cell and cell culture technologies. His research work has been published in various high-impact factor journals (Science, PNAS, Nature Medicine) with a high number of citations. He has received many awards and honors in India and abroad including various Young Scientist Awards, BBSRC India Partnering Award, and Dr. JC Bose National Award of Department of Biotechnology, Min. of Science and Technology, Govt. of India. Dr. Saxena is a fellow of various international societies/academies including the Royal College of Pathologists, United Kingdom; Royal Society of Medicine, London; Royal Society of Biology, United Kingdom; Royal Society of Chemistry, London; and Academy of Translational Medicine Professionals, Austria. He was named a Global Leader in Science by The Scientist. He is also an international opinion leader/expert in vaccination for Japanese encephalitis by IPIC (UK).",institutionString:"King George's Medical University",institution:{name:"King George's Medical University",country:{name:"India"}}},{id:"94928",title:"Dr.",name:"Takuo",middleName:null,surname:"Mizukami",slug:"takuo-mizukami",fullName:"Takuo Mizukami",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/94928/images/6402_n.jpg",biography:null,institutionString:null,institution:{name:"National Institute of Infectious Diseases",country:{name:"Japan"}}},{id:"233433",title:"Dr.",name:"Yulia",middleName:null,surname:"Desheva",slug:"yulia-desheva",fullName:"Yulia Desheva",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/233433/images/system/233433.png",biography:"Dr. Yulia Desheva is a leading researcher at the Institute of Experimental Medicine, St. Petersburg, Russia. She is a professor in the Stomatology Faculty, St. Petersburg State University. She has expertise in the development and evaluation of a wide range of live mucosal vaccines against influenza and bacterial complications. Her research interests include immunity against influenza and COVID-19 and the development of immunization schemes for high-risk individuals.",institutionString:'Federal State Budgetary Scientific Institution "Institute of Experimental Medicine"',institution:null},{id:"238958",title:"Mr.",name:"Atamjit",middleName:null,surname:"Singh",slug:"atamjit-singh",fullName:"Atamjit Singh",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/238958/images/6575_n.jpg",biography:null,institutionString:null,institution:null},{id:"252058",title:"M.Sc.",name:"Juan",middleName:null,surname:"Sulca",slug:"juan-sulca",fullName:"Juan Sulca",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/252058/images/12834_n.jpg",biography:null,institutionString:null,institution:null},{id:"191392",title:"Dr.",name:"Marimuthu",middleName:null,surname:"Govindarajan",slug:"marimuthu-govindarajan",fullName:"Marimuthu Govindarajan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/191392/images/5828_n.jpg",biography:"Dr. M. Govindarajan completed his BSc degree in Zoology at Government Arts College (Autonomous), Kumbakonam, and MSc, MPhil, and PhD degrees at Annamalai University, Annamalai Nagar, Tamil Nadu, India. He is serving as an assistant professor at the Department of Zoology, Annamalai University. His research interests include isolation, identification, and characterization of biologically active molecules from plants and microbes. He has identified more than 20 pure compounds with high mosquitocidal activity and also conducted high-quality research on photochemistry and nanosynthesis. He has published more than 150 studies in journals with impact factor and 2 books in Lambert Academic Publishing, Germany. He serves as an editorial board member in various national and international scientific journals.",institutionString:null,institution:null},{id:"274660",title:"Dr.",name:"Damodar",middleName:null,surname:"Paudel",slug:"damodar-paudel",fullName:"Damodar Paudel",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/274660/images/8176_n.jpg",biography:"I am DrDamodar Paudel,currently working as consultant Physician in Nepal police Hospital.",institutionString:null,institution:null},{id:"241562",title:"Dr.",name:"Melvin",middleName:null,surname:"Sanicas",slug:"melvin-sanicas",fullName:"Melvin Sanicas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/241562/images/6699_n.jpg",biography:null,institutionString:null,institution:null},{id:"117248",title:"Dr.",name:"Andrew",middleName:null,surname:"Macnab",slug:"andrew-macnab",fullName:"Andrew Macnab",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of British Columbia",country:{name:"Canada"}}},{id:"322007",title:"Dr.",name:"Maria Elizbeth",middleName:null,surname:"Alvarez-Sánchez",slug:"maria-elizbeth-alvarez-sanchez",fullName:"Maria Elizbeth Alvarez-Sánchez",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidad Autónoma de la Ciudad de México",country:{name:"Mexico"}}},{id:"337443",title:"Dr.",name:"Juan",middleName:null,surname:"A. Gonzalez-Sanchez",slug:"juan-a.-gonzalez-sanchez",fullName:"Juan A. Gonzalez-Sanchez",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Puerto Rico System",country:{name:"United States of America"}}},{id:"337446",title:"Dr.",name:"Maria",middleName:null,surname:"Zavala-Colon",slug:"maria-zavala-colon",fullName:"Maria Zavala-Colon",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Puerto Rico, Medical Sciences Campus",country:{name:"United States of America"}}}]}},subseries:{item:{id:"1",type:"subseries",title:"Oral Health",keywords:"Oral Health, Dental Care, Diagnosis, Diagnostic Imaging, Early Diagnosis, Oral Cancer, Conservative Treatment, Epidemiology, Comprehensive Dental Care, Complementary Therapies, Holistic Health",scope:"
\r\n\tThis topic aims to provide a comprehensive overview of the latest trends in Oral Health based on recent scientific evidence. Subjects will include an overview of oral diseases and infections, systemic diseases affecting the oral cavity, prevention, diagnosis, treatment, epidemiology, as well as current clinical recommendations for the management of oral, dental, and periodontal diseases.
",coverUrl:"https://cdn.intechopen.com/series_topics/covers/1.jpg",hasOnlineFirst:!0,hasPublishedBooks:!0,annualVolume:11397,editor:{id:"173955",title:"Prof.",name:"Sandra",middleName:null,surname:"Marinho",slug:"sandra-marinho",fullName:"Sandra Marinho",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRGYMQA4/Profile_Picture_2022-06-01T13:22:41.png",biography:"Dr. Sandra A. Marinho is an Associate Professor and Brazilian researcher at the State University of Paraíba (Universidade Estadual da Paraíba- UEPB), Campus VIII, located in Araruna, state of Paraíba since 2011. She holds a degree in Dentistry from the Federal University of Alfenas (UNIFAL), while her specialization and professional improvement in Stomatology took place at Hospital Heliopolis (São Paulo, SP). Her qualifications are: a specialist in Dental Imaging and Radiology, Master in Dentistry (Periodontics) from the University of São Paulo (FORP-USP, Ribeirão Preto, SP), and Doctor (Ph.D.) in Dentistry (Stomatology Clinic) from Hospital São Lucas of the Pontifical Catholic University of Rio Grande do Sul (HSL-PUCRS, Porto Alegre, RS). She held a postdoctoral internship at the Federal University from Jequitinhonha and Mucuri Valleys (UFVJM, Diamantina, MG). She is currently a member of the Brazilian Society for Dental Research (SBPqO) and the Brazilian Society of Stomatology and Pathology (SOBEP). Dr. Marinho's experience in Dentistry mainly covers the following subjects: oral diagnosis, oral radiology; oral medicine; lesions and oral infections; oral pathology, laser therapy and epidemiological studies.",institutionString:null,institution:{name:"State University of Paraíba",institutionURL:null,country:{name:"Brazil"}}},editorTwo:null,editorThree:null,series:{id:"3",title:"Dentistry",doi:"10.5772/intechopen.71199",issn:"2631-6218"},editorialBoard:[{id:"267724",title:"Prof.",name:"Febronia",middleName:null,surname:"Kahabuka",slug:"febronia-kahabuka",fullName:"Febronia Kahabuka",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRZpJQAW/Profile_Picture_2022-06-27T12:00:42.JPG",institutionString:"Muhimbili University of Health and Allied Sciences, Tanzania",institution:{name:"Muhimbili University of Health and Allied Sciences",institutionURL:null,country:{name:"Tanzania"}}},{id:"70530",title:"Dr.",name:"Márcio",middleName:"Campos",surname:"Oliveira",slug:"marcio-oliveira",fullName:"Márcio Oliveira",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRm0AQAS/Profile_Picture_2022-08-01T12:34:46.jpg",institutionString:null,institution:{name:"State University of Feira de Santana",institutionURL:null,country:{name:"Brazil"}}}]},onlineFirstChapters:{paginationCount:8,paginationItems:[{id:"83117",title:"Endothelial Secretome",doi:"10.5772/intechopen.106550",signatures:"Luiza Rusu",slug:"endothelial-secretome",totalDownloads:0,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Luiza",surname:"Rusu"}],book:{title:"Periodontology - New Insights",coverURL:"https://cdn.intechopen.com/books/images_new/11566.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"83087",title:"Role of Cellular Responses in Periodontal Tissue Destruction",doi:"10.5772/intechopen.106645",signatures:"Nam Cong-Nhat Huynh",slug:"role-of-cellular-responses-in-periodontal-tissue-destruction",totalDownloads:8,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Periodontology - New Insights",coverURL:"https://cdn.intechopen.com/books/images_new/11566.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"82654",title:"Atraumatic Restorative Treatment: More than a Minimally Invasive Approach?",doi:"10.5772/intechopen.105623",signatures:"Manal A. Ablal",slug:"atraumatic-restorative-treatment-more-than-a-minimally-invasive-approach",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Caries - The Selection of Restoration Methods and Restorative Materials",coverURL:"https://cdn.intechopen.com/books/images_new/11565.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"82735",title:"The Influence of Salivary pH on the Prevalence of Dental Caries",doi:"10.5772/intechopen.106154",signatures:"Laura-Cristina Rusu, Alexandra Roi, Ciprian-Ioan Roi, Codruta Victoria Tigmeanu and Lavinia Cosmina Ardelean",slug:"the-influence-of-salivary-ph-on-the-prevalence-of-dental-caries",totalDownloads:13,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Caries - The Selection of Restoration Methods and Restorative Materials",coverURL:"https://cdn.intechopen.com/books/images_new/11565.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"82357",title:"Caries Management Aided by Fluorescence-Based Devices",doi:"10.5772/intechopen.105567",signatures:"Atena Galuscan, Daniela Jumanca and Aurora Doris Fratila",slug:"caries-management-aided-by-fluorescence-based-devices",totalDownloads:6,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Caries - The Selection of Restoration Methods and Restorative Materials",coverURL:"https://cdn.intechopen.com/books/images_new/11565.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"81894",title:"Diet and Nutrition and Their Relationship with Early Childhood Dental Caries",doi:"10.5772/intechopen.105123",signatures:"Luanna Gonçalves Ferreira, Giuliana de Campos Chaves Lamarque and Francisco Wanderley Garcia Paula-Silva",slug:"diet-and-nutrition-and-their-relationship-with-early-childhood-dental-caries",totalDownloads:20,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Caries - The Selection of Restoration Methods and Restorative Materials",coverURL:"https://cdn.intechopen.com/books/images_new/11565.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"78064",title:"The Salivary Secretome",doi:"10.5772/intechopen.98278",signatures:"Luís Perpétuo, Rita Ferreira, Sofia Guedes, Francisco Amado and Rui Vitorino",slug:"the-salivary-secretome",totalDownloads:108,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Periodontology - New Insights",coverURL:"https://cdn.intechopen.com/books/images_new/11566.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"65334",title:"Introductory Chapter: Some Important Aspects of Root Canal Treatment",doi:"10.5772/intechopen.83653",signatures:"Ana Luiza de Carvalho Felippini",slug:"introductory-chapter-some-important-aspects-of-root-canal-treatment",totalDownloads:852,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Ana Luiza",surname:"De Carvalho Felippini"}],book:{title:"Root Canal",coverURL:"https://cdn.intechopen.com/books/images_new/7133.jpg",subseries:{id:"1",title:"Oral Health"}}}]},publishedBooks:{paginationCount:4,paginationItems:[{type:"book",id:"10794",title:"Potassium in Human Health",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10794.jpg",slug:"potassium-in-human-health",publishedDate:"July 20th 2022",editedByType:"Edited by",bookSignature:"Jie Tang",hash:"0fbab5c7b5baa903a6426e7bbd9f99ab",volumeInSeries:12,fullTitle:"Potassium in Human Health",editors:[{id:"181267",title:"Dr.",name:"Jie",middleName:null,surname:"Tang",slug:"jie-tang",fullName:"Jie Tang",profilePictureURL:"https://mts.intechopen.com/storage/users/181267/images/system/181267.png",institutionString:"Brown University",institution:{name:"Brown University",institutionURL:null,country:{name:"United States of America"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10835",title:"Autonomic Nervous System",subtitle:"Special Interest Topics",coverURL:"https://cdn.intechopen.com/books/images_new/10835.jpg",slug:"autonomic-nervous-system-special-interest-topics",publishedDate:"July 20th 2022",editedByType:"Edited by",bookSignature:"Theodoros Aslanidis and Christos Nouris",hash:"48ac242dc6c5073b2590a509c44628e2",volumeInSeries:14,fullTitle:"Autonomic Nervous System - Special Interest Topics",editors:[{id:"200252",title:"Dr.",name:"Theodoros",middleName:null,surname:"Aslanidis",slug:"theodoros-aslanidis",fullName:"Theodoros Aslanidis",profilePictureURL:"https://mts.intechopen.com/storage/users/200252/images/system/200252.png",institutionString:"Saint Paul General Hospital of Thessaloniki",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8430",title:"Neurodevelopment and Neurodevelopmental Disorder",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8430.jpg",slug:"neurodevelopment-and-neurodevelopmental-disorder",publishedDate:"November 27th 2019",editedByType:"Edited by",bookSignature:"Michael Fitzgerald",hash:"696c96d038de473216e48b199613c111",volumeInSeries:6,fullTitle:"Neurodevelopment and Neurodevelopmental Disorder",editors:[{id:"205005",title:"Dr.",name:"Michael",middleName:null,surname:"Fitzgerald",slug:"michael-fitzgerald",fullName:"Michael Fitzgerald",profilePictureURL:"https://mts.intechopen.com/storage/users/205005/images/system/205005.jpg",institutionString:"Independant Researcher",institution:{name:"Trinity College Dublin",institutionURL:null,country:{name:"Ireland"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8797",title:"Adipose Tissue",subtitle:"An Update",coverURL:"https://cdn.intechopen.com/books/images_new/8797.jpg",slug:"adipose-tissue-an-update",publishedDate:"November 6th 2019",editedByType:"Edited by",bookSignature:"Leszek Szablewski",hash:"34880b7b450ef96fa5063c867c028b02",volumeInSeries:4,fullTitle:"Adipose Tissue - An Update",editors:[{id:"49739",title:"Dr.",name:"Leszek",middleName:null,surname:"Szablewski",slug:"leszek-szablewski",fullName:"Leszek Szablewski",profilePictureURL:"https://mts.intechopen.com/storage/users/49739/images/system/49739.jpg",institutionString:"Medical University of Warsaw",institution:{name:"Medical University of Warsaw",institutionURL:null,country:{name:"Poland"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},testimonialsList:[{id:"27",text:"The opportunity to work with a prestigious publisher allows for the possibility to collaborate with more research groups interested in animal nutrition, leading to the development of new feeding strategies and food valuation while being more sustainable with the environment, allowing more readers to learn about the subject.",author:{id:"175967",name:"Manuel",surname:"Gonzalez Ronquillo",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/175967/images/system/175967.png",slug:"manuel-gonzalez-ronquillo",institution:{id:"6221",name:"Universidad Autónoma del Estado de México",country:{id:null,name:"Mexico"}}}},{id:"18",text:"It was great publishing with IntechOpen, the process was straightforward and I had support all along.",author:{id:"71579",name:"Berend",surname:"Olivier",institutionString:"Utrecht University",profilePictureURL:"https://mts.intechopen.com/storage/users/71579/images/system/71579.png",slug:"berend-olivier",institution:{id:"253",name:"Utrecht University",country:{id:null,name:"Netherlands"}}}},{id:"8",text:"I work with IntechOpen for a number of reasons: their professionalism, their mission in support of Open Access publishing, and the quality of their peer-reviewed publications, but also because they believe in equality.",author:{id:"202192",name:"Catrin",surname:"Rutland",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",slug:"catrin-rutland",institution:{id:"134",name:"University of Nottingham",country:{id:null,name:"United Kingdom"}}}}]},submityourwork:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:11,numberOfPublishedChapters:91,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:108,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:33,numberOfPublishedChapters:333,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:14,numberOfPublishedChapters:145,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:11,numberOfPublishedChapters:144,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:126,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:113,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:23,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:13,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:"2753-6580",doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],subseriesList:[{id:"3",title:"Bacterial Infectious Diseases",scope:"